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 Prenatal aneuploidy screening assesses the likelihood that a fetus will have a 
chromosomal anomaly.  If a screen reveals a high probability, the pregnant woman will 
be offered diagnostic testing and the possibility of pregnancy termination if a serious 
anomaly is confirmed.  Evidence indicates that incomplete understanding of prenatal 
aneuploidy screens, unclear risk perception, and the rapid integration of prenatal 
aneuploidy screening early in the first trimester of pregnancy may compromise the 
educational and decisional processes needed for women to make informed choices about 
prenatal aneuploidy screening.  As prenatal aneuploidy screening occurs in a complex 
social, ethical, and political reality, a women’s health literacy likely influences her 
understanding of and decisions made for prenatal aneuploidy screening.   
 Therefore, the purpose of this study was to explore women’s informed decision-
making for prenatal aneuploidy screening by investigating the relationships between 
women’s understanding of prenatal aneuploidy screening, their health literacy, and their 
subsequent satisfaction with decisions made for prenatal aneuploidy screening.  The 
study was guided by Faden and Beauchamp’s (1986) model of informed consent, 
Nutbeam’s (2000) concept of health literacy, and Holmes-Rovner and colleague’s (1996) 
concept of satisfaction with a decision.  The five domains of health literacy examined in 
this study include Feeling understood and supported by health care providers, Appraisal 
of health information, Ability to actively engage with health care providers, Ability to 
 
 
find good health information, and Understand health information enough to know what to 
do (Osborne, Batterham, Elsworth, Hawkins, & Buchbinder, 2013).   
 A convenience sample of 95 adult women living in western North Carolina who 
were ≥ 18 weeks pregnant was recruited to participate in this descriptive, correlational 
study using cross-sectional methodology.  Potential participants were invited to complete 
an online survey which was distributed via electronic mail to recipients of an electronic 
pregnancy and parenting newsletter.  The survey was used to collect data on women’s 
understanding of prenatal aneuploidy screening, their health literacy, and their 
satisfaction with decisions made for prenatal aneuploidy screening.  Data analyses 
included descriptive statistics, bivariate correlational analysis, and multiple linear 
regression. 
 The majority of participants were Caucasian/White non-Hispanic and college-
educated.  Results indicate that 42.1% of participants did not report satisfaction with 
decisions made for prenatal aneuploidy screening.  Higher levels of Ability to actively 
engage with health care providers was significantly associated with increased 
understanding of prenatal aneuploidy screening.  Feeling understood and supported by 
health care providers, Appraisal of health information, Ability to find good health 
information, and Understand health information enough to know what to do were not 
significantly associated with understanding of prenatal aneuploidy screening.  Feeling 
understood and supported by health care providers and Ability to find good health 
information were significantly associated with increased satisfaction with decisions made 
for prenatal aneuploidy screening.  Appraisal of health information, Ability to actively 
 
 
engage with health care providers, Understand health information enough to know what 
to do, and understanding of prenatal aneuploidy screening were not significantly 
associated with satisfaction with decisions made for prenatal aneuploidy screening.  This 
new knowledge has important implications for nursing practice, education, and policy.  
This study’s findings can be used to guide the development of interventions to promote 
women’s informed decision-making for prenatal aneuploidy screening.
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CHAPTER I 
 
INTRODUCTION 
 
 
 Prenatal aneuploidy screening is offered with the goal of providing women with 
the opportunity to make informed choices about their pregnancy.  Prenatal aneuploidy 
screening aims to detect chromosomal aneuploidy, the presence of an extra chromosome 
(Griffiths, Wessler, Carroll, & Doebley, 2015).  Chromosomal aneuploidies that are 
compatible with life, but cause considerable morbidity, affect 0.67% of live births 
(American Congress of Obstetrics and Gynecology [ACOG], 2016a).  The most common 
type of viable human aneuploidy is trisomy 21 or Down syndrome, occurring at a 
frequency of about 0.15% of all live births (Griffiths et al., 2015).  Down syndrome is the 
most common genetic cause of intellectual disability worldwide (Centers for Disease 
Control and Prevention [CDC], 2015).  As detection of fetal aneuploidy previously 
required invasive procedures associated with iatrogenic fetal loss, advanced maternal age 
was formerly the criterion for offering clinical detection of fetal aneuploidy.  However, 
over the past two decades, identification of maternal biochemical markers that denote the 
risk of carrying an affected fetus through non-invasive serum screens has resulted in the 
incorporation of prenatal aneuploidy screening in routine prenatal care for all women 
regardless of age (Latendresse & Deneris, 2015).  The decision to use prenatal 
aneuploidy screening therefore impacts each of the estimated 6,369,000 pregnancies that 
occur in the U.S. annually (Curtin, Abma, Ventura, & Henshaw, 2013).  This decision 
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marks the beginning of a series of profoundly important decisions, including subsequent 
decisions on invasive diagnostic testing and whether to continue or terminate a 
pregnancy.  Women are routinely asked to consent to prenatal aneuploidy screening early 
in pregnancy, despite evidence that many women do not understand the decision they are 
being asked to make or its implications for pregnancy (Farrell, Nutter, & Agatisa, 2011; 
Chiang, Chao, & Yuh, 2006; Van den Berg, Timmermans, Ten Kate, Van Vugt, & Van 
der Wal, 2005).  As a result, there is a crucial need for substantive knowledge to guide 
interventions that can improve women’s understanding of prenatal aneuploidy screening 
and facilitate women’s informed decision-making for prenatal aneuploidy screening. 
Background 
 The increasing availability of medical technology has offered answers to certain 
questions of health and illness that can be perceived as providing patients with increased 
control over their health care.  However, patients often find it difficult to refuse tests or 
treatments that are suggested to them, due to their trust in authoritative knowledge and 
the expertise of their health care providers, as well as the inherent difficulty of making 
decisions for which the perceived risks and benefits are uncertain (Aune & Möller, 2012; 
Chiang et al., 2006; Tymstra, 1991).  Additionally, a culture of risk has been created in 
health care in which patients are evaluated not only by their present health condition, but 
by their potential for future disease (Lupton, 2009).  This is particularly evident in the 
area of prenatal care.  During the 20th century, a change occurred in the perception of 
pregnancy as an uncomplicated, normal event to one that is potentially pathological, 
requiring continued surveillance (Barker, 1998).  Routine medical care throughout the 
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nine months of pregnancy, provided by a physician or midwife, is now standard in 
contemporary Western society.  Beginning at the 8-9th week of pregnancy, the objectives 
of prenatal care are assessment of the maternal response to pregnancy and monitoring of 
fetal growth and development.  Prenatal care includes maternal physical exams as well as 
prenatal screens and tests to detect fetal abnormalities. 
 The American Congress of Obstetrics and Gynecology (ACOG) currently 
recommends that screening for fetal aneuploidy be offered to all women presenting for 
prenatal care before 20 weeks’ gestation (ACOG, 2016b).  By definition, screening is 
considered secondary prevention among healthy persons with the goal of distinguishing 
those individuals who may have a condition from those individuals who likely do not 
(Latendresse & Deneris, 2015).  Since first emerging in the 1990s, modalities of prenatal 
screening for fetal aneuploidy have continually evolved with technological innovations.  
The general types of prenatal aneuploidy screening currently offered include (a) maternal 
serum screening, which measures levels of specific biochemicals in the woman’s blood 
between 12-18 weeks of gestation, (b) nuchal translucency, an ultrasound technique 
wherein the fluid volume at the back of the fetal neck is measured between 10-14 weeks’ 
gestation, and (c) non-invasive prenatal testing (NIPT), which uses fragmented fetal 
DNA circulating in maternal blood, beginning at 10 weeks of gestation (Latendresse & 
Deneris, 2015).    
Prenatal Aneuploidy Screening in Clinical Practice  
 The distinction between a screen and a test.  The purpose of a screen is to 
detect indicators of disease, while the purpose of a test is to establish the presence or 
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absence of a condition (Vogt, 2005).  A measure’s sensitivity is its ability to correctly 
classify an individual as having indicators of a disease, thereby avoiding false positives 
(Vogt, 2005).  A measure’s specificity is its ability to correctly classify an individual as 
not having a disease, thereby avoiding false negatives.  The sensitivity and specificity of 
the measure determines whether it functions in clinical practice as a screen or test.  While 
a screen has higher sensitivity at the expense of specificity in order to not miss potential 
cases of disease, a test has higher specificity than selectivity, with emphasis on precision 
in identifying the absence of disease (Vogt, 2005).   
 The information provided with prenatal aneuploidy screening.  Typically, 
women are given a pamphlet on the screening options for fetal aneuploidy at their first 
prenatal appointment and non-directive counsel from their care providers (K. Patten, 
personal communication, April 20, 2016).  The information presented in the pamphlets is 
largely biomedical and focused on procedural details and facts about the timing of the 
screening options, with omission of information about the potential emotional and moral 
implications associated with positive screens (Bryant et al., 2001; Lawson, Carlson, & 
Shynkaruk, 2012; Michie, Michie, di Lorenzo, Lane, Armstrong, & Sanderson, 2004).  
Lawson et al. (2012) found that in the minimal information given about the conditions 
screened, an unbalanced and negative characterization of Down syndrome is presented 
with emphasis on its epidemiological origin and resultant intellectual disability.   In an 
evaluation of patient educational materials for prenatal aneuploidy screening, Kloza et al. 
(2015) found that these informational pamphlets are typically written at 10-12th grade 
reading level.  The average American reads at an 8th grade reading level (U. S. 
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Department of Education, National Center for Educational Statistics, 2013).  While the 
woman’s health care provider may engage in non-directive counsel with the patient to 
review the screening options, evidence suggests that physicians spend less than five 
minutes discussing prenatal screening in general with their patients (Cavanaugh, 
Matthews, & Crane, 2007; Park & Matthews, 2009).  A commonly reported finding in the 
literature on prenatal aneuploidy screening is that health care providers’ discussions 
about screening are narrowly focused on the technical and procedural differences 
between the screening options rather than why screening is done or the ethical issues 
surrounding screening, such as the potential for subsequent decision-making about 
pregnancy termination (Farrell, Agatisa, & Nutter, 2014; Park & Matthews, 2009; 
Pilnick, 2008; Williams, Sandall, Lewando-Hundt, Heyman, Spencer, & Grellier, 2002). 
 Prenatal aneuploidy screening is based on risk assessment.  After consenting 
to prenatal aneuploidy screening, a sample of maternal blood is drawn. With maternal 
serum screening, biochemical markers circulating in maternal blood are compared against 
median levels normed on women of corresponding gestational and maternal age to 
demarcate if a woman is at high risk of carrying a fetus with a chromosomal aneuploidy 
(Latendresse & Deneris, 2015).  Non-invasive prenatal testing (NIPT) uses fragmented 
fetal DNA circulating in maternal blood to assess risk of fetal aneuploidy.  Although 
NIPT is marketed and labeled as a test, it functions in practice as a screen (ACOG, 2012, 
2016a).  This confusing terminology may obfuscate the available options when women 
are making decisions about prenatal aneuploidy screening.   If positive results occur from 
any type of prenatal aneuploidy screening, indicating that a woman is at high risk of 
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carrying a fetus with a chromosomal aneuploidy, current practice guidelines are to offer 
confirmatory diagnosis through invasive testing (ACOG, 2012, 2016a).  Chorionic villus 
sampling or amniocentesis are the invasive procedures used to obtain a definitive 
diagnosis, which entail an increased risk for fetal injury or demise.  At present, there is no 
treatment for the fetal condition if diagnosis of fetal aneuploidy is confirmed; elective 
termination of the pregnancy or continuation of the pregnancy are the only options 
(Fuchs & Peipert, 2005).  
 Key influences on decisions for prenatal aneuploidy screening.  Women’s 
decisions for prenatal aneuploidy screening are primarily driven by beliefs and attitudes 
about health and disability, pregnancy termination, the value of information, and modern 
medicine’s role in pregnancy (García, Timmermans, & van Leeuwen, 2009; Hawthorne 
& Ahern, 2009; Kuppermann et al., 2006; Van den Berg et al., 2005).  Decisions for 
prenatal aneuploidy screening are also influenced by numerous maternal characteristics 
including age, education, culture, race and ethnicity, and individual reproductive and life 
histories (Etchegary et al., 2008; Kuppermann et al., 2004).  Lower rates of prenatal 
aneuploidy screening among minority women and lower income women in the U.S. have 
been found to be mediated by religious beliefs and fatalism (Kuppermann et al., 2006).  
Higher rates of prenatal aneuploidy screening among women with higher education have 
been found to be mediated by reduced fatalism and increased perceived procedure-related 
risk of fetal demise (Kuppermann et al., 2006).  Women with higher educational 
attainment and economic privilege are more likely to decide to consent to prenatal 
aneuploidy screening (Kupperman et al., 2006).  Additionally, women who are likely to 
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terminate an affected pregnancy are more likely to accept the screen, while women who 
feel that modern medicine interferes too much in pregnancy are more likely to decline 
prenatal aneuploidy screening (Kupperman et al., 2006; Van den Berg et al., 2005).   
 Emergent technology for prenatal aneuploidy screening results in women 
making decisions for prenatal aneuploidy screening very early in pregnancy.  The 
current standard of care for prenatal aneuploidy screening for women in the United States 
involves maternal serum screening of biochemical markers between 12-18 weeks of 
pregnancy, which corresponds to late in the first trimester or early in the second trimester 
of pregnancy (ACOG, 2016b).  This practice had allowed for at least two points of 
contact between an expectant woman and her prenatal care provider prior to making 
decisions for prenatal aneuploidy screening.  However, the techniques used with NIPT 
that emerged commercially in 2011 have rapidly changed the patterns of practice for 
prenatal aneuploidy screening by allowing for assessment of fetal anomaly as early as the 
10th week of pregnancy.  
 As the technology used with cell-free fetal DNA is still evolving, the laboratory 
techniques used with NIPT vary according to the companies that offer this screening test, 
as do the specificity and selectivity for the tests (Norton, Rose, & Benn, 2013).  As a 
result, quality control and validity claims associated with NIPT have been called into 
question (Norton et al., 2013).  Companies that market NIPT highlight their high positive 
predictive ability for aneuploidy and emphasize the ability of NIPT to provide results for 
aneuploidy detection, paternity, and fetal sex as early as the 10th week of pregnancy 
(Allyse et al., 2015).  Citing concerns about the validity of NIPT across the prenatal 
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population, ACOG currently does not recommend NIPT unless a woman is at high risk of 
having a fetus with aneuploidy, such as women over the age of 35 years, women with a 
history of a previous pregnancy affected by fetal aneuploidy, and women with 
ultrasonographic findings indicating risk for fetal aneuploidy (ACOG, 2012, Allyse et al., 
2015).  Nonetheless, physicians are routinely offering NIPT and women are increasingly 
using NIPT (Allyse et al., 2015).  Further, a recent survey indicates that many prenatal 
care professionals believe that NIPT will soon replace conventional maternal serum 
screening for prenatal aneuploidy screening (Haymon, Simi, Moyer, Aufox, & Ouyang, 
2014).  As screening with NIPT occurs as early as 10 weeks of pregnancy, women 
increasingly are making decisions whether or not to use prenatal aneuploidy screening as 
early as their first prenatal care appointment, shortly after many women have first learned 
that they are pregnant (Farrell et al., 2011).  Therefore, women are being faced with this 
decision at the same time that they are adjusting to the new reality of being an expectant 
mother and with little time to learn about the screens and how they may impact the 
pregnancy.  Further, as the screening occurs so early in pregnancy, women have little 
time to consider the ethical import of the screen as it relates to their personal beliefs, 
values, and life circumstances. 
Informed Decision-making in Women’s Health Care 
 When seeking to understand the factors influencing women’s informed decision-
making for prenatal aneuploidy screening, one can look to the broader body of research 
on women’s health care decision-making in the clinical setting.  In this section, an 
explanation of the rational model of decision-making in women’s health care is 
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presented, followed by a discussion of women’s informed decision-making across the 
lifespan, with regards to cancer screening, and in the context of pregnancy-related screens 
and tests.  Within these topical areas, the similarities and differences between decision-
making for prenatal aneuploidy and other types of decisions in women’s health care are 
considered.  A delineation of how prenatal aneuploidy is a uniquely complex decision 
within women’s health care concludes this section. 
 The rational model of decision-making in the context of women’s health care.  
Pierce and Hicks (2001) assert that women’s health care decisions can generally be 
examined from the foundation of a rational model of decision-making.  They contend that 
health care decision-making centers on decisional dilemmas, which include not only the 
alternatives of a decision but the possible outcomes and probabilities attached to the 
alternative outcomes.  Pierce and Hicks (2001) claim that decisions have four general 
options which comprise the alternatives from which to choose.  Three options are 1) the 
personal appraisal of each outcome; 2) the probabilities of the outcomes of each 
alternative, which can be derived from objective or subjective data; and 3) the 
consequence or outcome, which may present one option as more attractive than another.  
The fourth option is described as a decisional hazard in clinical practice, which occurs 
when one alternative is presented as more attractive than another, thereby deterring 
adequate appraisal of other alternatives.  Pierce and Hicks (2001) delineate objectives to 
guide research on patient decision-making in clinical practice.  The objectives include (a) 
helping patients become more efficient, given their limited physical and cognitive 
resources; (b) mitigating the psychological stress of making the decision; (c) helping 
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patients avoid decision hazards; and (d) supporting patients to make decisions that 
accurately reflect their beliefs, values, and preferences.  
 Themes of women’s informed health care decision-making across the 
lifespan.  Brown, Carroll, Boon, and Marmoreo (2002) reviewed three separate 
qualitative studies about women’s decision-making about healthcare issues to note 
common themes.  The women’s health issues spanned the life cycle and encompassed 
prenatal genetic screening, hormone replacement therapy, and use of 
complementary/alternative medicine in treatment for breast cancer.  Emergent themes 
included information seeking about the health issue and information sources, with the use 
of both trusted health care providers and friends and family members as reliable sources 
of information.  The third prevalent theme identified was information sharing within the 
context of the professional relationship.  Brown et al. (2002) write that women who did 
not perceive an open informational sharing process with their health care providers were 
left “waiting, wondering, and unnecessarily anxious” (p.228).  The fourth theme was 
accepting the consequences in terms of their individual beliefs and values.  Brown and 
colleagues summarize their analyses by stating that the evidence overwhelmingly 
indicates that women consistently demonstrate a desire to have an active role in the 
decision-making process when confronted with a serious health care decision that can 
have positive or negative consequences for their individual future health and the well-
being of their family.  Further, Wildschut, Peters, and Weiner (2006) conducted an 
integrative review of the essential elements of screening across three domains in 
women’s health where early detection can improve the quality and duration of life: 
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screening for Down syndrome and other chromosomal anomalies, osteoporosis, and 
breast cancer.  Their findings indicate that it is imperative for women to receive clear and 
comprehensive information about the screening, including details of the screening 
options, the physical, economic, and psychological costs associated with the screens, and 
the implications for treatment and diagnosis.  This finding is supported by Price and 
Bently’s (2013) investigation of pharmacological decision-making among pregnant and 
post-partum women and their health care providers.  Price and Bently found that when 
making decisions, women prioritized accurate, unbiased, and complete information and 
authentic information-sharing, problem-solving, and active communication with their 
health care providers.   
 Informed decision-making for cancer screening.  Examinations of informed 
decision-making for cancer screening typically identify knowledge and perceived threat 
as key constructs (Mullen et al., 2006).  Perceived threat is usually understood as as a 
component of the Health Belief Model and the larger category of value expectancy 
models, which assumes a rational model of decision-making (Huston, Bagozzi, & 
Kirking, 2010; Simons-Morton, McLeroy, & Wendel, 2012).  Evidence indicates that 
informed decision-making for cancer screening is highly influenced by perceived threat 
of cancer in terms of the perceived risk and gravity of cancer.   Examinations of informed 
decision-making for mammography screening and cervical cancer screening indicate that 
women with a family history of cancer or high perceived risk of cancer are more likely to 
undergo cancer screening (Hoffman et al., 2010; Pace & Keating, 2014).  However, as 
with the estimates of probability of having a child with a chromosomal abnormality, 
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quantified estimates of probability of having cancer and the risks associated with cancer 
screening are difficult for women to comprehend, leading to uninformed decisions 
(Hoffman et al., 2010).  For example, Fallowfield et al. (2010) found that women tend to 
underestimate the risk of developing ovarian cancer while overestimating the potential 
benefits of ovarian cancer screening.  In contrast, women tend to overestimate their risk 
of breast cancer mortality while also overestimating the potential benefit of screening 
with mammography to reduce that risk (Pace & Keating, 2014).  Pace and Keating (2014) 
present a systematic review of informed decision-making for breast cancer screening with 
mammography that reflects the complexities of informed decision-making for medical 
screening more broadly.  Their review highlights the importance of nuanced 
communication with patients to delineate the potential benefits of mammography while 
also explaining that the benefit of mammography is less than once believed and that the 
potential associated risks are greater than anticipated.  Similar to prenatal aneuploidy 
screening, these potential risks include both a cascade of subsequent decision-making 
related to further medical testing and intervention (with biopsies, mastectomies, and 
radiation) as well as false positives and over-diagnosis (with the detection of non-life-
threatening lesions) (Pace & Keating, 2014).  Additionally, patient education concerning 
decisions for prenatal aneuploidy screening is similar to patient education concerning 
decisions for breast cancer and ovarian cancer screening in that health care providers 
have demonstrated difficulty in articulating the nuance and uncertain risks associated 
with morbidity and screening and they are more likely to discuss the benefits of screening 
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rather than the potential risks, while neglecting to elicit woman’s preferences (Hoffman 
et al., 2010).  
 Informed decision-making for pregnancy-related screens and tests.  Decisions 
for prenatal aneuploidy screening are closely akin to decisions concerning fetal 
ultrasonography, amniocentesis, and chorionic villus sampling.  When a screen, such as 
the 20-week fetal ultrasound or prenatal aneuploidy serum screen, is abnormal, the 
expectant woman discusses the finding with her health care provider and is advised about 
diagnostic testing options, which include amniocentesis and chorionic villus sampling 
(Latendresse & Deneris, 2015).  These invasive diagnostic procedures typically occur 
between the 10th -16th week of pregnancy, with the results in the form of a genetic 
karyotype available approximately four weeks later, in the middle of pregnancy (Allyse 
et al., 2015).  These invasive diagnostic tests carry a small but significant risk of 
iatrogenic fetal demise and infection (Latendresse & Deneris, 2015).  This narrow 
timeline adds to the difficulty of the decision to undertake prenatal diagnostic tests along 
with the anxiety following designation of high risk for fetal abnormality following a 
screen (Green, Hewison, Bekker, Bryant, & Cuckle, 2004; Heyman et al., 2006).  
 Anxiety surrounding prenatal decision-making.  Decisions for diagnostic testing 
have been shown to be emotionally laden and associated with increased maternal stress 
(Green, et al., 2004; Pivetti, Montali, & Simonetti, 2012).  In particular, the decision-
making process is characterized by anxiety concerning fetal health and development, the 
fear of an abnormal result, and the possibility of pregnancy termination (Sarkar, 
Bergman, Fisk, & Glover, 2006).  Moreover, anxiety surrounding the decision-making 
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for invasive prenatal diagnosis is heightened among women with favorable attitudes 
toward termination and lower among women who voice refusal to consider termination 
(Tercyak, Johnson, Roberts, & Cruz, 2001).  This suggests that as the potential need for 
moral discernment and decision-making concerning pregnancy continuation or 
termination becomes imminent, women experience greater anxiety with prenatal 
decision-making.   
 The tentative pregnancy.  Katz Rothman (1986) writes that during the four-week 
interval between the amniocentesis and the results, women experience a “tentative 
pregnancy,” in that while the pregnancy is medically acknowledged, the baby is not yet 
accepted until confirmation of fetal health via amniocentesis.  Further, Katz Rothman 
asserts that the availability of amniocentesis and chorionic villus sampling has changed 
how women experience pregnancy in that women may have a disembodied and 
psychologically disengaged sense of pregnancy with possible delayed attachment to the 
unborn baby until fetal health is affirmed through medical technology.  Hunt, de Voogd, 
and Catadneda’s (2005) qualitative examination of women’s experiences with 
communication in prenatal genetic decision-making suggests that the experience of a 
tentative pregnancy may extend to the experience of prenatal screening for aneuploidy.  
Once a pregnancy is designated “at-risk,” it acquires an ambiguous state, transforming a 
time of hopeful anticipation into a time of fear and doubt (Hunt et al., 2005).   
 Decisions made for prenatal aneuploidy screening are uniquely complex due 
to the moral implications of genetic screening, the relational state of pregnancy, and 
the temporal sensitivity of the decision.  Comparisons of women’s health care decisions 
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broadly with decisions for prenatal screening and testing illuminate the impact of genetic 
knowledge and technological advancement on the complexity of health care decision-
making.  As the array of genetic screening options increases, the nuances and 
implications of the decisions become more obscured.  Katz Rothman (2015) asserts that 
the big questions brought about by genetics often make people uncomfortable.  For 
pregnant women, these questions entail choices about the kind of baby she wants to have 
and the types of disability that she views as acceptable.  Further, these bigger ethical 
questions are typically couched in the smaller questions concerning which screens and 
predictive tests are desired for ourselves and our unborn children (Katz Rothman, 2015).  
 The relational aspect of pregnancy impacts decisions for prenatal aneuploidy 
screening.  The decision for prenatal aneuploidy screening is also different from many 
other health care decisions in that it does not conform to the rational decision-making 
model which views choice as an objective activity that occurs in isolation based on 
individual interests (Sherwin, 2000).  The decision for prenatal aneuploidy screening 
emerges within the relational dimensions between the expectant mother, her partner, her 
unborn baby, and her family members.  The embodied state of pregnancy results in a 
unique relational state physically, emotionally, and psychologically between the 
expectant mother and to her pregnancy/unborn child.  Evidence indicates that the extent 
to which a woman assigns personhood to her fetus impacts her sense of what is lost when 
perinatal loss occurs (Côté-Arsenault & Dombeck, 2001).  Thus, the value of the fetus 
can be viewed as relational to the woman carrying the fetus (Sherwin, 2000).  It follows 
that a woman’s conceptualization of the pregnancy as a fetal person increases the ethical 
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stakes of her decision for prenatal aneuploidy screening.  Further, Brauer (2016) suggests 
that because the fetus is within the pregnant female body, a women’s consent or 
declination of prenatal aneuploidy screening creates the presumption that the expectant 
mother takes responsibility for her unborn baby’s health.  Indeed, evidence suggests that 
the relational state of being pregnant may cause women to construct their decisions to 
accept or decline prenatal aneuploidy screening as expressions of their moral agency and 
sense of responsibility to the pregnancy/fetal person as well as to living family members 
(García, Timmermans, & van Leeuwen, 2012; Williams et al., 2005).   
 The decision for prenatal aneuploidy screening differs from most women’s health 
care decisions in its temporal urgency.  The decision for prenatal aneuploidy screening 
must be made in the early stages of pregnancy, within a few weeks that a woman learns 
she is pregnant.  This temporal urgency is in stark contrast to the other screening 
decisions women make, such as for cervical cancer or mammography.  Further, in order 
for the options of invasive diagnosis and termination to be available, the woman must 
make her decision for prenatal aneuploidy screening by 12-14 weeks of pregnancy 
(Farrell et al., 2011.  Thus, the decision for prenatal aneuploidy screening does not 
conform to the rational model of decision-making because the rational model denies the 
temporal and political context of decision-making (Sherwin, 2000).  Sherwin (2000) 
cautions that by the time a particular decision must be made, treatment options have been 
limited by a layer of political and policy decisions that occur in the institutions of health 
care and government.  The set of options made available to women reflect a series of 
earlier decisions concerning the prioritization of the rights of the fetus and the rights of 
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the pregnant female (Sherwin, 2000).  Hence, the temporal sensitivity of decisions made 
for prenatal aneuploidy screening is shaped by political decisions that establish the 
screening and treatment options made available vis-à-vis commercial access to the 
screens and legal access to termination (elective abortion).  In summary, consideration of 
prenatal aneuploidy screening in the context of women’s health care decision-making 
more broadly illustrates the unique complexity, urgency, and ethical dimensions of 
decision-making for prenatal aneuploidy screening, which underline the importance of 
gaining new knowledge to guide interventions to support women’s informed decision-
making for prenatal aneuploidy screening. 
Rationale for the Study 
 Prenatal aneuploidy screening is offered on the basis of informed decision-
making, yet the current practice of prenatal aneuploidy screening fails to ensure that 
women are making informed decisions.  Prenatal aneuploidy screening has been 
integrated into prenatal care and marketed with the goals of providing women with 
information on the health status of their fetus and the opportunity to make informed 
decisions about their pregnancies.  Empirical evidence suggests that many women have 
inadequate understanding of the purpose and scope of prenatal aneuploidy screening 
(Constantine, Allyse, Wall, Vries, & Rockwood, 2014; Farrell et al., 2011; Jaques, 
Sheffield, & Halliday, 2005; Schoonen, Wildschut, Essink-Bot, Peters, Steegers, & de 
Koning, 2012; Skirton & Barr, 2010; Van den Berg et al., 2005).  Both qualitative and 
quantitative findings indicate that many women lack sufficient knowledge and 
understanding about the purpose and scope of prenatal aneuploidy screens and the 
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conditions they aim to detect (Cho, Plunkett, Wolf, Simon, & Grobman, 2007; Farrell et 
al., 2011; Farrell, Hawkins, Barragan, Hudgins, & Taylor, 2015; Skirton & Barr, 2010).  
Women often are not aware of the possibility of subsequent invasive testing and decision-
making concerning pregnancy management following a positive screen (Farrell et al., 
2011; Griffiths & Kuppermann, 2008; Seror & Ville, 2009; Skirton & Barr, 2010).  In 
addition, women demonstrate inadequate knowledge of what their testing and health care 
options would be in the case of abnormal screen results (Farrell et al., 2011).  The result 
of inadequate understanding of prenatal aneuploidy screening is that many women are 
falsely reassured by a low-risk (negative) result or unprepared to make life-altering 
decisions and manage the anguish that results from a high-risk (positive) result.  
Additionally, the rapid integration of prenatal aneuploidy screening into early prenatal 
care may impoverish the process of informed decision-making.  The routinization of 
screening combined with the earlier window for first trimester screening reduces the time 
and attention given to the educational and decisional processes needed to make an 
informed choice (Farrell et al., 2011).  Accordingly, the routinization of screening can 
have the effect of limiting rather than expanding individual choice because the more 
routine a test becomes, the less scrutiny and consideration of its ethical dimensions it 
receives from prospective parents and providers (Suter, 2002).  That women often 
perceive the offer of the screen as assent to care rather than choice underscores the 
impact of the routinization of screening (Chiang et al., 2006; Jaques et al., 2005; Pilnik, 
2008).  When women do recognize the offer of prenatal aneuploidy screening as a choice, 
many are often left alone to think about the gravity of their decision and its moral 
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implications rather than in meaningful consultation with health care providers (Williams 
et al., 2005).  Women report a need for increased dialogue with health care providers 
concerning the implications of prenatal aneuploidy screening as related to their personal 
needs, preferences, and their perceptions of disability (Ahmed, Bryant, Tizro, & Shickle, 
2014; Farrell et al., 2011; Park & Matthews, 2009). 
 Decisions for prenatal aneuploidy screening profoundly impact the course of 
pregnancy.  As women typically enter pregnancy with feelings of hope, the possibility 
that they may have a baby with an anomaly is quickly discounted (Tercyak et al., 2001).  
Many women do not understand that positive prenatal aneuploidy screening results will 
require subsequent decisions concerning diagnostic testing and termination of pregnancy 
(Farrell et al., 2011).  Additionally, many women are not fully aware of the strengths and 
limitations of the screening options offered or the conditions for which they screen 
(Jaques et al., 2005; Van den Berg et al., 2005; Skirton & Barr, 2010).  False positives 
and negatives occur with each type of prenatal screening.  False positive results for 
maternal serum screening (the Quad screen) occur at a rate of approximately 5% for 
trisomy 21 (Down’s syndrome) (Driscoll & Gross, 2009; Durkovic, Andoelic, Mandic, & 
Lazar, 2011).  For NIPT, the reported rate of false positives for trisomies 21 and 18 
varies, ranging from <1% (Nicolaides, Syngelaki, Ashoor, Birdir, & Touzet, 2012) to 
10.7% (Dar et al., 2014); the false positive rate may exceed the false negative rate for 
rarer trisomies (Reiss & Cherry, 2013).  While the impact of false positive results is deep 
and produces sustained maternal anxiety and guilt, the sense of loss and mental anguish 
associated with a false negative result is overwhelming, destabilizing, and life-altering 
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(Chiang, Chao, & Yuh, 2007; Heyman et al., 2006; Sandelowski & Barros, 2005).  
Moreover, when women fail to understand that the screen is not diagnostic, they risk 
making the grave decision to terminate the pregnancy without adequate understanding of 
how to interpret the results of the screen (Mennuti, Cherry, Morissette, & Dugoff, 2013). 
 New knowledge on informed decision-making and health literacy is needed to 
guide professional support for women in making informed decisions for prenatal 
aneuploidy screening.  Evaluations of prenatal aneuploidy screening programs are limited 
and typically involve estimations of the uptake or acceptance of prenatal aneuploidy 
screening (Allyse et al., 2015; Dondorp et al., 2015).  This seems to imply that high 
uptake of prenatal aneuploidy screening is the goal of offering prenatal aneuploidy 
screening.  However, according to ACOG, the purported goal in offering women prenatal 
aneuploidy screening is to enable them to make an autonomous, informed decision about 
whether or not they want to participate in a risk assessment of carrying a fetus with 
aneuploidy (ACOG, 2016a).  Thus, it is essential to examine whether women believe that 
they are making informed decisions that reflect their beliefs and values.  Further, as 
current clinical practice fails to ensure women’s informed choice for prenatal aneuploidy 
screening, there is an urgent need for knowledge generation to elucidate influences on 
women’s understanding of prenatal aneuploidy screening.  Higher health literacy is 
associated with better health knowledge, health behaviors, clinical outcomes, and 
engagement in healthcare decisions among non-pregnant adults (Goggins, Wallston, 
Nwosu, Schildcrout, Castel, & Kripalani, 2014; Kutner, Greenberg, Jin, Paulsen, & 
White, 2006).  While there is minimal research on health literacy among prenatal 
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populations, it is known that women have inadequate understanding of prenatal 
aneuploidy screening.  It is likely that health literacy influences women’s understanding 
of and decisions made for prenatal aneuploidy screening (Lori, Dahlem, Ackah, & 
Adanu, 2014).  Therefore, this study aims to explore women’s informed decision-making 
for prenatal aneuploidy screening by investigating the relationships between women’s 
understanding of prenatal aneuploidy screening, health literacy, and women’s satisfaction 
with decisions made for prenatal aneuploidy screening. 
Conceptual Framework 
Conceptual models serve as the lens for research and offer a network of concepts 
within the phenomenon (Fawcett, 2005). This empirical analysis of women’s informed 
decision-making for prenatal aneuploidy screening is informed by Faden and 
Beauchamp’s model of informed consent, Nutbeam’s concept of health literacy, and 
Holmes-Rovner’s concept of satisfaction with a decision.  These concepts were selected 
to identify women’s needs when making informed decisions for prenatal aneuploidy 
screening and to illuminate potential decisional risks resulting from insufficient 
understanding of prenatal aneuploidy screening and reduced health literacy.  
Faden and Beauchamp’s Model of Informed Consent  
Autonomy is recognized as an individual’s capacity for self-determination.  It 
entails the capacity to decide for oneself and follow a course of action in one’s life (Buss, 
2016).  Autonomy is deeply valued in Western society due to the historical and political 
influences of John Locke’s libertarian views of self-governance and natural rights 
(Zwolinski, n.d.).  In health care, autonomy is protected by the theory and process of 
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informed consent or informed decision-making.  The bioethicists Faden and Beauchamp 
(1986) developed a patient-centered model of informed consent derived from moral 
theory.  Faden and Beauchamp outline three elements of informed consent: substantial 
understanding of the act and its consequences, freedom from control, and intentional 
authorization to proceed with the treatment in question.  Faden and Beauchamp’s model 
of informed consent holds that “Personal autonomy encompasses, at a minimum, self-rule 
that is free from both controlling interferences by others and from certain limitations such 
as an inadequate understanding that prevents meaningful choice” (p.99-100).  According 
to Faden and Beauchamp’s model, an informed decision occurs when one has the 
capacity to freely evaluate one’s options and motives on the basis of his/her beliefs and 
desires and then acts in coherence with those evaluations.   
 Faden and Beauchamp’s (1986) delineation of an informed decision, as occurring 
through (a) substantial understanding, (b) non-control or freedom from controlling 
influences, and (c) intentional authorization, is focused on the needs of the patient, rather 
than the legal requirements of the provider, and is specific enough to guide empirical 
inquiry.  Substantial understanding includes cognitive awareness of the proposed 
treatment, the alternatives, and the possible consequences of that act as well as 
cognizance that one is granting authorization.  Freedom from controlling influence is 
understood as freedom from coercion, persuasion, manipulation, and mental impairment.  
Intentional authorization involves a behavior that is willed in accordance with a plan 
wherein the actor has identified what will be done and how it will be done (Faden & 
Beauchamp, 1986).  
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 Faden and Beauchamp (1986) contend that substantial understanding is generally 
the condition most in jeopardy with informed decision-making.  Faden and Beauchamp 
(1986) claim that this increased jeopardy is due to the relationship between the condition 
of substantial understanding and the conditions of intentional authorization and non-
control.  If a patient truly understands what she is doing, then she will not have a problem 
with acting intentionally.  Additionally, if a patient truly understands that the decision is 
for her to make autonomously, then she will not have a problem with non-control.  
Conversely, if either intentional authorization or non-control is not satisfied, it is also 
likely that substantial understanding has not occurred.  Further, Faden and Beauchamp 
contend that if there are no problems with the condition of non-control, the establishment 
of substantial understanding is generally sufficient to secure informed consent.  Thus, if 
the substantial understanding condition of informed consent has been satisfied for a 
medical treatment, then it is likely that an informed decision has occurred (Faden & 
Beauchamp, 1986).   
 Empirical application of Faden and Beauchamp’s model of informed 
consent.  Faden and Beauchamp’s model of informed consent is widely regarded as the 
foundational model of informed consent in health care.  Faden and Beauchamp’s model 
has served as the framework for numerous empirical inquiries.  It has recently guided 
examination of the need for informed consent in comparative effectiveness research 
studies, the process of obtaining informed consent for whole genome sequencing, and the 
quality of informed consent obtained by doctors and nurses in an acute care setting 
(Bernhardt et al., 2015; Chima, 2013; Hamel, Faden, Beauchamp, & Kass, 2014). 
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 Application of Faden and Beauchamp’s model of informed consent to 
decisions for prenatal aneuploidy screening.  Prenatal aneuploidy screening is offered 
on the principles of self-determination and respect for autonomous decisions in 
reproductive health.  In assessing women’s decision-making for prenatal aneuploidy 
screening, Faden and Beauchamp’s (1986) model of informed consent demonstrates the 
need to investigate the potential limitations on informed decision-making that occur 
through inadequate understanding of prenatal aneuploidy screening.  These limitations 
may be due to insufficient understanding of (a) the screening options, including the 
option of no screening at all; (b) the possibility of subsequent decision-making following 
a positive screen result; and (c) the likelihood of having a positive screen result (Gert, 
2000).   Faden and Beauchamp’s model of informed consent demonstrates the need to 
investigate individual-level factors that may limit women’s understanding of prenatal 
aneuploidy screening.  Therefore, Faden and Beauchamp’s conception of substantial 
understanding will be operationalized and function as a key variable in this study.  
Nutbeam’s Concept of Health Literacy 
First appearing in health-related literature in the 1990s, health literacy was 
originally conceptualized as a set of reading comprehension and numeracy skills required 
to understand health-related information (Mancuso, 2009).  Nutbeam (2000) has 
suggested that a narrow definition of health literacy, limited to description of the 
relationship between patient literacy levels and understanding of health-related 
information, misses the deeper meaning of health literacy.  Nutbeam (2000) contends that 
a broader and more complex understanding of health literacy is needed to understand and 
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identify what it is that health literacy enables people to do.  Health literacy has evolved to 
entail the communication skills, information-seeking behaviors, and problem-solving 
abilities required to function within the health care system (Jordan, Osborne, & 
Buchbinder, 2011).  The United States Health Resources and Services Administration’s 
Agency for Health Care Research and Quality (AHRQ) define health literacy as “the 
degree to which individuals have the capacity to obtain, process, and understand basic 
health information needed to make appropriate health decisions.” (U.S. Department of 
Health and Human Services, 2016).  The National Academies of Science, Engineering, 
and Medicine (2015) describe health literacy as the place where an individual’s skills and 
abilities intersect with the complexities and demands of health systems.  
 In this study, health literacy is used as a composite term to describe a range of 
skills and communication behaviors that promote individual health outcomes and 
facilitate health care decision-making.  Therefore, this study is guided by the World 
Health Organization’s conception of health literacy, which defines health literacy as “the 
cognitive and social skills which determine the motivation and ability of individuals to 
gain access to, understand, and use information in ways which promote and maintain 
good health,” (Nutbeam, 1998, p. 10).  According to Nutbeam (2000; 2015), health 
literacy encompasses the following: (a) functional health literacy, which includes 
sufficient skills in reading, writing, and numeracy, (b) interactive health literacy, which 
includes the cognitive and social skills used to participate in and extract meaning from 
communication and apply it to new situations, and (c) critical health literacy, which 
involves the more advanced cognitive skills that allow individuals to critically apply 
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information to achieve greater control over decisions and life events.  This conception of 
health literacy indicates that health literacy may have serious implications on patient 
autonomy and self-efficacy in that one’s access to health information and the ability to 
use it effectively is critical to empowerment (Nutbeam, 2000; 2015).  Moreover, this 
taxonomy of health literacy suggests that the different categories of health literacy 
progressively promote greater autonomy in health care decision-making. 
Empirical application of Nutbeam’s concept of health literacy.  Numerous 
measures of health literacy have been developed and validated in empirical literature 
(Sorensen et al., 2013).  The majority of these measures are unidimensional and only 
assess one aspect of health literacy, typically health-related reading and numeracy ability 
(Jordan et al., 2011; Sorensen et al., 2013).  Additionally, these traditional measures of 
health literacy were designed to function as short screening tools of functional health 
literacy for clinicians to use in daily practice.  In the last five years, a more sophisticated, 
multidimensional measure of health literacy has been developed that aims to assess 
functional, interactive, and critical health literacy as described by Nutbeam (1998; 2015) 
(Osborne, Batterham, Elsworth, Hawkins, & Buchbinder., 2013).  This measure aims to 
assess an individual’s capacity to gain access to information from a variety of sources, to 
discriminate between sources of information, to understand and personalize health 
information, and to demonstrate self-efficacy to apply salient health information when 
making personal health care decisions (Osborne et al., 2013).  In this study, health 
literacy will be an independent variable measured by five subscales of the Health 
Literacy Questionnaire.  The Health Literacy Questionnaire has been used to apply 
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Nutbeam’s (1998; 2015) conceptual understanding of health literacy in numerous 
empirical inquiries.  The Health Literacy Questionnaire has been used to examine the 
relationship between health literacy and (a) socioeconomic characteristics and 
comorbidity among patients with chronic disease, (b) sociodemographic characteristics 
and use of hospital health services, (c) the needs of women living with breast cancer, and 
(d) educational attainment and health behavior (Friis, Lasgaard, Osborne, & Maindal, 
2016; Friis, Lasgaard, Rowlands, Osborne, & Maindal, 2016; Jessup, Osborne, 
Beauchamp, Bourne, & Buchbinder, 2017; Huang, Lin, Lu, Tam, Chen, Hou, & Hsieh, 
2017).  The Health Literacy Questionnaire was designed using a validity-driven 
approach, which included in-depth grounded consultations, cognitive interviews with a 
diverse patient population, and extensive psychometric analyses, including confirmatory 
factor analyses (Osborne et al., 2013).  
Application of Nutbeam’s concept of health literacy to decisions for prenatal 
aneuploidy screening.  The experience of pregnancy places a woman in the situation 
where she must make difficult decisions with unclear outcomes that will profoundly 
affect her own future, as well as the future of her unborn baby and her family.  Pregnancy 
is a state of transition and liminality for women in that “a woman is no longer who she 
was, and not yet who she will be,” (Côté-Arsenault, Brody, & Dombeck, 2009, p.73).  
Accordingly, pregnancy requires women to make important health decisions while in an 
unfamiliar, evolving context and with uncertain consequences.  The decision to consent 
to or decline prenatal aneuploidy screening is complex, as it requires women to make a 
decision based on risk assessment and evaluation of values in a short amount of time.  
 
 28 
Additionally, pregnancy places a woman in the role of patient in a health care system that 
is traditionally paternalistic, wherein the physician’s offer of the prenatal aneuploidy 
screen can be perceived as implicit endorsement of the screen.  Thus, the health care 
provider’s structure or “choice architecture” for the offer of prenatal aneuploidy 
screening can unconsciously incline the patient’s decision in a particular manner that 
compromises autonomy (Thaler & Sustein, 2008, p. 6).  Further, as alternatives become 
increasingly unfamiliar and complex, the structure and presentation of the choice is more 
likely to influence the outcome (Thaler & Sunstein, 2008).  As a result, expectant women 
likely need strong health literacy to fully understand the options for prenatal aneuploidy 
screening, to assess the associated risks, and to make decisions that are congruent with 
their personal beliefs and values.  Faden and Beauchamp’s (1986) explication of 
informed consent as requiring adequate understanding of the choices involved in order to 
make a meaningful decision underscores the need to evaluate the influence of health 
literacy on autonomous, informed decisions for prenatal aneuploidy screening.  Thus, a 
woman’s health literacy, which encompasses her ability to access, process, and 
understand health-related information, may be a key influence on her understanding of 
prenatal aneuploidy screening which affects her ability to make an informed decision for 
prenatal aneuploidy screening.  Therefore, Nutbeam’s concept of health literacy will be 
operationalized through five subscales of the Health Literacy Questionnaire (Osborne et 
al., 2013), which will function as independent variables in this study.  
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Satisfaction with a Decision 
The decisions that patients make in health care are frequently complex and value-
laden.  As competing alternative options often require a risk-benefit analysis, complete 
determination of the “right” choice is not readily apparent at the time of the decision.  
Holmes-Rovner et al. (1996) suggest that in evaluation of health care decisions for which 
there is no objective right or wrong choice, it is necessary to focus on the quality of the 
decision-making process.  Holmes-Rovner et al. conceptualized satisfaction with a 
decision as the outcome of a deliberative process of decision-making.  In this deliberative 
process, the choice is based on intentional evaluation of available evidence, the options 
and risks involved, and consideration of the patient’s values.  The manifestation of this 
deliberative process of decision-making is satisfaction with the decision.  According to 
Holmes-Rovner et al., a person experiences satisfaction with a decision when the decision 
is adequately informed, based on the decision-maker’s values, and behaviorally 
implemented.  
Empirical application of Holmes-Rovner’s concept of satisfaction with a 
decision.  The Satisfaction with Decision Scale was developed to examine global 
satisfaction in decision-making (Holmes-Rovner et al., 1996).  The Satisfaction with 
Decision Scale captures three aspects of an effective decision that results in satisfaction.  
These attributes inquire if the decision was informed, consistent with the person’s values, 
and behaviorally enacted.  The Satisfaction with Decision Scale was developed as a 
standardized measure of an outcome of decision-making to inform the design of patient-
centered decision-support interventions for specific decision-making contexts (Holmes-
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Rovner et al., 1996).  A dependent variable in this study will be satisfaction with a 
decision as measured by the Satisfaction with Decision Scale (Holmes-Rovner et al., 
1996).  The Satisfaction with Decision Scale has been used to examine satisfaction with 
decisions made for treatment among primary care patients who were diagnosed with 
depression, type of surgery for women diagnosed with breast cancer, participation in 
cancer clinical trials, and cancer treatment in relation to support from health care 
providers and significant others (Lantz et al., 2005; Palmer-Wackerly, Kriger, & Rhodes, 
2017; Stryker, Wray, Emmons, Winer, & Demetri, 2006; Willis & Holmes-Rovner, 
2003).  The Satisfaction with Decision Scale has also been used to evaluate decision aids 
to support informed choice for genetic testing for breast cancer and for treatment 
decisions for patients newly diagnosed with prostate cancer (Chabrera et al., 2015; Green, 
Peterson, et al., 2004).  In this study, satisfaction with decisions made for prenatal 
aneuploidy screening will be operationalized using the Satisfaction with Decision Scale, 
which will function as a dependent variable. 
 Application of satisfaction with a decision to informed decision-making for 
prenatal aneuploidy screening and health literacy.  Integration of Faden and 
Beauchamp’s (1986) model of informed consent with Holmes-Rovner’s concept of 
satisfaction with a decision and Nutbeam’s (1998) concept of health literacy results in the 
following assumptions that constitute the conceptual framework for this study: (a) A 
decision that is authorized, free from controlling interferences, and based on substantial 
understanding is an informed decision; (b) An individual’s health literacy likely 
contributes to the substantial understanding that is necessary for informed decision-
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making; (c) An informed decision that is based on the decision-maker’s values and is 
behaviorally implemented results in satisfaction with the decision; (d) An individual’s 
health literacy likely contributes to satisfaction with a decision.  Based on this conceptual 
framework, this study posits that women’s understanding of prenatal aneuploidy 
screening will be influenced by health literacy.  Additionally, this study posits that 
women’s satisfaction with decisions made for prenatal aneuploidy screening will be 
influenced by health literacy and substantial understanding of prenatal aneuploidy 
screening.  Operationalization of the concepts of substantial understanding, satisfaction 
with a decision, and health literacy will allow for measurement of these concepts and 
empirical examination of the relationships between these constructs that likely influence 
women’s informed decision-making for prenatal aneuploidy screening.  The conceptual 
framework for this study is depicted in Figure 1.1 below.  
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Figure 1.1 
 
Conceptual Framework to Guide Study 
 
 
Schematic drawing of the conceptual framework to guide the proposed study, 
wherein health literacy as described by Nutbeam (2000; 2016) influences substantial 
understanding as described by Faden and Beauchamp (1986), and substantial 
understanding influences satisfaction with a decision as described by Holmes-Rovner et 
al. (1996).  The areas shaded in gray indicate the relationships to be examined in the 
proposed study. 
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Purpose 
 The purpose of this study is to explore the relationships between women’s 
understanding of prenatal aneuploidy screening, health literacy, and satisfaction with 
decisions made for prenatal aneuploidy screening.  The goals of the study are to advance 
nursing science and the practice of nursing with prenatal populations by providing a 
better understanding of women’s needs when making informed decisions for prenatal 
aneuploidy screening.  To do this, it is important to (a) examine how health literacy 
influences women’s understanding of prenatal aneuploidy screening and (b) examine how 
health literacy and understanding of prenatal aneuploidy screening influence women’s 
satisfaction with their decisions for prenatal aneuploidy screening.  The findings of this 
study will be used to inform education for prenatal care providers and interventions for 
clients to facilitate prenatal care that upholds the ethical principles of self-determination 
and informed choice. 
Assumptions 
The following are assumptions related to the study: 
1.! Women are actually routinely offered prenatal aneuploidy screening. 
2.! The sample of pregnant women who answer survey questions are able to answer 
questions about their understanding of prenatal aneuploidy screening, health 
literacy, and their decision-making for prenatal aneuploidy screening. 
3.! Participants will respond honestly to the survey questions. 
4.! The selected instruments measure variables appropriately and adequately through 
documented evidence of validity and reliability. 
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5.! Participants’ perceptions about their health literacy, understanding of prenatal 
aneuploidy screening, and satisfaction with decisions made for prenatal 
aneuploidy screening, as obtained from the selected instruments, will provide 
meaningful information from which to draw conclusions about their decision-
making for prenatal aneuploidy screening. 
Chapter Summary 
 Evidence indicates that the routinization and rapid integration of prenatal 
aneuploidy screening in prenatal care has impoverished women’s informed decision-
making for prenatal aneuploidy screening.  Women are routinely asked to consent to 
prenatal screening for fetal aneuploidy early in pregnancy despite evidence that many 
women do not understand to what they are consenting (Farrell et al., 2015; Farrell et al., 
2011).  Prenatal screening relies on assessment of risk rather than direct diagnosis.  The 
decision to use prenatal screening is uniquely complex due to the bioethical questions 
posed by genetics, the relational state of pregnancy, and the temporal sensitivity of 
decision.  The decision for prenatal aneuploidy screening marks the beginning of a series 
of profoundly important decisions, including subsequent decisions on invasive diagnostic 
testing and whether to continue or terminate a pregnancy.  Due to inadequate 
understanding of the purpose and scope of prenatal screening and the difficulty of 
interpreting estimates of risk, many women are falsely reassured by a low-risk result and 
unprepared to make life-altering decisions and manage the despair that results from a 
high-risk result (Aune & Möller, 2012; Chiang et al., 2007).  As a result, many women 
are inadequately prepared to make the decision for prenatal aneuploidy screening, a 
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decision that will affect the course of their pregnancy and may impact the trajectory of 
their lives.  There is critical need for knowledge generation to illuminate influences on 
women’s understanding of prenatal aneuploidy screening in order to guide professional 
support for women in making informed decisions for prenatal aneuploidy screening 
 A conceptual framework that integrates Faden and Beauchamp’s (1986) model of 
informed consent with Holmes-Rovner’s concept of satisfaction with a decision and 
Nutbeam’s (1998) concept of health literacy provides the foundation for investigating the 
links between health literacy, women’s understanding of prenatal aneuploidy screening, 
and their satisfaction with decisions made for prenatal aneuploidy screening.  Applying 
this framework will allow investigation of (a) how health literacy influences women’s 
understanding of prenatal aneuploidy screening and (b) how health literacy and 
understanding of prenatal aneuploidy screening influence women’s satisfaction with their 
decisions for prenatal aneuploidy screening.  The findings of this investigation will be 
used to guide interventions to promote women’s informed decision-making for prenatal 
aneuploidy screening.  In Chapter Two, an integrative review to evaluate and synthesize 
the available literature on women’s experiences with prenatal genetic screening is 
presented to provide context for this proposed study. 
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CHAPTER II 
 
REVIEW OF THE LITERATURE 
 
 
      Shea, T. L. (2016). Prenatal paradox: an integrative review of women’s experiences   
     with prenatal screening for fetal aneuploidy and neural tube defects. Contemporary  
     Nurse, 1–27. doi: 10.1080/10376178.2016.1269609 
 
 
Abstract 
Background  
 Prenatal screening for fetal aneuploidy and neural tube defects has been 
incorporated in prenatal care through much of the industrialized world.  As prenatal 
screening evolves technologically and becomes increasingly utilized worldwide, a 
summary and evaluation of the available evidence on women’s experiences with prenatal 
screening is warranted. 
Aims 
 To conduct an integrative review to evaluate and synthesize available literature to 
enhance understanding of women’s experiences with prenatal screening for fetal 
aneuploidy and neural tube defects.   
Design 
 Systematic literature searches from January 2005 through January 2016, using the 
CINAHL, PubMed, and PsychInfo electronic databases and ancestry searches of included 
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studies to identify previously published, peer-reviewed quantitative and qualitative 
studies.   
Review Methods 
 The integrative review method as proposed by Whittemore and Knafl (2005) was 
selected to provide a rigorous course for the integration of qualitative and quantitative 
research findings. 
Results  
 Thirty-nine studies were included in the review.  The literature reveals that 
prenatal screening occurs in a complex social, ethical, and political reality in which 
experiential knowledge and biomedical authority are key influences.  A theme of paradox 
emerged in the literature due to the incongruity between reported risk and perceived risk, 
the tension between informational utility and moral decisions concerning pregnancy 
management, and the pervasive influence of authoritative knowledge combined with 
women’s reliance on experiential knowledge in their decisions for prenatal screening. 
Conclusion 
 There is a need for future inquiry to critically examine the interrelationships of 
individual, biomedical, ethical, and sociopolitical factors surrounding prenatal screening. 
Keywords: antenatal screening, prenatal screening, fetal aneuploidy, Down 
syndrome, neural tube defects, maternal serum screening, nuchal translucency, non-
invasive prenatal testing 
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Background 
 Women are increasingly being asked to consent to prenatal screening for fetal 
aneuploidy and neural tube defects early in pregnancy, often at their first or second 
prenatal care appointments (Cleary-Goldman, Morgan, Malone, Robinson, D’Alton, & 
Schulkin, 2006).  Fetal aneuploidy occurs when there are an abnormal number of 
chromosomes (Griffiths et al., 2015).  Having an extra copy of a chromosome changes 
embryonic, and postnatal development, and physiology of the brain and major organs 
systems (Torres & Busciglio, 2014).  The most common type of viable human aneuploidy 
is trisomy 21 or Down syndrome, occurring at a frequency of about 0.15 to 0.25% of all 
live births (International Clearinghouse for Birth Defects Surveillance and Research, 
2014).  Down syndrome is the most common genetic cause of intellectual disability 
worldwide and the leading cause of specific anomalies including congenital heart defects 
(Torres & Busciglio, 2014).  Neural tube defects affect more than 300,000 live births 
each year worldwide and occur due to incomplete closure of the neural tube in the cranial 
region (anencephaly) or along the spine (spina bifida) (Cordero et al., 2010; Flores, 
Vellozzi, Valencia, & Sniezek, 2014).  Infants born with anencephaly typically expire 
spontaneously within a few days of birth, while infants born with spina bifida have 
extensive physical impairment with varying degrees of paralysis (Cordero et al., 2010).  
The costs associated with chromosomal aneuploidy and neural tube defects include the 
financial and psychological burdens incurred due to long term management of physical 
and intellectual disabilities and the effects of caregiver burden on economic stability and 
psychological well-being (Tétreault et al., 2014).   
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Advanced maternal age or family history was formerly the criteria for prenatal 
screening for fetal aneuploidy, particularly Down syndrome (American Congress of 
Obstetrics and Gynecology [ACOG] 2016a; Latendresse & Deneris, 2015).  However, the 
identification of maternal serum markers that denote the risk of carrying an affected fetus 
has resulted in prenatal screening being incorporated into routine prenatal care for women 
regardless of age (ACOG, 2016a).  Uptake rates for prenatal screening exhibit geographic 
variation, with reported rates of 92% in Western Australia, 90% in Denmark, 83% in the 
United Kingdom, and 50% in China (Ekelund et al., 2011; Huang, Chen, & Pong, 2015; 
Hui, Muggli, & Halliday, 2016; Maxwell et al., 2011).  Modalities of prenatal screening 
for fetal aneuploidy and neural tube defects include (a) maternal serum screening to 
measure levels of specific biochemicals in the woman’s blood, (b) nuchal translucency, 
an ultrasound technique wherein the fluid collection at the back of the fetal neck is 
measured, and c) non-invasive prenatal testing (NIPT), which uses fragmented fetal DNA 
circulating in maternal blood (Latendresse & Deneris, 2015).  Table 2.1 provides a 
description of these various modes of screening.   
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Table 2.1  
 
Description of Prenatal Screens1 
Screen Description Recommended 
Gestational Age 
Condition Screened 
Aneuploidy ONTD 
Maternal Serum 
Screen 
Measurement of 
biochemical 
markers: PAPP-A 
and hCG  
 
10-14 weeks 
 
X 
 
AFP, hCG, uE3, and 
inhibin A (Quad 
screen) 
15-18 weeks X X 
Non-invasive 
Prenatal Testing 
(NIPT) 
Maternal serum 
collected to sample 
cell-free fetal DNA 
10+ weeks X  
Nuchal 
Translucency 
Ultrasonographic 
measurement of 
thickness of fetal 
nuchal fold; 
Commonly used in 
combination with 
maternal serum 
screening 
10-14 weeks  X  
 
Note: 1. Abbreviations: AFP, alpha fetoprotein; hCG, human chorionic gonadotropin;  
ONTD, open neural tube defect; PAPP-A, pregnancy associated plasma protein A;  
uE3, unconjugated estriol (Latendresse & Deneris 2015). 
2. Variance occurs with the screens offered and the timing based on regional differences 
in authorities’ recommendations. 
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False positives and negatives occur with each type of prenatal screen, with false 
positives for the commonly used Quad screen occurring at a rate of approximately 7% for 
trisomy 21 (Durković, Anđelić, Mandić, & Lazar, 2011).  While NIPT purportedly yields 
improved selectivity and specificity, it is not widely recommended due to limited validity 
and quality control (Norton, Rose, & Benn, 2013).  Additionally, diagnostic confirmation 
through invasive testing following NIPT is still required (ACOG, 2012).  As each type of 
prenatal screen relies on a risk assessment rather than direct diagnosis, a positive screen 
indicating high risk for fetal anomaly entails subsequent decision-making by prospective 
parents about diagnostic testing and the possibility of termination. 
For the majority of women, prenatal screening for fetal aneuploidy and neural 
tube defects is typically performed as maternal serum screening alone or in combination 
with nuchal translucency (Boyd et al. n.d.).  Women with positive screening results are 
designated as higher risk for carrying a fetus with aneuploidy or neural tube defects.  
High risk women are then presented with the option of invasive testing via amniocentesis 
or chorionic villus sampling to obtain definitive diagnosis, which entails risk for fetal 
injury or demise (ACOG, 2016b).  
 Prenatal screening is offered in the context of perinatal health care.  Perinatal 
well-being is understood as the cognitive and affective self-evaluation of a woman’s life 
surrounding the period before and after childbirth (Allan, Carrick-Sen & Martin, 2013).  
Perinatal well-being encompasses physical, psychological, social, spiritual, economical, 
and environmental elements surrounding pregnancy (Allan et al., 2013).  This ecological 
conception of perinatal well-being requires that the evaluation of prenatal screening 
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methods and implementation include women’s estimations of (a) the effects of screening 
on self, fetus, and family, (b) the influence of prenatal screening on maternal fetal 
attachment and maternal identity, which have lasting impact on maternal and neonatal 
outcomes, and (c) the experience of decision-making in consenting to or declining 
prenatal screening (Allan et al., 2013, Yarcheski, Mahon, Yarcheski, Hanks, & Cannella, 
2009).  These issues potentially have an impact on women’s thinking regarding screening 
during pregnancy.  In nursing practice, this author has noted the complexity of feelings 
that women express concerning whether or not to undergo prenatal screening for fetal 
anomalies.  As prenatal screening evolves technologically and becomes increasingly 
utilized worldwide, a summary and evaluation of the available evidence on women’s 
experiences with prenatal screening is warranted.   
The Review 
The aims of this integrative review are (a) to determine the state of the science of 
women’s experiences with prenatal screening, (b) to synthesize the findings into a 
cohesive whole, and (c) to identify areas for future research. 
Design 
 An integrative review is a method of review that is appropriate for the purpose of 
providing a comprehensive portrayal of a complex health care issue (Whittemore & 
Knafl, 2005).  A distinction of the integrative review method is that it allows for the 
inclusion and synthesis of findings from both experimental and non-experimental 
research (Whittemore & Knafl, 2005).  A design specialized to the integrative review as 
proposed by Whittemore and Knafl (2005) was deliberately selected to provide a rigorous 
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course for the collection, evaluation, analysis, and integration of separate qualitative and 
quantitative research findings into a meaningful whole.    
Search Methods 
A comprehensive search of the literature was performed using the electronic 
databases CINAHL, PsychInfo, and PubMed.  The key terms were prenatal/antenatal 
screening, and maternal serum screening.  Key terms were combined using the Boolean 
operator AND with the following terms: informed consent, decision-making, and 
experience.  Inclusion criteria were original research, peer-reviewed, and published in the 
English language inclusive of January 2005 through January 2016.  Exclusion criteria 
included: reviews, discussion papers, studies focused on diagnostic testing, and studies 
focused on the experiences of health care providers. 
Search Outcome 
         In total, 209 potentially relevant studies were initially identified.  Review of the 
reference citations of relevant papers yielded three additional reports.  A diagram of 
information flow is depicted in Figure 2.1.  Titles, abstracts, and full-text articles were 
examined to screen for relevant studies.  Forty studies met inclusion criteria.  Table 2.2 
provides information on each study’s purpose, sample, methodology, and findings.  
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Figure 2.1 
PRISMA Flow Diagram 
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Table 2.2 
 
Characteristics of Reviewed Studies in Chronological Order by Publication Date 
 
Authors 
 (Year) 
& Country 
Purpose Study Design  
& Measures 
Sample Main findings 
Jaques et al. 
(2005)  
Australia 
To determine  
whether women 
having 1st trimester 
screening had made 
an informed 
choice 
Cross-sectional  
descriptive survey;  
Multidimensional  
Measure of  
Informed Choice  
(MMIC) (Marteau 
 et al. 2001) 
n = 163  
pregnant 
women  
undergoing 
nuchal  
translucency  
screening 
Although two- 
thirds of women 
made informed  
choice, 46%  
understood the  
screen to be a  
routine part of  
prenatal care.  
Lobel et al.  
(2005) 
United  
States 
To identify factors 
associated with 
emotional distress  
among women  
having maternal  
serum alpha 
 fetoprotein 
 screening 
Longitudinal  
comparative;  
Spielberger State- 
Trait Personality 
Inventory  
(Spielberger 1995) 
Life Orientation  
Test (Scheier &  
Carver 1985) 
n = 87  
pregnant  
women who 
had  
obtained  
negative 
screen 
result, 
 n = 12 who 
declined  
screening 
Satisfaction with  
information  
received was the 
strongest predictor 
of lower distress  
prior to the screen, 
while  
dispositional  
optimism and  
other medical  
concerns were 
predictors of  
distress after the 
screen. Women  
who screened  
exhibited more 
distress than those 
who declined. 
Van den  
Berg et al.  
(2005) 
Netherlands 
To assess informed 
choices and the  
psychological  
effects of informed 
choice about  
prenatal screening 
Cross-sectional  
comparative  
descriptive;  
Decisional Conflict 
Scale (O'Connor 
1995) 
n =  
1159  
pregnant 
women  
Informed choice 
was associated  
with less  
decisional conflict 
and more 
satisfaction with  
decision, but not  
anxiety. One-third 
of women did not 
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make informed  
choice.  
Williams 
et al. 
(2005) 
United  
Kingdom 
To describe the 
experiences of  
1st trimester nuchal  
translucency  
and maternal serum  
screening 
In-depth interviews 
with open-ended  
questions  
n= 14 
women, 12 18 weeks pregnant,  
after the  
results of 
nuchal  
translucency 
screening 
were  
known 
The majority of  
women were  
active agents in 
the decision- 
making and  
thought carefully  
about their moral 
values prior to 
prenatal  
screening.  
Women voiced  
feeling  
responsible for the 
quality of their 
unborn child's life. 
Chiang et al. 
(2006) 
Taiwan,  
Republic of  
China 
To describe  
decision- 
making for maternal  
serum screening  
from the perspective 
of pregnant women 
Grounded theory  n = 26  
pregnant  
women who 
were  
informed of 
positive   
results  
Although  
screening was  
presented as a  
choice, women  
perceived it as  
routine. Women 
chose to screen to  
avoid having a  
child with  
Down syndrome,  
and because they 
trusted  
technology. 
Lalor &  
Begley 
(2006) 
United  
Kingdom 
To explore  
women’s  
experiences of  
receiving news of  
fetal anomaly with 
routine ultrasound  
examination 
Grounded theory n = 38 
pregnant  
women  
who had 
received  
news of  
adverse 
finding 
The detection of  
fetal anomaly was 
shocking for  
women, yet they 
appreciated  
having  
foreknowledge of 
the condition.  
The expectation 
of fetal health  
intensified the 
adverse feelings.   
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Lawson &  
Turriff- 
Jonasson  
(2006) 
Canada 
To examine how 
maternal serum 
screening influences  
prenatal attachment 
Longitudinal  
comparative;  
Prenatal 
Attachmen  
Inventory 
(Muller 1993). 
n=101  
pregnant  
women,  
identified as 
high risk for 
fetal  
anomaly  
Lower attachment 
was associated  
with uptake of  
maternal serum  
screening, which  
may lead to  
feelings of  
ambiguity and 
confusion toward 
the fetus. 
Georgsson 
Öhman  
et al. (2006) 
Sweden 
To explore  
women’s 
responses to nuchal 
translucency results 
indicating high-risk 
for Down syndrome 
In-depth semi- 
structured  
interviews 
occurring at 3  
separate times 
during pregnancy 
 
n = 24  
pregnant  
women  
designated  
as high-risk 
following 
scan 
A false-positive 
screen for Down  
syndrome may  
result in profound 
anxiety with  
potential rejection 
of the fetus. 
Heyman  
et al. (2006) 
United  
Kingdom 
To explore  
women’s  
perspective of being 
designated higher  
risk for  
chromosomal  
anomalies following 
prenatal screening 
Descriptive,  
semi-structured  
interviews 
pregnant  
women,  
n = 7 high  
risk, n = 14 
low risk,  
n = 5 who  
declined  
screening, 
n = 1 with  
miscarriage 
prior to screening 
Women declined  
to screen due to 
opposition to  
pregnancy  
termination,  
positive view of  
Down syndrome,  
or to reduce  
anxiety. Some 
women designated 
high risk  
following the  
screen reported  
difficulty  
reconciling that no 
fetal health  
problem ever  
existed, even after 
confirmation of  
fetal health.  
. 
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Rowe et al. 
(2006) 
Australia 
To establish if  
decisions 
for prenatal  
screening 
are well informed  
and if informed 
decision- 
making is  
associated with  
better mood during 
 pregnancy 
Longitudinal  
prospective cohort 
study;   
Multidimensional  
Model of Informed 
 Choice (MMIC)  
(Marteau, 2001);  
The Hospital 
Anxiety and Depression Scale (HADS) 
 
n = 77  
pregnant  
women  
37% of  
decisions were  
informed; Women  
who participated 
in the screen were 
more likely to  
make an informed 
choice. Short term 
anxiety levels in  
those who were 
well-informed  
were not  
significantly  
different from  
those who were 
poorly informed. 
 
 
Chiang et al. 
(2007)  
Taiwan,  
Republic of 
China 
To explore how  
receiving abnormal  
results from  
prenatal serum  
screening 
affects the  
maternal self 
Grounded theory  n = 27 
pregnant 
women 
who had  
been  
informed of 
abnormal  
results of 
maternal  
serum  
screening 
Three forms of  
maternal self were 
identified: self- 
stigmatizing,self- 
knowledgeable,  
and self- 
conflicted.  
Kleinveld 
et al.  
(2007) 
Netherlands 
To determine if the  
offer and  
performance 
of prenatal  
screening 
influences a  
woman's sense of  
attachment to her  
fetus 
Longitudinal  
Randomized 
control trial  
with women 
randomized  
into nuchal 
translucency,  
serum screening, 
or no screen;  
Pregnancy 
Involvement List  
(Kleinveld et al.  
2007); Prenatal  
Attachment 
n = 1031  
pregnant  
women 
The offer of  
prenatal screening 
temporarily  
increased  
maternal-fetal  
attachment.  
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 Inventory (Muller 
1993). 
Etchegary  
et al. (2008) 
Canada 
To explore how  
women make  
prenatal 
screening and  
testing decisions,  
particular 
the impact of 
experiential 
knowledge  
Descriptive,  
semi-structured  
interviews 
n = 22  
mothers 
who 
had 
accepted  
the screen,  
n = 16  
mothers 
who 
declined the 
screen 
Experiential  
embodied and 
empathetic  
knowledge 
influence  
women's  
understanding and 
risk perception. 
Li et al.  
(2008) 
United 
States 
To understand  
factors that 
influence a  
woman’s decision 
to participate in  
expanded alpha- 
fetoprotein 
screening 
Cross-sectional,  
population-based 
case-control study 
 
n = 199  
women who 
declined the  
screen, 
n = 229  
controls 
who  
accepted the 
screen, 70% 
were college  
educated 
Factors  
significantly  
associated with  
screen decline:  
skepticism of its  
usefulness,  
influence of 
family, low  
educational level, 
willingness to  
keep affected  
fetus, not finding 
providers as  
useful sources of  
information, and  
misunderstanding 
the purpose of  
screening.  
Pilnick  
(2008) 
United 
Kingdom 
To investigate 
information-giving  
by midwives and  
decision-making for  
nuchal translucency 
screening 
Descriptive,  
discourse analysis 
n = 14  
pregnant  
women who 
were offered 
nuchal  
translucency 
screening 
While women 
understood that a 
decision was  
needed, many did 
not perceive it as 
choice but as  
assent to routine 
and standard care. 
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Van den  
Berg et al. 
(2008) 
Netherlands 
To understand  
prenatal screening 
decision-making  
Path analysis;  
Pregnancy Related 
Anxieties  
Questionnaire 
 
 
n = 1666  
women;  
majority  
were middle 
to high  
educational 
level 
Attitude toward 
pregnancy  
termination,  
perceived test  
efficacy, and  
subjective norm of 
the desirability of 
having prenatal  
screening  
determined a  
woman’s attitude  
toward having the 
 screen. 
García et al. 
(2009) 
Netherlands 
 
 
To explore the  
effect of the offer  
of screening on 
decision-making 
and the factors  
women consider in 
the decision 
Semi-structured  
interviews  
embedded within a 
randomized  
controlled trial,  
with data analyzed  
with qualitative  
coding software 
n = 59  
women who 
were  
deciding  
whether to  
participate  
in screening 
 
Women  
approached the  
moral dilemma of 
screening by  
considering their  
family members 
who will be  
affected by the  
possibility of  
having a disabled  
child, rather than 
abstract ethical  
principles. 
Georgsson 
Öhman 
et al.  
(2009) 
Sweden 
To explore how 
women reacted to  
high risk status and  
to evaluate whether  
actual risk and  
perceived risk are  
associated with  
worryor depressive 
symptoms 
Longitudinal  
descriptive;  
Swedish  
Cambridge Worry 
 Scale (Georgsson  
Öhman 2004); 
Edinburgh  
Postnatal  
Depression Scale  
(Cox et al. 1987) 
n = 796 
pregnant women who had 
undergone nuchal translucency 
screening 
Women's  
perceived risk  
may be vastly  
incongruent with 
screening- 
determined risk,  
with over half of  
the women who  
interpreted their  
risk as high  
actually having 
low risk. High risk 
was not   
associated with 
worry or  
depression 
postpartum. 
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Hawthorne 
& Ahern 
(2009) 
Australia 
To describe the  
experiences of  
women who are  
contemplating  
nuchal translucency 
screening for Down 
syndrome 
Phenomenological n = 20  
pregnant 
women at 
11-12 weeks 
gestation,  
before  
undergoing 
screening 
translucenscreening 
Women expressed 
that nuchal  
translucency is  
valuable due to  
providing  
reassurance that  
one is not having 
a child with  
disability.  
Although women  
expressed anxiety 
concerning  
screening, they  
identified it as part 
of the role of good 
parenting. 
Park &  
Matthews 
(2009)  
Canada 
To investigate what 
women learn about 
prenatal screening  
and determine the 
role their physician 
plays in the decision 
Descriptive, semi- 
structured  
telephone  
interviews 
n =11  
women 
between 21-26 weeks pregnant 
Women were  
most influenced  
by family and  
friends in  
decisions to  
uptake screening.  
Women need  
more time to learn 
about screening 
options. 
 
Rowe et al.  
(2009) 
Australia 
To compare the  
growth of maternal 
fetal attachment in  
groups of women  
whose decisions  
about prenatal  
screening 
were informed 
versus  
not informed 
Longitudinal 
comparative; Multidimensional Model of 
Informed Choice (MMIC) (Marteau et al. 
2001); The Hospital Anxiety and 
Depression Scale (HADS); The Antenatal 
Attachment Questionnaire (AAQ) 
(Condon 1993). 
n = 68  
pregnant 
women between 8-14 weeks, most 
with post- 
secondary 
training or  
college  
degree 
Informed  
decision-making 
of maternal serum 
screening was  
significantly  
associated with 
lower maternal- 
fetal attachment 
prior to screening, 
but this difference 
resolved after  
screening results  
were known. 
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Seror &  
Ville 
(2009) 
France 
To investigate  
women’s attitudes  
and decisions 
toward prenatal screening for Down 
syndrome 
Cross-sectional 
ass ciation l  
n = 341  
women in a  
maternity  
unit who 
had recently 
given birth 
to a healthy infant 
Approximately  
one-half of the 
women screened 
did not know that 
results of the  
screen might  
require future 
decisions on  
pregnancy  
termination. One- 
third did not  
anticipate that 
screening might 
lead to decisions 
on invasive  
testing.   
Czerwinski  
et al. (2010) 
United 
States 
To investigate the  
anxiety level of  
women based on  
how results of  
prenatal screens 
are disclosed, and to 
assess the accuracy 
of patient’s  
perception of risk. 
Descriptive 
comparative; Six- 
item short form 
Spielberger State- 
Trait Anxiety 
Inventory  
(Martreau &  
Bekker 1992) 
n = 170  
pregnant  
women  
referred to 
genetic  
counseling  
for  
advanced  
maternal 
age,  
abnormal 
screen,  
or other 
indication 
Women born  
outside the United 
States were less  
likely to be aware  
of the screen prior 
to result  
disclosure.  
Most women did  
not respond to a  
question asking 
them to indicate what their numerical 
risk was.  
Fransen  
et al. 
(2010) 
Netherlands 
To assess ethnic  
differences in 
informed 
and background  
characteristics in  
decision-making on 
prenatal screening 
Cross-sectional  
comparative 
descriptive 
n = 65  
Dutch, 
n = 54  
Turkish and 
n = 19  
Surinamese 
pregnant 
women  
Significant  
differences existed 
in informed  
decision-making 
on prenatal 
screening for Down's syndrome: 71%  
of Dutch, 5% of  
Turkish and 26%  
of Surinamese  
made informed  
decisions.  
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Seror &  
Ville  
(2010)  
France 
To explore women's  
attitudes toward  
decisions with 
prenatal screening 
and to assess if their 
attitudes correspond 
with their decisions 
Cross-sectional 
descriptive  
n = 341 
women, three days postpartum 
Decisions on 
screening were  
made based on  
attitudes toward 
termination,  
estimation of risk 
associated with 
invasive  
diagnostic testing, 
and the  
informational  
value of screens. 
results.  
Skirton & 
Barr  
(2010) 
United  
Kingdom 
To investigate  
knowledge about  
prenatal screening 
and explore the  
influences on  
decisions 
Cross-sectional 
descriptive 
n = 100 
women,  
n = 11  
partners, 
n = 78  
midwives 
Women reported 
that informatio  from health care 
providers was useful, but lack of 
meaningful discourse was a barrier.   
Dahl et al. 
(2011) 
Denmark 
To evaluate the  
relationship  
between women's  
knowledge 
of prenatal  
screening 
and the  
psychological 
management of  
screen decisions 
Cross-sectional  
descriptive;  
Decisional Conflict 
(O'Connor 1995); 
WHO Well-being 
Index  
(WHO, 1998);  
Cambridge Worry  
Scale (Green et al.,  
2003) 
n = 4111 
pregnant women who were offered 
nuchal translucency scanning 
Higher knowledge 
was associated  
with reduced  
decisional  
conflict, but 
knowledge was  
not associated 
with worries in  
pregnancy. 
Farrell et al. 
(2011) 
United 
States 
To assess  
knowledge 
and decision- 
making  
among women who  
present for first  
trimester screening 
Cross-section  
associational with 
survey 
n = 139 Women had  
inadequate 
knowledge of the 
clinical features of 
Down syndrome  
and the possibility 
that screen results 
may require future 
complex decision- 
making. 
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Aune & 
Möller 
(2012)  
Sweden  
and Norway 
To understand how  
women experience 
early ultrasound  
screening  
Grounded theory  n = 10 
pregnant 
women 
A theme of "I  
want a choice but  
I don't want to  
decide" emerged. 
Women made  
choices  
independently,  
with a strong  
sense of personal 
responsibility 
Carroll et al. 
(2012) 
United  
Kingdom 
To inquiry how  
couples regard 
information and  
make decisions  
about prenatal  
screening 
Qualitative 
description with semi-structured 
interviews 
n = 16 
pregnant women at 22+ weeks  
gestation,  
n = 13 male 
spouses 
Couples voiced a 
preference for  
joint yet private  
decision-making 
with the  
midwife’s primary 
role being to  
provide  
information.   
García et al. 
(2012) 
Netherlands 
To determine if the 
offer of prenatal 
screening leads  
women to believe 
that they are  
morally 
compelled to screen 
Cross-sectional  
descriptive with  
open-ended  
questionnaire,  
embedded in a  
randomized  
controlled trial  
n = 111  
pregnant  
women  
Women did not  
feel morally  
compelled to  
consent to  
screening, but  
rather expressed  
that decisions to  
screen were based 
on perceived  
moral duties to 
existing family  
members. 
Schoonen  
et al. (2012) 
Netherlands 
To evaluate the  
provision of  
information for  
PGS using informed 
consent as a quality 
indicator 
Cross-sectional  
design;  
A modified   
Multidimensional  
Model of Informed 
Choice (MMIC) 
(Marteau et al. 2001) 
n = 510  
pregnant  
women  
75.5 % of women 
made an informed 
choice. Th se who screened were more  
likely to make an 
 informed choice 
 (94.3%)  
compared with 
those who did not 
participate in  
screening (64.9%) 
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Wätterbjörk 
et al. (2013) 
Sweden 
To explore how  
couples make 
decision about  
prenatal screening 
Exploratory using 
interpretive  
description 
n = 15  
pregnant  
women, 
n = 16  
couples, 
 n = 6 with 
partners  
For some couples 
decision-making 
was  
straightforward. 
For others,  
decision-making 
was complex and 
confusing.   
Discourse with  
family and friends 
aided decisions. 
Ahmed et al. 
(2014) 
United 
Kingdom 
To understand what  
women believe the  
dialogue between  
them and health  
professionals should  
be about to facilitate 
informed choices 
Descriptive with  
semi-structure  
interviews and  
Framework  
analysis 
n = 98  
pregnant  
women of 5 
ethnicities:  
African,  
British  
White,  
Caribbean,  
Pakistani  
and Chinese  
Women value the 
advice of health  
professionals in  
the context of  
decision-making  
for screening.   
Advice meant  
different things to  
different  
individuals,  
ranging from  
information to  
direction. 
Constantine  
et al. (2014) 
United  
States 
To evaluate  
Informed 
consent and  
compare screen 
acceptors to  
those who refused  
the screen 
Cross-section  
associational 
n = 226  
pregnant  
women 
56.2% of women 
did not make an  
informed decision. 
The decision to  
screen was less of 
an informed and  
deliberative action 
than the decision 
not to screen. 
Dixon &  
Burton  
(2014)  
Canada 
To evaluate how  
well midwives 
implement informed 
choice for prenatal 
screening in Ontario 
Informed choice  
was measured using 
a modified   
Multidimensional  
Model of Informed 
Choice (MMIC)  
(Marteau  
et al. 2001) 
n = 171  
midwifery 
clients 
93.0% of  
participants made 
an informed  
choice. Women  
who chose to  
utilize prenatal 
screening had  
lower knowledge  
scales than those  
who declined. 
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Van  
Schendel  
et al. (2014) 
Netherlands 
To explore the  
attitudes of pregnant 
women and their 
partners related  
to non-invasive  
prenatal testing 
(NIPT) 
Focus groups 
(face-to-face and  
online) and  
semi-structured 
interviews 
Five focus 
groups of  
women  
n = 28 
 
Participants  
expressed concern 
that earlier testing 
could lead to 
diminished time to 
make an informed 
decision and that  
widespread testing 
could increase 
social stigma of 
Down syndrome. 
Vanstone  
et al. (2015) 
Canada 
To identify  
women’s 
values about  
decision- 
making through 
examining how  
women 
experience publicly  
funded non-invasive 
prenatal testing 
(NIPT) 
Constructivist 
grounded theory 
n = 38  
women  
designated 
at high risk 
for fetal  
aneuploidy 
  
The values by  
which women  
base their  
decisions are  
modulated by the 
timing of  
screening,  
accuracy, and  
perceived risk.  
Many participants 
interpreted risk in 
a way that does  
not reflect clinical 
risk. 
Martin et al. 
(2016) 
Netherlands 
To examine if  
communication by  
clients during  
counseling for  
anomaly screening 
is related to 
midwives’  
psychosocial  
questions 
& communication  
Cross-sectional  
associational; 
Roter Interaction 
Analysis System 
184  
videotaped  
prenatal 
counseling 
session with 
20  
midwives 
The amount of  
client’s 
psychosocial  
communication 
was positively related to the midwives’  
psychosocial and  
affective  
communication  
and the duration  
of counseling. 
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Quality Appraisal 
          Due to the diversity of primary sources, the need to systematically critique the 
rigor of the studies was recognized.  Reports were scored according to a critique tool 
based on Bowling’s (2009) checklist for quantitative research and Whittemore, Chase, 
and Mandle’s (2001) guidelines for qualitative research.  Of the 40 studies that met 
inclusion criteria, 39 were deemed high or adequate quality.  One report failed to provide 
sufficient description of methods and analysis and was therefore removed prior to data 
analysis.   
Data Abstraction and Synthesis 
During the first stage of data abstraction, each article was read to obtain an 
overview.  A data extraction matrix was used to capture and abstract qualitative and 
quantitative data.  Relevant data were entered into a matrix to facilitate synthesis 
according to author(s), year, design, measures, sample characteristics, and findings.  
Whittemore and Knafl (2005) suggest using a qualitative analytic strategy to enhance 
rigor when synthesizing data from diverse methodologies.  Thus, qualitative content 
analysis (Sandelowski, 2000) was chosen as the analytical method.  First, open coding 
was used to organize key content in literature.  Axial coding was then used to connect 
content and identify latent themes.  Data abstraction, synthesis, and analysis was 
performed by the author. 
Description of the Studies   
In this integrative review, 39 original research reports on women’s decision-
making and experiences with prenatal screening were identified, reviewed, critiqued, and 
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synthesized.  Of the articles reviewed, 21 used quantitative methods, 17 used qualitative 
methods, and one used mixed methods.  The literature was represented internationally 
with numerous countries of publication, including Australia (4), Canada (5), Denmark 
(1), France (2), the Netherlands (9), Norway and Sweden (1), Sweden (3), United 
Kingdom (7), United States (5), and Taiwan (2).  Although there was broad international 
representation, 23 of the 39 studies reviewed were conducted in northern Europe. The 
majority of the samples were comprised of pregnant women between 11-24 weeks 
pregnant, corresponding to the timing of prenatal screening.  Four studies included male 
partners in addition to the female participants (Skirton & Barr, 2010; Carroll, Owen-
Smith, Shaw, & Montgomery, 2012; Wätterbjörk, Blomberg, Nilsson, & Sahlberg-Blom, 
2013; Van Schendel et al., 2014).  Samples were predominantly middle to upper 
socioeconomic class, Caucasian, and possessing some university education.  The 
predominantly operationalized constructs include: anxiety, maternal-fetal attachment, 
attitude toward screening, attitude toward termination of pregnancy, decisional conflict, 
informed consent, intention to screen, and knowledge of the screen.  While ten studies 
measured knowledge of the screen, the type and number of items assessing knowledge 
varied considerably, thereby limiting comparison of knowledge of the screen across 
studies.  
Results 
To illuminate the multifarious aspects of a woman’s experience with prenatal 
screening, the thematic findings from this review are categorized as (a) experiential 
knowledge, which encompasses embodied, subjective experiences and empathetic 
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knowledge obtained from people with whom one closely identifies; and (b) authoritative 
knowledge, which includes biomedical, technological, and expert professional knowledge 
that is perceived as legitimate and consequential for how health and illness are defined 
(Abel & Browner, 1998; Jordan, 2014).  
Experiential Knowledge 
Emotional distress.  Lobel, Dias, and Meyer (2005) found that women who 
opted for maternal serum screening were modestly, but significantly more emotionally 
distressed throughout pregnancy than those who declined, even after receiving normal 
results.  Women describe the receipt of a positive screen (indicating high risk for fetal 
abnormality) and the aftermath of time-sensitive decisions concerning confirmatory 
diagnosis and the possibility of termination as emotionally devastating and traumatic life 
experiences (Chiang et al., 2007; Etchegary et al., 2008; Heyman et al., 2006).  
Additional emotional distress arises from doubt about which fetal conditions would make 
termination acceptable (García, Timmermans, & van Leeuwen, 2009).  While a positive 
prenatal screen can result in profound anxiety, a heightened sense of risk and fear, and 
possible rejection of the fetus (Georgsson Öhman, Saltvedt, Waldenström, Grunewald, & 
Olin-Lauritzen, 2006; Hawthorne & Ahern, 2009; Heyman et al., 2006), it has not been 
found to be associated with depression (Georgsson Öhman, Grunewald, & Waldenström, 
2009).  Being labeled screen-positive can result in self-stigmatization, shame, guilt, and 
self-conflict both during pregnancy and even following the birth of a healthy, non-
affected infant (Chiang et al., 2007; Heyman et al. 2006).  Thus, while a negative screen 
(indicating low risk for fetal abnormality) may provide a sense of reassurance of fetal 
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health, a positive screen may result in emotional anguish, sustained anxiety, and altered 
adaptation to the parenting role. 
Liminality. “Liminal space is a place of ambiguity and anxiety, of no-longer and 
not-yet,” (Carson, 2002, p.180).  An emergent theme of the literature is the pronounced 
liminality of pregnancy in the context of prenatal screening, in that there is a cautious, 
hesitant approach to pregnancy, with an oscillation between committing to and holding 
back from the fetus emotionally (Georgsson Öhman et al., 2006; Hawthorne & Ahern, 
2009; Rowe, Fisher, & Quinlivan, 2009).  Kleinveld, Timmermans, Van den Berg, Van 
Eijk, and Ten Kate (2007) found that the offer of prenatal screening temporarily 
increased maternal fetal attachment, although this difference abated as pregnancy 
progressed.  This finding sharply contrasts with research by Lawson and Turriff-Jonasson 
(2006) who determined that women who underwent prenatal screening experienced lower 
maternal fetal attachment than women who declined screening.  Further, Rowe et al. 
(2009) found that women who made informed choices on prenatal screening 
demonstrated significantly lower attachment compared with women who did not make 
informed choices.  Additionally, Hawthorne and Ahern (2009) learned that women who 
declined prenatal screening demonstrated a greater sense of connection with and 
responsibility to protect their pregnancies than women who participated in screening.  
These studies suggest that the offer of prenatal screening may increase feelings of 
attachment toward the pregnancy for some women, while other women postpone feelings 
of attachment until receipt of reassuring screening results.  The discordant findings on 
maternal fetal attachment as related to prenatal screening should be evaluated in 
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consideration that these studies used widely divergent designs, samples, and 
instrumentation.   
Unchartered territory.  Prenatal screening is a situation in which risk cannot be 
defined objectively; rather, potential risk is depicted via a calculated odds ratio.  The 
resultant interpretation of the probability of parenting a child with disabilities and the 
associated decision-making are identified as alien and destabilizing for women (Aune & 
Möller 2012; Hawthorne & Ahern 2009; Vanstone, Yacoub, Giacomini, Hulan, & 
McDonald, 2015).  Women struggle with how to evaluate the results of screening 
(Czerwinski et al., 2010; Georgsson Öhman et al., 2009; Hawthorne & Ahern, 2009; 
Farrell et al., 2011).  The language of chance and probability used to explain results of 
prenatal screening exacerbates feelings of confusion and anxiety, with the odds ratio so 
foreign and difficult for women to understand that it either is often grossly 
misinterpreted, unmemorable, or rendered meaningless (Czerwinski et al., 2010; 
Georgsson Öhman et al., 2009; Hawthorne & Ahern, 2009; Seror & Ville, 2009). 
The prospect of facing ethical decisions concerning pregnancy management is 
unfamiliar and unanticipated for many women (Rowe, Fisher, & Quinlivan., 2006; Farrell 
et al., 2011).  Seror and Ville (2009) learned that one-third of women considering 
prenatal screening were unaware that they may need to subsequently consider invasive 
diagnostic testing or pregnancy termination.  Farrell et al. (2011) found that only about 
one-third of women considered the cascade of post-test decisions as an important factor 
to consider in their decision to screen.  While women want the choice to screen, they 
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typically expect fetal health and are unready to make critical decisions following a 
positive screen result (Aune & Möller, 2012; Lalor & Begley, 2006).  
Moral tension. A predominant theme in the literature is tension concerning the 
utility and morality of prenatal screening.  Tension exists between the value of the 
foreknowledge provided by the screen and the uncertainty about how to act upon receipt 
of information concerning fetal anomaly (Aune & Möller, 2012; Hawthorne & Ahern, 
2009; Seror & Ville, 2010 Van Schendel et al., 2014).  Women make decisions about 
screening according to five main criteria: attitudes toward pregnancy termination, 
perceived risk of having a child with a disability, perception of risks associated with 
diagnostic testing, perceived benefit of obtaining information, and subjective norm of 
screening desirability (Li, Karlberg, Wi, & Norem, 2008; Van den Berg et al., 2008; 
Seror & Ville 2010).  Although women desire the relief that accompanies a reassuring 
screen, they are conflicted in discerning how to proceed with non-reassuring results 
(Aune & Möller, 2012; García, Timmermans, & van Leeuwen, 2012; Vanstone et al., 
2015).  Tension is also expressed between the value of the screen in providing 
information, and the fear that prenatal screening may lead to limitless screens toward the 
creation of the idealized child, with selection for gender or cosmetic traits (Van Schendel 
et al., 2014). 
Women experience conflict between moral duties arising from commitments to 
both the pregnancy and to existing family members.  Torn between the fetus’ life and the 
happiness of existing children and spouses, women voice concern that the hardship of 
caring for a disabled child will devastate family harmony (García et al., 2012; Hawthorne 
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& Ahern, 2009).  Rather than analyzing the moral dimensions of prenatal screening 
according to abstract principles, women consider the concrete realities of family members 
whose lives will be affected by the decision (Aune & Möller, 2012; García et al., 2009; 
Hawthorne & Ahern, 2009; Wätterbjörk et al., 2013). 
Exposure to disability.  There is the suggestion that the stigma of parenting a 
disabled child and lack of experience with people with disabilities may color decisions 
related to prenatal screening (Chiang et al., 2006; García et al., 2012; Hawthorne & 
Ahern, 2009; Skirton & Barr, 2010).  While women are typically aware that the screen is 
used to detect risk of having a child with Down syndrome, women possess inadequate 
knowledge of the clinical features of Down syndrome prior to making decisions about the 
screen (Farrell et al., 2011).  Skirton and Barr (2010) found that while 35% of couples 
considering prenatal screening wanted to know more about people with Down syndrome, 
19% of respondents believed that information about Down syndrome was irrelevant to 
their decisions.  Alternatively, Chiang et al. (2007) found that many women designated 
high risk for carrying a fetus with Down syndrome experienced self-transcendence, with 
increased empathy for people whose lives are affected by Down syndrome.  
 Friends and family.  Attitudes and decisions concerning prenatal screening may 
be more influenced by friends and family than health care professionals (Hawthorne & 
Ahern 2009; Li, Karlberg, Wi, & Norem, 2008; Park & Matthews, 2009).  In a 
population-based case-control study, Li et al. (2008) found that women who decline 
screening were more likely to actively seek information on the screen from their friends 
and to involve their partners in the decision.  Qualitative evidence indicates that women 
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assume a deep and personal responsibility toward decision-making and draw upon the 
experiences of friends and family to inform their decisions (Aune & Möller 2012; 
Etchegary et al., 2008; Williams et al., 2005).   
Authoritative Knowledge 
 Inadequate understanding.  Both qualitative and quantitative findings indicate 
that many women lack sufficient knowledge and understanding about the scope and 
limits of prenatal screening, Down syndrome, and subsequent testing prior to making a 
decision (Constantine et al., 2014; Farrell et al., 2011; Jaques et al., 2005; Schoonen et 
al., 2012; Skirton & Barr, 2010; Van den Berg et al., 2005).  Substantial reports concern 
the extent to which informed choice occurs with prenatal screening (Chiang et al. 2006; 
Constantine et al., 2014; Dixon & Burton, 2014; Fransen, Essik-Bot, Vogel, Mackenbach, 
Steegers, & Wildschut, 2010; Jaques et al., 2005; Rowe et al., 2006; Rowe et al., 2009; 
Schoonen et al., 2012; Skirton & Barr, 2010; Van den Berg et al., 2005).  The literature 
identifies two core characteristics of informed choice: first, that the choice occurs based 
on relevant and accurate information, and second, that the choice is aligned with the 
decision-maker’s values.  To evaluate knowledge of prenatal screening and informed 
choice, the studies reviewed most often used researcher-generated survey questions 
(Constantine et al., 2014; Dahl, Hvidman, Jørgensen, & Kesmodel, 2011; Farrell et al., 
2011; Skirton & Barr, 2010; Van den Berg et al., 2005Van den Berg et al., 2005), the 
Multidimensional Measure of Informed Choice (MMIC; Marteau, Dormandy, & Michie, 
2001) (Jacques et al., 2005; Rowe et al., 2006; Rowe et al., 2009), or a modified version 
of the MMIC (Dixon & Burton, 2014; Fransen et al., 2010; Schoonen et al., 2012).  The 
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MMIC is a measure derived from a definition of informed choice as “one that is based on 
relevant knowledge, consistent with the decision-maker’s values, and is behaviorally 
implemented,” (Marteau et al., 2001, p. 100).  The MMIC utilizes knowledge in 
combination with value-consistency, which occurs when an individual has a positive 
attitude and accepts screening or a negative attitude and declines to screen; all other 
combinations of attitude and screen utilization are classified as uninformed choices 
(Marteau et al., 2001).   
The prevalence of women who make uninformed choices varies geographically as 
follows: 33.3% in Australia (Jaques et al., 2005), 7% in Canada (Dixon & Burton, 2014), 
25 - 33.3% in the Netherlands (Schoonen et al., 2012; Van den Berg et al., 2005), and 
56.2% in the United States (Constantine et al., 2014).   In studies using the MMIC, 12% 
to 73.5% of women made uninformed choices due to value inconsistency only, 37.3% to 
49% made uninformed choices due to inadequate knowledge only, and 14.5% to 39% 
made uninformed choices due to both value inconsistency and inadequate knowledge 
(Fransen et al., 2010; Rowe et al., 2006).  These findings indicate that even when women 
are given adequate information, a substantial minority do not possess sufficient 
understanding or clarity of values to make informed decisions. 
Antecedent correlates of informed choice include higher educational level 
(Schoonen et al., 2012; Van den Berg et al., 2005), higher knowledge scores (Jaques et 
al., 2005), awareness that the screen is optional (Jaques et al., 2005), and being a member 
of the racial/ethnic majority (Fransen et al., 2010).  Evidence on the relationship between 
the utilization of the screen and informed choice is contradictory.  Rowe et al. (2006) and 
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Schoonen et al. (2012) found a positive correlation between utilization of the screen and 
informed choice, while Jaques et al. (2005) and Constantine et al. (2014) found that 
informed choice was less likely to occur among women who utilized the screen compared 
with women who declined the screen.  The only statistically significant predictors of 
informed choice that are reported in the reviewed literature are educational level (Jaques 
et al., 2005; Schoonen et al., 2012), race/ethnicity (Constantine et al., 2014; Fransen et 
al., 2010), and income (Constantine et al., 2014), with lower educational attainment, 
lower income level, and status as a racial or ethnic minority associated with making an 
uninformed decision.  Outcomes associated with informed choice for prenatal screening 
include reduced decisional conflict and greater satisfaction with the decision (Van den 
Berg et al., 2005).  Outcomes associated with higher knowledge of prenatal screening 
alone include reduced decisional conflict and greater personal well-being (Dahl et al., 
2011). 
Professional advice.  Women and their partners consider the decision to consent 
or decline screening a private, personal choice (Carroll et al., 2012; Williams et al., 
2005), yet they still value professional advice when making decisions (Ahmed, Bryant, 
Tizro, & Shickle, 2014; Carroll et al., 2012).  However, advice means different things to 
different women, particularly among diverse racial groups and ethnic cultures.  For 
example, in assessing decision-making for prenatal screening among an all-White British 
sample, Carroll et al. (2012) found that couples did not consult with their health care 
providers and predominantly viewed the health care provider’s role as purveyor of 
information.  In contrast, in a racially diverse sample that included African, British 
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White, Caribbean, Chinese, and Pakistani women, Ahmed et al. (2014) found that some 
participants believed that the health professional’s role entailed giving a recommendation 
or directive counsel on whether or not to screen.  Despite these variations, many women 
express the need for increased discourse with care providers prior to making decisions 
about screening.  Women report a lack of clarity about the risks and benefits of screening, 
the implications of screening, and what options are available following a positive screen 
(Ahmed et al., 2014; Park & Matthews, 2009).  Notably, the duration of counseling and 
the health care provider’s communication are positively associated with increased client 
psychosocial communication concerning the screen, indicating that the health care 
provider may need to take the lead in these conversations (Martin et al., 2016). 
Routinization 
  A concern raised by several authors is that the integration of prenatal screening in 
routine prenatal care creates a technological imperative with women perceiving prenatal 
screening as compliance with protocol rather than an option (Chiang et al., 2006; 
Constantine et al., 2014; Jaques et al., 2005; Park & Matthews, 2009; Pilnick, 2008; 
Skirton & Barr, 2010; Van Schendel et al., 2014).  Pilnick (2008) and Constantine et al. 
(2014) explicate that the offer of prenatal screening may be perceived as assent to a 
decision that is already endorsed by health experts rather than a choice requiring 
deliberation.  However, García et al. (2012) found that the offer of prenatal screening did 
not lead women to believe that they are morally compelled to consent to the screen; the 
participants recognized that mothers have a responsibility to seek the best health for their 
child but opined that this responsibility does not include prenatal screening.  Nonetheless, 
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women express that the earlier timing and widespread use of screening may lead to 
uncritical uptake and reduced discernment and dialogue concerning screening decisions 
(Hawthorne & Ahern 2009; Pilnick, 2008; Van Schendel et al., 2014).  
Paradox 
The final phase of data analysis in an integrative review involves coalescing 
specific findings to create a succinct summary (Whittemore & Knafl, 2005).  In this 
review, a global theme of paradox was identified in the extant literature on women’s 
experiences with prenatal screening for fetal aneuploidy and neural tube defects.  A 
paradox is a proposition that is contradictory in nature (Oxford University Press, 2016).  
The proposition of prenatal screening presents three inherently contradictory situations 
for women.  First, while women recognize the informational utility of prenatal screening, 
they are conflicted about making increasingly difficult choices.  Second, while the option 
to screen is intended to empower women through the provision of information, women do 
not demonstrate sufficient understanding of the risk and benefits of screening, the 
conditions screened, the implications of screening, and their risk of having an infant 
affected by an anomaly.  Third, although biomedical authority has a powerful and 
pervasive influence in prenatal care, paradoxically, women widely report a need for 
increased information, communication, and guidance from health care professionals. 
Discussion 
 Incongruence occurs between the implementation of prenatal screening, the 
ethical imperative of informed choice, and women’s experiences with prenatal screening.  
The goal of prenatal screening is to enable women to make informed choices about 
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whether they want to learn if they are at increased risk of having a child with an anomaly 
(ACOG, 2016a; Ames, Metcalfe, Archibald, Duncan, & Emery, 2015).  Through 
informed choice, women should be empowered to voluntarily decide what is right for 
them.  However, the offer of prenatal screening presents a paradox with inherently 
contradictory situations that combine to disempower rather than empower women.  The 
discussion will focus on two central points of this paradox: (1) the conflict between the 
utility and morality of prenatal screening in the context of technologically-laden modern 
obstetric care and social bias against disability and (2) decision-making with insufficient 
knowledge, inadequate understanding, and incomplete professional guidance and 
discourse.   
 Although women recognize the informational utility of prenatal screening and 
widely voice the desire to have a choice, they express considerable uncertainty about 
whether to accept or decline the screens (Aune & Möller, 2012; Carroll et al., 2012; 
Chiang et al., 2007; García et al., 2009; Vanstone et al., 2015).  Women often value the 
reassurance provided by a negative screen result, but have moral confliction about the 
nexus of prenatal screening to decisions about pregnancy termination and what fetal 
conditions might warrant termination.  Further, concern has been raised regarding health 
professional bias that problematizes all fetal anomalies, focusing on the associated 
medical complications, while failing to imagine that people with disabilities can lead 
lives as rich and fulfilling as their own (Bauer, 2011; Parens & Asch, 2003).  Juxtaposing 
these concerns with the findings of this review reveals that the process of receiving 
modern prenatal care in the context of a society and health care community that 
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uncritically integrates genetic technology and stigmatizes disability may have an internal 
momentum that drives toward prenatal screening as an imperative.  Yet the findings here 
indicate that the experience and emotional impact of uncritically accepting prenatal 
screening may be profound and lasting.  Nonetheless, the routinization of screening, the 
powerful influence of biomedical authority, and social norms of parenting and disability 
combine to create an environment in which it becomes difficult for women to opt out of 
prenatal screening, thereby impeding freedom of choice (Chiang et al., 2006; Constantine 
et al., 2014; Jaques et al., 2005; Pilnick, 2008; Van Schendel et al., 2014; Williams et al., 
2005).  As Hubbard explains, “as choices become available they all too rapidly become 
compulsions to ’choose’ the socially endorsed alternative,” (Hubbard, Henifin, & Fried, 
1982, p.210). 
 Current practice fails to secure women’s understanding of prenatal screening.  
Despite the receipt of information about prenatal screening, women have inadequate 
knowledge of the screens, the implications of screening, and the conditions detected 
(Farrell et al., 2011; Fransen et al., 2010; Georgsson Öhman et al., 2009; Seror & Ville, 
2009; Park & Matthews, 2009).  While many health professionals work toward the ideal 
of informed consent, women widely express that prenatal care providers do not 
communicate enough information about the risks and benefits of screening and the 
conditions they aim to detect.  It is not surprising then that uninformed choice due to 
inadequate knowledge and value inconsistency is reported at average rates of 33% of 
cases where prenatal screens are offered worldwide (Constantine et al., 2014; Jaques et 
al., 2005; Rowe et al., 2006; Schoonen et al., 2012; Van den Berg et al., 2005).  
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Inadequate information about what life is like for those with disabilities results in women 
making their decisions about screening based on misinformation about the conditions 
screened.  Additionally, there is discordance between a woman’s clinical risk and her 
interpretation of that risk, with the majority of women misinterpreting their probability of 
having a child with a disability (Czerwinski et al., 2010; Hawthorne & Ahern, 2009; 
Vanstone et al., 2015).  This skewed risk perception, in combination with the social 
stigma of disability and the milieu of risk awareness and geneticism prevalent in modern 
health care, contribute to a disempowering sense of fear and anxiety about having a less 
than ideal baby (Chiang et al., 2006; Chiang et al., 2007; Georgsson Öhman et al., 2009; 
Hawthorne & Ahern, 2009; Van Schendel et al., 2014).   
 The moral complexity of the decision whether or not to use prenatal screening 
requires that sources of knowledge elucidate choices that align with women’s values.  
Therefore, it is vital that women understand the risks and benefits of screening and what 
treatment options are available if the screen indicates abnormality.  However, the findings 
of this review indicate that the advice and information provided by health professionals is 
often superficial, incomplete, or too ambiguous to be useful (Ahmed et al., 2014; Farrell 
et al., 2011; Park & Matthews, 2009; Skirton & Barr, 2010).  Women widely report a 
need for increased discourse with their health care providers to clarify their understanding 
of prenatal screening and facilitate decision-making.  Thus, while the option to screen for 
fetal anomalies is intended to empower women through the provision of information and 
the opportunity to make an autonomous choice, current screening practices may 
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disempower women because they fail to adequately educate women, support their 
understanding, and insure informed choice.   
Implications   
 Decisions about prenatal screening are value-laden, time-sensitive, and require 
risk assessment, discernment of preferences, and moral judgment.  The findings of this 
review overwhelmingly demonstrate a need for interventions to support women’s 
informed decision-making for prenatal screening.  Evidence indicates that video tutorials, 
focused discussion with health professionals, and written and electronic decisional aides 
can support women’s understanding of prenatal screening and facilitate decision-making 
that reflects women’s preferences and values (Ahmed et al., 2014; Carroll et al., 2012; 
Kuppermann et al., 2009).  These tools should be widely integrated in the first trimester 
at the initial prenatal care appointments to give women the opportunity to gain 
understanding of prenatal screening options, the conditions the screens detect, and the 
implications of screening.  Sectors of the population of pregnant women, including 
racial/ethnic minorities and those with lower education, who are especially vulnerable to 
making decisions about prenatal screening that are inadequately informed may require 
targeted intervention to improve their understanding about prenatal screening (Fransen et 
al., 2010; Schoonen et al., 2012).  The findings of this review indicate that many women 
do not understand that a low risk screen result does not guarantee a healthy child and a 
high risk result does not mean the fetus has an anomaly (Farrell et al., 2011; Pilnick, 
2008).  It is critical that all women who receive prenatal screening understand the 
distinction between a screen and a diagnostic test prior to any irreversible pregnancy 
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management decisions such as termination.  Moreover, the routinization of prenatal 
screening underscores the importance of women understanding that the decision to use or 
decline a prenatal screen is their individual choice.  Therefore, prenatal care providers 
can support women’s understanding of prenatal screening by intentionally 
communicating the distinction between a screen and a test, and the volitional nature of 
prenatal screening. 
Salient questions about women’s experiences with prenatal screening are raised 
by the findings of this review and warrant future research: (1) Low educational level and 
minority race/ethnicity are associated with reduced rates of informed decision-making for 
prenatal screening.  What other patient-level variables might explain insufficient 
knowledge and inadequate informed choice?  (2) Evidence of the relationships between 
informed decision-making, screening uptake, and maternal fetal attachment is equivocal.  
How might informed consent and screening uptake impact maternal role identity both in 
the antepartum and postpartum periods?  (3) While qualitative evidence emphasizes the 
situational and cultural context of women’s experiences with prenatal screening, the 
evidence is largely limited to the perspectives of middle and upper class women in 
Northern Europe and Australia.  What are the experiences of prenatal screening for ethnic 
minorities, economically disadvantaged women, and women outside of these geographic 
areas?  Future research aimed at answering these questions will aid in supporting 
informed decision-making for prenatal screening for women across the world.   
 Finally, the value of prenatal screening is traditionally based on the principle of 
autonomy and the rational choice model of decision-making, with the premise that 
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women who have enough information can freely decide whether or not to undergo 
screening (Lalor & Begley 2006; Ames et al., 2015).  Given the findings of this review, 
the rational choice model presents two problematic assumptions: the assumption of an 
independent decision-maker who makes decisions apart from social, cultural, and 
political influences and the assumption that objectivity results when ostensibly neutral 
information is produced and disseminated.  In contrast, the findings here indicate that 
decisions about prenatal screening are embedded in a relational morality, which is 
contextually bound by the woman’s experiences, environment, risk perception, and moral 
obligations to existing family members.  A woman’s risk perception is often incongruent 
with the screening-determined risk, and the milieu of risk awareness may constrain rather 
than enable free choice.  Further, the moral tensions surrounding prenatal screening 
become increasingly complex and ethically contentious with the prospect of subsequent 
decisions.  Therefore, additional inquiry and ethical debate is needed to illuminate how 
underlying presuppositions and ideological norms influence informed decision-making 
for prenatal screening. 
Limitations 
 This integrative review is subject to several limitations.  When synthesizing the 
findings of quantitative and qualitative studies and diverse methodologies, inaccuracy 
and bias may result.  To mitigate this limitation, the guidelines established for integrative 
review by Whittemore and Knafl (2005) were followed.  It is possible that some relevant 
studies were not included due to the limitations of review methods which rely on 
database searches with inconsistent key terms and indexing problems.  Generalizability, 
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while supported by the international representation of the reviewed studies, is restricted 
due to variation in international policies and guidelines on prenatal screening, health care 
systems, and cultural beliefs and values.  Further, this review grouped nuchal 
translucency, maternal serum screening, and NIPT under the inclusive umbrella of 
prenatal screening, which may obfuscate findings.  However, the findings of this review 
suggest that the relevant variables and themes concerning women’s decision-making and 
experiences with prenatal screening may not be test-specific, but rather inherent to the 
phenomenon of prenatal screening for fetal anomaly. 
Conclusion 
This review provides strong evidence that prenatal screening occurs in a complex 
social, ethical, and political reality in which women’s experiential knowledge as well as 
biomedical authority act as key influences.  A theme of paradox was identified that 
encompasses the moral ambiguity, insufficient knowledge, incomplete understanding, 
and unclear risk perception that surround decision-making for prenatal screening.  This 
review highlights the need for future inquiry to identify individual-level factors that 
influence informed decision-making, to elucidate the prenatal screening-experiences of 
women globally and among racial and ethnic minorities, and to guide interventions that 
support informed decision-making for prenatal screening.  Further, this review heralds a 
need for further ethical analysis on how prenatal screening is integrated and evaluated in 
prenatal care.  
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CHAPTER III 
 
METHODS 
 
 
Specific Aims and Research Questions 
 The overall goal of this study was to explore the relationships between women’s 
understanding of prenatal aneuploidy screening, health literacy, and satisfaction with 
decisions made for prenatal aneuploidy screening.   
Specific Aim 1: To assess women’s satisfaction with decisions made for prenatal 
aneuploidy screening.   
Research Question 1: Are women satisfied with the decisions they make for prenatal 
aneuploidy screening? 
Specific Aim 2: To assess the influence of health literacy on women’s understanding of 
prenatal aneuploidy screening. 
Research Question 2: What is the relationship of health literacy to women’s 
understanding of prenatal aneuploidy screening?  
Specific Aim 3:  To assess the influences of health literacy and understanding of prenatal 
aneuploidy screening on women’s satisfaction with decisions made for prenatal 
aneuploidy screening. 
Research Question 3: What is the relationship of health literacy and understanding of 
prenatal aneuploidy screening to women’s satisfaction with decisions made for prenatal 
aneuploidy screening? 
 
 
77 
Conceptual Definition of Terms 
Decision-making: A process of cognitive reflection and evaluation of alternative options 
that leads to an outcome or behavior. 
Educational level: The highest formal education attained by the participant. 
Health literacy: An individual’s ability to seek, understand, and utilize health 
information within the broad social and environmental context of health services. 
Informed decision: An autonomous, deliberate decision based on substantial 
understanding of available evidence of alternative options and risks of a proposed 
treatment and its implications.   
Prenatal aneuploidy screening: The offer of a laboratory analysis to provide a risk 
assessment of carrying a fetus with chromosomal aneuploidy. This includes maternal 
serum screens (with or without nuchal translucency) or non-invasive prenatal testing. 
Race/ethnicity: Self-identified ancestral origin according to socially constructed 
categories. 
Satisfaction with a decision: The result of a choice that is adequately informed, based 
on the decision-maker’s values, and behaviorally implemented. 
Satisfaction with a decision made for prenatal aneuploidy screening: The result of a 
choice for prenatal aneuploidy screening that is adequately informed, based on the 
decision-maker’s values, and behaviorally implemented. 
Understanding of prenatal aneuploidy screening:  Cognitive awareness that occurs 
when an individual has sufficient knowledge of prenatal aneuploidy screening and the 
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possible consequences of that act, including subsequent decision-making and ancillary 
diagnostic tests. 
Uptake of prenatal aneuploidy screening: The behavioral implementation of the 
decision to consent to prenatal aneuploidy screening (uptake) or decline (no uptake). 
Operational Definition of Terms 
Educational level: The response to the question asking the participant to select their 
highest educational attainment: some high school, high school diploma or equivalent, 
college degree (associate or bachelor’s), or graduate degree. 
Gravidity: The response to the obstetrical history question asking the participant how 
many times she has been pregnant. 
Health literacy: The scores of five domain scales of the Health Literacy Questionnaire 
(HLQ) (Osborne et al., 2013). The five domains are: 1) Feeling understood and supported 
by healthcare providers; 2) Appraisal of health information; 3) Ability to actively engage 
with healthcare providers; 4) Ability to find good health information; 5) Understand 
health information enough to know what to do. 
Parity: The response to the obstetrical history question asking the participant how many 
children she has carried to at least 20 weeks of pregnancy. 
Race/ethnicity: The response to the demographic question asking the participant which 
of the following categories best describes herself: a) Caucasian/White, b) African 
American/ Black, c) Hispanic/Latino, d) American Indian/Alaska Native, e) Asian, f) 
Hawaiian Native/Pacific Islander, g) other.   
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Satisfaction with decisions made for prenatal aneuploidy screening: The scores of the 
Satisfaction with Decision Scale (SWDS) (Holmes-Rovner et al., 1996).  
Understanding of prenatal aneuploidy screening: The scores of the Maternal Serum 
Screening Knowledge Questionnaire (MSSKQ) (Goel, Glazier, Holzapfel, Pugh, & 
Summers, 1996).   
Uptake of prenatal aneuploidy screening: The affirmative or negative response to the 
question: “Did you have a screening test to see if your baby might have a chromosome 
problem?”   
Design 
 This study employed a correlational design to explore adult women’s decision-
making for prenatal aneuploidy screening using cross-sectional methodology.  The cross-
sectional design allows for examination of relationships among a target population at one 
point in time (Polit & Beck, 2016).  Correlational research provides a systematic 
investigation of relationships between variables, without necessarily determining cause 
and effect.  A questionnaire was used to assess the relationships between women’s 
satisfaction with decisions made for prenatal aneuploidy screening, health literacy, and 
women’s understanding of prenatal aneuploidy screening.  Decisions made for prenatal 
aneuploidy screening are complex and have a profound impact on prenatal care and 
pregnancy outcomes.  Therefore, it is necessary (a) to examine how health literacy 
influences women’s understanding of prenatal aneuploidy screening and (b) to examine 
how health literacy and understanding of prenatal aneuploidy screening influence 
women’s satisfaction with their decisions made for prenatal aneuploidy screening.  The 
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results of this study will aid in the development of education for prenatal care providers 
and interventions for clients to facilitate women’s informed choice in decisions for 
prenatal aneuploidy screening.   
 Electronic survey methodology utilizing the online data collection software 
Qualtrics (Provo, Utah) was used in this study to allow a large number of expectant 
women living in western North Carolina to participate in the research.  The online survey 
was distributed to eligible participants to recipients of an electronic pregnancy newsletter 
with an anonymous link.  The electronic survey protected participants’ anonymity while 
providing convenience, as participants could complete the survey at any computer, tablet, 
or smart phone with internet access.  
Sample 
 The target population was adult pregnant women who are 18 or more weeks 
pregnant, 18 years of age or older, and attending prenatal care visits in western North 
Carolina.  Participants were recruited using convenience sampling of the population of 
women receiving an electronic parenting newsletter through Mission Hospital, a regional 
obstetrical tertiary care center in western North Carolina.  The electronic newsletter, The 
Parent Review, is received by approximately 1,500 recipients each month.  The Parent 
Review is a free weekly pregnancy and parenting e-mail tailored to the recipient’s week 
of pregnancy and to the age of the newborn through age three years.  It includes 
information, news, and resources for expectant and new parents. 
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Setting 
 The Parent Review is received by current parents and expectant families living in 
the service area of Mission Hospital, where over 3,500 babies are delivered annually 
(WNC Healthy Impact, 2016).  Mission Hospital is a not-for-profit, independent 
community health system that provides maternity services for women representing 19 
counties in western North Carolina (Mason, 2014).  Mission’s service population 
primarily includes residents of the following counties in North Carolina: Buncombe, 
Haywood, Henderson, Madison, McDowell, Transylvania, and Yancey.  The percentage 
of residents of these counties who are over age 25 years and have a high school diploma 
or higher degree ranges from 80.7-89.0%, and those with a bachelor’s degree or higher 
ranges from 19.3-29.7% (U.S. Census Bureau, 2014).  It was anticipated that a sufficient 
sample of pregnant women representing diverse educational levels could be recruited 
within three months.  Data were collected using a convenience sample. 
Sampling Plan   
 Inclusion and exclusion criteria.  Inclusion criteria for the study were: women ≥ 
18 years old, ≥ 18 weeks pregnant, and who consent to enroll in the study.  The exclusion 
criteria included the following: maternal age < 18 years old, < 18 weeks pregnant, and 
non-English speaking women.  Women who do not speak English were excluded because 
the instruments selected for this study had not been translated or validated with non-
English speaking populations.  Women under 18 years old were excluded because 
cognitive reasoning abilities are still developing in women under 18 years of age, which 
affect their perceptions of pregnancy and likely impact their understanding and decision-
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making for prenatal aneuploidy screening (Wong, Hockenberry, & Wilson, 2011).  
Women who are less than 18 weeks pregnant were excluded because prenatal aneuploidy 
screening typically occurs up to 18 weeks of pregnancy, and the aims of this study 
include assessment of satisfaction with the decision made for prenatal aneuploidy 
screening, which requires data to be collected after the participant has made the decision. 
 Sample size.  A power analysis was done to determine the needed sample size 
using G*Power 3.1 (Düsseldorf, Germany).  For a multiple linear regression of nine 
independent variables (educational level, five domain scores of the HLQ, one indicator 
variable representing majority/minority race/ethnicity, uptake of prenatal aneuploidy 
screening, and MSSKQ scores) on satisfaction with decisions made for prenatal 
aneuploidy screening (SWDS scores), a sample size of 92 is required to detect a medium 
effect size (Cohen’s f2 = .15) at a two-sided .05 significance level with 80% power. 
Therefore, the target sample size for this study is at least 92.  An invitation to participate 
in the study was sent to recipients of Mission Health System’s electronic pregnancy and 
parenting newsletter via electronic mail.  
Protection of Human Subjects 
 Approval to conduct this study was sought and exempt status obtained from the 
Institutional Review Board for Mission Memorial Health System in Asheville, North 
Carolina and from the Institutional Review Board at The University of North Carolina at 
Greensboro (Appendix A. Mission Institutional Review Board Exempt Status Letter; 
Appendix B. The University of North Carolina Greensboro Exempt Status Letter).  
Participants were invited to participate in the study through an electronic parenting 
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newsletter distributed through Mission Health System (Appendix C. Recruitment E-
mail).  Potential participants were informed that their participation in the study is strictly 
voluntary. Consent forms were distributed at the beginning of the electronic survey.  
Potential participants could click a button to consent or not, where if they did not consent, 
the survey would automatically end.  Signed consent forms were not required. 
 Personally identifiable health information was not collected.  The Qualtrics 
survey was configured so that ISP addresses were not collected.  There was little 
likelihood of any physical risk as a result of participating in this study.  There was the 
potential for, yet unlikely risk of, emotional response for thinking about decisions related 
to the pregnancy.  Participants were advised within the consent form that they are under 
no obligation to complete the survey and may stop the survey at any time.  There were no 
anticipated direct benefits for the participants.  Potential indirect benefits may accrue to 
women who participated in the study in that participation may increase understanding and 
self-awareness of one’s understanding of screening tests, one’s process of decision-
making, and personal communication and informational needs related to health literacy.  
This increased awareness of self and identification of needs may lead to empowerment to 
seek and gain support in current and future health care decisions.  The information gained 
in the course of this research will inform interventions and education for care providers to 
facilitate prenatal care that upholds the ethical principles of self-determination and 
informed choice for prenatal screening for fetal aneuploidy.  Thus, the minimal and low 
potential risks to participants were deemed reasonable in relation to the potential benefits 
to participants and others. 
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 Confidentiality and anonymity were maintained.  Informed consent, the purpose 
of the study, and the study process was explained to participants on the face page of the 
electronic survey (Appendix D. Consent Form).  The surveys and consent forms were 
electronically distributed and administered through the online data collection software 
Qualtrics via an anonymous survey link.  The survey link was attached to the invitation to 
participate in the study which was emailed to recipients through Mission Health System.  
To minimize the possibility that non-pregnant women would happen upon the survey via 
an internet search engine, the survey was designed using Qualtrics survey protection 
settings to prevent indexing of the survey by internet search engines.  To prevent a person 
from responding to the survey multiple times, Qualtrics survey protections were 
configured with the Prevent Ballot Box Stuffing option (Qualtrics Survey Software, n.d.).  
The collected data were stored by Qualtrics on secure servers equipped with firewalls 
until accessed by the researcher with correct login and password protection.  Data were 
exported to the Statistical Package for the Social Sciences version 24 (SPSS v24) (IBM 
Corp., Armonk, NY), and the SPSS data file was password protected.  Data files were 
also stored on a password protected Box account through the University of North 
Carolina Greensboro.  
 To encourage participation, potential participants were informed that upon 
completion of the survey, they would be eligible to enter a lottery to win one of two $50 
gift cards to Target or Walmart.  Upon completion of the study survey, participants were 
redirected to a separate web link to enter their email address to enter the lottery for the 
gift cards.  Participants were informed that entering their email address is optional and 
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they could click on a decline button if they did not want to enter the lottery.  To maintain 
the anonymity of survey responses, the lottery drawing for the gift cards was separate 
from the main study survey, so responses could not be linked to participants’ email 
addresses. 
Measurement 
 A researcher-designed tool was used to collect demographic data with 
race/ethnicity and obstetric history.  The demographic tool has a Flesch-Kincaid reading 
level of 4.9.  Participants were asked to indicate their numbers of living children and 
previous pregnancies, the number of pregnancies they carried to at least 20 weeks of 
gestation, if they have any history of having a pregnancy in which their baby had a 
chromosomal disorder, and if they are aware of any ultrasonographic findings indicating 
a chromosome problem with their current pregnancy.  To assess uptake of prenatal 
aneuploidy screening, participants were asked, “Did you have a screening test to see if 
this baby might have a chromosome problem?”  To assess education, participants were 
asked to indicate their highest educational attainment: less than high school diploma, high 
school diploma or equivalent, some college, college degree, or graduate degree.  
Additional constructs were assessed using three instruments to measure the identified 
concepts: (a) the Health Literacy Questionnaire (HLQ) (2013), (b) the Maternal Serum 
Screening Knowledge Questionnaire (MSSKQ) (1996), and (c) the Satisfaction with 
Decision Scale (SWDS) (1996).  The three instruments are outlined in Table 3.1 below.  
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Table 3.1 
Key Variables and Measures 
Variables Instrument/Measure Scoring Reliability 
Health 
literacy 
Health Literacy Questionnaire 
domains (Osborne et al., 2013) 
Domain scores are 
summed and divided by 
number of items  
Estimates 
of 
reliability  
4-point Likert scale, 4 items each Score range __ 
Feeling understood and supported 
by healthcare providers  
1 – 4 ρ1 = 0.88 
 
Appraisal of health information 1 – 4 ρ = 0.77 
5-point Likert scale, 5 items each Score range __ 
Ability to actively engage with 
healthcare providers  
1 – 5 ρ = 0.90 
Ability to find good health 
information  
1 – 5 ρ = 0.89 
Understand health information 
enough to know what to do  
1 – 5 ρ = 0.88 
Satisfaction 
with decisions 
made for 
prenatal 
aneuploidy 
screening 
The Satisfaction with Decision 
Scale. A 6-item measure to assess 
degree of satisfaction with the 
process of decision-making 
(Holmes-Rovner et al., 1996) 
Responses are on a 5-
point Likert scale. Scores 
are summed for a range 
of 5 – 30. 
α = 0.86  
 
Understanding 
of prenatal 
aneuploidy 
screening 
The Maternal Serum Screening 
Knowledge Questionnaire. 
A 14-item instrument, 12 of which 
are applicable to prenatal 
aneuploidy screening (Goel et al., 
1996). 
Responses occur on a 5-
point scale (range -2 to 
2). Scores are summed 
and divided by the 
number of items, for a 
range of -2 to 2.  
α = 0.74  
 
Note. 1. ρ = Index of composite reliability (Raykov’s rho) 
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The Health Literacy Questionnaire 
 Health literacy was measured using the Health Literacy Questionnaire (HLQ) 
(Osborne et al., 2013; Osborne et al., 2014).  The HLQ is a 44-item multi-dimensional 
assessment of health literacy that was developed using a validity-driven approach 
(Buchbinder et al., 2011).  The development process for the HLQ included in-depth 
grounded consultations with a broad range of adult populations, patients, clinicians, and 
policy makers in combination with concept mapping, cognitive interviews, and extensive 
psychometric analyses (Osborne et al., 2013).  The HLQ measures nine domains of health 
literacy and is designed to be used for program evaluation, needs assessment, and 
intervention development.  Each domain of health literacy is captured by a scale in the 
HLQ.  Five of the domains reflect core behavioral competencies necessary for health care 
decision-making and will be measured in this study.  These domains are: 1) Understand 
health information enough to know what to do; 2) Ability to find good health 
information; 3) Feeling understood and supported by healthcare providers; 4) Ability to 
actively engage with healthcare providers; and 5) Appraisal of health information.  For 
this study, health literacy is operationalized using the scale scores for these five domains 
of health literacy.  These domains correspond to Nutbeam’s three levels of health literacy 
as depicted in Table 3.2 below.  
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Table 3.2 
Connection Between Nutbeam’s Schema1 and Health Literacy Questionnaire Domains2 
Nutbeam’s Schema for Health Literacy Health Literacy Questionnaire 
Domain 
Basic/functional health literacy: sufficient 
basic numeracy and literacy skills to be able 
to function effectively in everyday situations 
Ability to find good health 
information 
Understand health information 
enough to know what to do 
Communicative/interactive health 
literacy: more advanced cognitive and 
literacy skills needed to actively participate 
in and derive meaning from various types of 
communication, and to apply new 
information to dynamic situations  
Feeling understood and supported 
by healthcare providers 
Ability to actively engage with 
healthcare providers 
Ability to find good health 
information 
Critical health literacy: more advanced 
cognitive skills, which together with social 
skills, can be applied to critically analyze 
information, and to use this information to 
exert greater control over life events and 
situations 
Appraisal of health information 
Note. 1. Schema adapted from Nutbeam (2000). 
2. Connection between Nutbeam’s schema and Health Literacy Questionnaire domains 
adapted from Osborne et al. (2013). 
 
 
 The HLQ scales each are comprised of four to five items that are scored as a 
graded Likert response.  The response set and scoring (in parentheses) for the scales 
Feeling understood and supported by healthcare providers and Appraisal of health 
information are: strongly disagree (1), disagree (2), agree (3), and strongly agree (4) 
(Health Literacy Questionnaire Scoring Algorithm Instructions, 2016).  The response set 
and scoring (in parentheses) for the scales Ability to actively engage with healthcare 
providers, Ability to find good health information, and Understand health information 
well enough to know what to do are: cannot do or always difficult (1), usually difficult 
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(2), sometimes difficult (3), usually easy (4), and always easy (5).  Initial psychometric 
testing of the HLQ was performed with samples comprised of adult patients attending a 
private rheumatology clinic, adults receiving home care through a metropolitan 
community care organization, and adult patients who were treated at the emergency 
department of a regional teaching hospital (Osborne et al., 2013).  Evidence of construct 
validity for the HLQ was supported empirically with confirmatory factor analysis (CFA) 
(Osborne et al., 2013).  For each of the subscales, CFA using a one-factor model 
demonstrated satisfactory fit, with each scale meeting the following criteria: Comparative 
Fit Index (CFI) > 0.95, Tucker-Lewis Index (TLI) > 0.95, and Weighted Root Mean 
Square Residual (WRMR) < 1.0.  Evidence of reliability for the HLQ scales was 
supported with additional CFA and calculation of Raykov’s rho (see Table 1) using a 
replication sample, which included patients with both chronic and acute illness.  
 While potential cultural differences may exist between Australian and American 
populations, the rigorous development of the HLQ and extensive psychometric testing 
across diverse adult populations provide evidence to support the use of the HLQ among 
English-speaking adult pregnant women in the United States (U.S.).  To date, there are no 
published records indicating that the HLQ has been tested in the U.S., nor among 
populations of women receiving prenatal care.  Thus, the HLQ has not been established 
as a reliable and valid instrument in the target population for this proposed study.  
However, its use among pregnant women from diverse socioeconomic, educational, and 
cultural backgrounds is supported in that the samples used for development and testing of 
the HLQ included adults, the majority being female, across a wide range of ages and 
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representing broad socioeconomic and health continuums in Western societies (Osborne 
et al., 2013).  The HLQ has a Flesch-Kincaid reading level of 7.6. 
The Maternal Serum Screening Knowledge Questionnaire  
 Understanding of prenatal aneuploidy screening was assessed using the Maternal 
Serum Screening Knowledge Questionnaire (MSSKQ) (Goel et al., 1996).  The MSSKQ 
is a 14-item instrument designed to assess women’s knowledge of maternal serum 
screening for chromosomal aneuploidy and neural tube defects.  The following four 
domains of knowledge are assessed in the MSSKQ: a) screening test characteristics, b) 
the timing and indications for the screen, c) the role of ancillary tests and risks associated 
with those tests, and d) the conditions screened and the risk factors for those conditions.  
As two of the items pertain to neural tube defects and not chromosomal aneuploidy, the 
instrument was modified to include the remaining 12 items that are relevant to prenatal 
aneuploidy screening.  Each item response occurs on a 5-point Likert scale.  Items are 
recoded with a value of 2 assigned if the correct response is given with a “strongly agree” 
or “disagree,” and a value of 1 for a correct response with an “agree” or “disagree” 
statement.  Incorrect responses are assigned a value of - 2 and - 1, respectively.  A value 
of 0 is assigned for a “not sure” response (Goel et al., 1996).  Sum scores are divided by 
the number of items, for a range of -2 to 2, with higher scores indicating greater 
understanding.  Construct validity of the MSSKQ is supported by correlations between 
higher MSSKQ scores among respondents with higher education and those who report 
having discussed prenatal screening with their health care providers.  Further, the 
MSSKQ has evidence supporting reliability with a coefficient alpha of 0.74 and test-
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retest reliability of 0.76 (Goel et al., 1996).  The MSSKQ has a Flesch-Kincaid reading 
level of 7.8. 
The Satisfaction with Decision Scale 
 Satisfaction with decisions made for prenatal aneuploidy screening was be 
assessed using the Satisfaction with Decision Scale (SWDS) (Holmes-Rovner et al., 
1996).  This six-item scale was developed by a nurse researcher to measure global 
satisfaction with an identified decision and the attributes of an effective decision 
(Holmes-Rovner et al., 1996).  The scale is designed to be tailored to the specific health 
care decision of interest.  The instrument employs a 5-point Likert scale to measure a 
respondent’s level of agreement with the following items: a) I am satisfied that I was 
adequately informed about the issues important to my decision about using a screening 
test to detect a chromosome problem with my baby; b) the decision I made was the best 
decision possible personally for me; c) I am satisfied that the decision was consistent with 
my personal values; d) I expect to carry out (or continue to carry out) the decision that I 
made; e) I had as much input as I needed in the decision about using a screening test to 
detect a chromosome problem with my baby; and f) I am satisfied with my decision about 
using a screening test to detect a chromosome problem with my baby (Wills & Holmes-
Rovner, 2003).  Responses are scored as follows: Strongly disagree (1), Disagree (2), 
Neither agree nor disagree (3), Agree (4), and Strongly agree (5).  Responses to the items 
are added together, for a range of 6-30.  The resulting score reflects a respondent’s degree 
of satisfaction with the decision made for prenatal aneuploidy screening, with higher 
scores indicating greater satisfaction with the decision.   
 
 
92 
 The Satisfaction with Decision Scale has evidence supporting reliability with a 
coefficient alpha reported at 0.86 (n = 252) (Holmes-Rovner et al., 1996).  Additionally, 
Holmes-Rovner and colleagues found evidence of discriminant validity for the measure 
based on its relationship to the Decisional Conflict Scale (r = -0.66), and evidence of 
concurrent validity based on the measure’s relationship to the Confidence in Decision 
Scale (r = 0.64) (Holmes-Rovner et al., 1996).  The SWDS has a Flesch-Kincaid reading 
level of 8.6. 
 Following consent, the HLQ, MSSKQ, and SWDS were presented first, followed 
by the tool for collecting demographic and obstetric data.  Directions for completing the 
questionnaire were included at the top of the first page of the questions.  Specific 
directions for completing each instrument were delineated at the top of the screen at the 
beginning of the series of questions for each instrument.  A copy of the survey (excluding 
the HLQ due to the license agreement) is available as an appendix (Appendix E. Study 
Survey).  Permission to use the HLQ was obtained (Appendix F. HLQ License), and the 
other measures are available for use in academia without permission.  The variables of 
interest in this study and their parameterization are summarized in Table 3.3.  
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Table 3.3 
 
Variable Categorization  
 
Variable Label  Description Type 
Key Variables 
Health care 
provider support 
Health literacy domain score: 
Feeling understood and supported 
by healthcare providers (1-4) 
Scale, ordinal 
Critical appraisal Health literacy domain score: 
Appraisal of health information (1-
4) 
Scale, ordinal 
Active 
engagement 
Health literacy domain score: 
Ability to actively engage with 
healthcare providers (range 1-5) 
Scale, ordinal 
Find health 
information 
Health literacy domain score: 
Ability to find good health 
information (1-5) 
Scale, ordinal 
Understand health 
information 
Health literacy domain score: 
Understand health information well 
enough to know what to do (1-5) 
Scale, ordinal 
MSSKQ Maternal Serum Screening 
Knowledge Questionnaire score (-2 
to 2) 
Scale, ordinal 
SWDS Satisfaction with Decision Scale 
score (6-30) 
Scale, ordinal 
Covariates 
Educational 
level 
0 = Less than high school diploma 
1 = High school diploma or    
      equivalent 
2 = Some college  
3 = Associate of Bachelor’s degree 
4 = Graduate degree 
Categorical, ordinal 
Parity Number of live births 
0 = 0 births 
1 ≥ 1 live birth 
Categorical, ordinal 
Race/Ethnicity 0 = Other 
1 = White, non-Hispanic 
Categorical, nominal 
Uptake Uptake of prenatal aneuploidy 
screening 
0 = No, 1 = Yes 
Dichotomous, nominal 
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Data Collection 
The survey was presented electronically via Qualtrics.  Following a brief 
description of the study, an invitation to participate in the study and the link to the survey 
was sent via electronic mail to the recipients of the electronic parenting newsletter.  
Consent to participate was obtained on the face page of the electronic survey.  The survey 
was presented with the measures as previously described in this chapter.  Completed data 
was saved in the survey program.  To eliminate data entry error, the data was 
electronically exported directly into SPSS.  To ensure confidentiality, no respondent 
identifiers or personally identifiable health information was collected. 
Strategies were implemented to ease navigation through the survey.  A neutral 
white color was used with black text to enhance readability (Ritter & Sue, 2007).  
Questions were bolded and responses were not in bold (Fanning, 2005).  Items required a 
response to proceed to the next question to avoid incomplete data.  A tracking bar was 
displayed on the screen to indicate the participant’s progress in completion of the survey. 
Data Analysis 
   Analyses were performed using the Statistical Package for the Social Sciences 
version 24 (SPSS v24) (IBM Corp., Armonk, NY).  To eliminate data entry error, the 
data were electronically exported directly into into SPSS v24.  Data were screened for 
missing values.  A two-sided p-value ≤ .05 was considered statistically significant.  
Continuous variables were assessed for outliers and normality in univariate analysis using 
box-plots, normal P-P plots, and Kolmogorov-Smirnov tests.  Scatter plots were used to 
assess the linearity of the relationships between continuous variables.  Spearman’s rho 
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and point-biserial coefficients were used for bivariate correlational analysis.  Regression 
assumptions were assessed with analysis of studentized deleted residuals.  
Multicollinearity was examined using variance inflation factors (VIFs).  Additional 
analyses occurred in accordance with each specific aim: 
Specific Aim 1: To assess women’s satisfaction with decisions made for prenatal 
aneuploidy screening.   
Analysis for Aim 1.  Descriptive statistics were used to describe the frequency at which 
women are satisfied with decisions made for prenatal aneuploidy screening.  The 
proportion of women who are satisfied with decisions made for prenatal aneuploidy 
screening was estimated along with a 95% confidence interval (CI). 
Specific Aim 2: To assess the influence of health literacy on women’s understanding of 
prenatal aneuploidy screening. 
Analysis for Aim 2.  Multivariable linear regression was used.  The five domain scores 
of health literacy (HLQ domain scores), the independent variables, were regressed on 
women’s understanding of prenatal aneuploidy screening (MSSKQ scores), the 
dependent variable, adjusting for uptake of prenatal aneuploidy screening, educational 
level, and race/ethnicity. 
Specific Aim 3:  To assess the influences of health literacy and understanding of prenatal 
aneuploidy screening on women’s satisfaction with decisions made for prenatal 
aneuploidy screening. 
Analysis for Aim 3: Multivariable linear regression was used.  The five domain scores of 
health literacy (HLQ domain scores) and understanding of prenatal aneuploidy screening 
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(MSSKQ scores), the independent variables, were regressed on women’s satisfaction 
with decisions made for prenatal aneuploidy screening (SWDS scores), the dependent 
variable, adjusting for uptake of prenatal aneuploidy screening and parity. 
Chapter Summary 
 A descriptive, correlational study was conducted to explore women’s informed 
decision-making for prenatal aneuploidy screening using cross-sectional methodology.  A 
convenience sample of 95 adult English-speaking women ≥ 18 weeks pregnant was 
recruited to participate in the study through an electronic parenting newsletter.  The study 
was guided by Faden and Beauchamp’s (1986) model of informed consent, Nutbeam’s 
(2000) concept of health literacy, and Holmes-Rovner and colleague’s (1996) concept of 
satisfaction with a decision.  Potential participants were invited to complete an online 
survey which included a tool to collect demographic information and obstetric history 
and three instruments to measure health literacy, understanding of prenatal aneuploidy 
screening, and satisfaction with decisions made for prenatal aneuploidy screening.  The 
plan for data analyses included descriptive statistics and multiple linear regression to 
assess the relationships between health literacy, understanding of prenatal aneuploidy 
screening, and satisfaction with decisions made for prenatal aneuploidy screening. 
  
 
 
97 
CHAPTER IV
 
RESULTS 
 
 
 The findings of this study are reported in this chapter.  The response to the survey 
is presented followed by a description of the participants.  The instrument scores are 
presented followed by results of univariate and bivariate analyses.  Results of the 
analyses for each research question are provided followed by a chapter summary.  A two-
sided p-value ≤ 0.05 was considered to be statistically significant.  All analyses were 
performed using SPSS v24 (IBM Corp., Armonk, NY). 
Response to the Survey 
 A survey was developed in Qualtrics to collect data on women’s understanding of 
prenatal aneuploidy screening, women’s satisfaction with decisions made for prenatal 
aneuploidy screening, and the five domains of health literacy.  The survey was distributed 
via an electronic pregnancy and parenting newsletter through Mission Health Services.  
An email was sent to recipients of the newsletter with an invitation to participate in the 
study and a link to the survey.  The survey was open for four weeks, with an electronic 
mail reminder distributed every ten days until the close of the survey.  The Qualtrics 
survey was opened by 31.7% (507) of the estimated 1600 recipients of the pregnancy and 
parenting newsletter.  Of those who opened the survey, 18.7% (95) submitted a 
completed survey.  This yielded an estimated return rate of approximately 6.0% of the 
possible newsletter recipients.   
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Analysis 
Descriptive Statistics of the Participants 
 The results of the demographic data collected in the survey are depicted in Table 
4.1. The women respondents had a mean age of 31.19 years (SD=4.88).  The mean 
gestational age of participants’ pregnancies was 28.07 weeks (SD=6.44). The participants 
reported their race/ethnicity as follows: 3.2% Asian, 13.7% Black/African American, 
78.9% Caucasian/White non-Hispanic, and 4.2% Hispanic. The educational level of 
participants was reported as 20.0% high school diploma or GED, 21.1% some college, 
33.7% college degree (Associate’s or Bachelor’s), and 25.3% graduate degree.  Nearly 
one-quarter (24.2%) of participants were pregnant for the first time.   The majority 
(43.2%) of participants had not completed a pregnancy beyond 20 weeks, 45.3% of 
participants were carrying a pregnancy beyond 20 weeks for the first time, and 11.5% of 
participants had completed one or more pregnancies beyond 20 weeks.  Nearly one-third 
(32.6%) of women reported never giving birth to a live infant.   
 Most women reported that they were offered a prenatal aneuploidy screen, while 
4.2% reported that they were not offered the screen and 7.4% were not sure if they were 
offered the screen.  Over one-half (55.3%) of women reported that they had the prenatal 
aneuploidy screen, while 38.9% reported not having the screen and 5.3% were not sure if 
they had the screen.  The information received about the prenatal aneuploidy screen was 
reported as follows: 24.2% oral explanation only, 24.2% oral explanation with 
discussion, 13.7% written (pamphlet) only, 14.7% written (pamphlet) and oral 
explanation, 17.9% written (pamphlet) with discussion, and 5.3% not sure.   
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 Most women (91.6%) reported that they were not told that their current pregnancy 
may be affected by a chromosome problem.  A few women (3.2%) reported that they 
were told that their pregnancy may be affected by a chromosome problem, and a few 
participants (5.3%) were not sure if they were told that their pregnancy may be affected 
by a chromosome problem.  Nearly one-quarter (26.3%) of respondents reported no 
experience with individuals with disabilities, with 45.3% reporting some experience, 
17.9% reporting above average experience, and 10.5% reporting frequent experience with 
individuals with disabilities.   
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Table 4.1 
Sample Description (N = 95) 
 
Variable 
Mean ± SD1 
(min, max) 
Age 
 
 
Gestational age in weeks 
 
31.19 ± 4.88 
(20, 41) 
 
28.07 ± 6.44 
(18, 41) 
 
Frequency (%) 
Race/ Ethnicity 
     Asian  
     Black/African American 
     Caucasian/White non-Hispanic 
     Hispanic 
     Other                                      
 
3 (3.2) 
13 (13.7) 
75 (78.9) 
4 (4.2) 
0 
Educational level 
     Some high school 
     High school diploma or GED 
     Some college 
     College degree (Associate’s or Bachelor’s) 
     Graduate degree 
 
0 
19 (20.0) 
20 (21.0) 
32 (33.7) 
24 (25.3) 
Gravida (# of pregnancies) 
     1 
     2 
     3 
     4  
     5 
     6 
 
23 (24.2) 
45 (47.4) 
19 (20.0) 
6 (6.3) 
1 (1.1) 
1 (1.1) 
Parity (# of completed pregnancies > 20 
weeks) 
     0 
     1 
     2 
     3 
 
 
 41 (43.2) 
43 (45.3) 
8 (8.4) 
3 (3.1) 
Note. 
1. SD: Standard deviation 
!
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Variable! Frequency (%)!
Number of live-born children 
     0 
     1 
     2 
     3 
     4 
 
31 (32.6) 
46 (48.4) 
15 (15.8) 
2 (2.1) 
1 (1.1)!
Was offered screen for chromosome 
problems 
     Yes 
     No 
     Not sure 
 
 
84 (88.4) 
4 (4.2) 
7 (7.4) 
Had screen for chromosome problem 
     Yes 
     No 
     Not sure 
 
53 (55.8) 
37 (38.9) 
5 (5.3) 
Type of information presented  
     Oral explanation only  
     Oral explanation with discussion 
     Written (pamphlet) only 
     Written and oral explanation  
     Written (pamphlet) with discussion 
     Not sure 
 
23 (24.2) 
23 (24.2) 
13 (13.7) 
14 (14.7) 
17 (17.9) 
5 (5.3) 
Was told this pregnancy may have 
chromosome problem 
     Yes 
     No 
     Not Sure 
 
 
3 (3.2) 
87 (91.6) 
5 (5.3) 
Experience with individuals with 
disabilities 
     None at all 
     Some 
     Above average 
     Frequent 
 
 
25 (26.3) 
43 (45.3) 
17 (17.9) 
10 (10.5) 
Note.  
1. SD: Standard deviation 
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Descriptive Statistics of the Instruments 
 The scales used in this study include the Maternal Serum Screening Knowledge 
Questionnaire (MSSKQ) (Goel et al., 1996), the Satisfaction with Decision Scale 
(SWDS) (Homes-Rovner et al., 1996), and the following five subscales of the Health 
Literacy Questionnaire (HLQ) (Osborne et al., 2013) : Feeling understood and supported 
by healthcare providers, Appraisal of health information, Ability to actively engage with 
health care providers, Ability to find good health information, and Understand health 
information enough to know what to do.  The seven scales used in this study were 
completed by each of the 95 participants.  Table 4.2 illustrates the results of the 
descriptive statistics for these scales. 
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Table 4.2 
 
Description of Instrument Scores (N = 95) 
 
Note. 1. α = Cronbach’s alpha; λ2 = Guttman’s lambda2 
         2. Maternal Serum Screening Knowledge Questionnaire (Goel et al., 1996) 
         3. Satisfaction with Decision Scale (Holmes-Rovner et al., 1996) 
         4. Subscale of the Health Literacy Questionnaire (Osborne et al., 2013) 
 
  
Scale Number 
of Items 
Possible 
Score 
Mean ± 
SD 
Range of 
Scores 
Estimate 
of 
Reliability1 
Maternal Serum 
Screening Knowledge 
Questionnaire2 
12 -2 - 2 0.63 ± 
0.29 
0 – 1.58 α = 0.69 λ2 = 0.70  
Satisfaction with 
Decision Scale3 
6 6 - 30 24.00 ± 
4.60   
12.00 – 
30.0 
α = 0.91 
 
Feeling understood and 
supported by healthcare 
providers4 
4 1.00 – 
4.00 
3.04 ± 
0.58 
1.00 – 
4.00 
α = 0.87  
 
Appraisal of health 
information4 
4 1.00 – 
4.00 
2.91 ± 
0.54 
1.20 – 
4.00 
α = 0.82  
 
Ability to actively engage 
with healthcare 
providers4 
5 1.00 – 
5.00 
3.73 ± 
0.58 
2.20 – 
5.00 
α = 0.90  
 
Ability to find good 
health information4 
5 1.00 – 
5.00 
3.92 ± 
0.50 
2.40 – 
5.00 
α = 0.83 
 
Understand health 
information enough to 
know what to do4 
5 1.00 – 
5.00 
3.73 ± 
0.58 
2.60 – 
5.00 
α = 0.80  
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 The MSSKQ is a 14-item instrument, of which 12 items apply to prenatal 
aneuploidy screening and were included in the survey (Goel et al., 1996).  For each item 
of the MSSKQ, a statement is given, which is true or false, and participants are asked to 
rate how much they agree or disagree with each statement.  In general, the majority of 
participants responded correctly to 8 of the 12 MSSKQ statements.  However, the 
majority of participants did not respond correctly to the following four statements: (a) If 
the prenatal screen is abnormal, something is usually wrong with the baby. (False) (b) 
Having prenatal screening is routine for all women. (False); (c) Amniocentesis can cause 
miscarriage in 1 in 200 women. (True); and (d) Amniocentesis is a test of the mother’s 
blood that can detect Down syndrome. (False).  The frequency and percentages of the 
responses to each of the items of the MSSKQ are depicted in Table 4.3.    
 
Table 4.3  
 
Descriptive Statistics for the Maternal Serum Screening Knowledge Questionnaire  
 (N = 95) 
 
Statement (True/False)1 Frequency (%) 
If the results of the prenatal screen are 
abnormal, further tests are needed to tell if 
something is wrong. (True) 
Correct 
Incorrect 
Not sure!
65 (64.2) 
16 (17.9) 
18 (18.9) 
Women who have a normal prenatal screen can 
be sure that they will have a healthy baby. 
(False) 
Correct 
Incorrect 
Not sure!
63 (66.3) 
4 (4.2) 
28 (29.5) 
The prenatal screen only detects Down 
syndrome. (False) 
Correct 
Incorrect 
Not sure!
79 (83.2) 
4 (4.5) 
12 (12.6) 
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Statement (True/False)1! Frequency (%)!
If the prenatal screen is abnormal, something is 
usually wrong with the baby. (False) 
Correct 
Incorrect 
Not sure!
35 (36.8) 
31 (32.6) 
29 (30.5) 
Prenatal screening is not accurate when done 
at the wrong time of pregnancy. (True) 
Correct 
Incorrect 
Not sure!
55 (59.0) 
6 (6.3) 
33 (34.7) 
Having prenatal screening is routine for all 
women. (False) 
 
Correct 
Incorrect 
Not sure!
40 (42.1) 
34 (35.8) 
21 (22.1 
Amniocentesis can cause miscarriage in 1 in 
200 women. (True) 
Correct 
Incorrect 
Not sure!
46 (48.4) 
8 (8.4) 
41 (43.2) 
Ultrasound can be used to find every kind of 
birth defect. (False) 
Correct 
Incorrect 
Not sure!
83 (87.3) 
2 (2.1) 
10 (12.6) 
Amniocentesis is a test of the mother’s blood 
that can detect Down syndrome. (False) 
Correct 
Incorrect 
Not sure!
40 (42.1) 
14 (14.7) 
41 (43.2) 
The chance of having a baby with Down 
syndrome is higher when the mother is older. 
(True)!
Correct 
Incorrect 
Not sure!
92 (96.8) 
0 
3 (3.2) 
All children born with Down syndrome have 
physical and mental disabilities that require 
lifelong care in an institution. (False) 
 
Correct 
Incorrect 
Not sure 
80 (84.2) 
6 (6.3)  
9 (9.5) 
If amniocentesis shows Down syndrome, the 
only options are to have a baby with Down 
syndrome or to terminate the pregnancy. (True) 
Correct 
Incorrect 
Not sure 
59 (62.1) 
9 (9.5) 
27 (28.4) 
Note. 1. Correct is response of Agree or Strongly agree for positively scored items and Disagree 
or Strongly disagree for negative scored items; Incorrect is response of Disagree or Strongly 
disagree for positively scored items and Agree or Strongly agree for negatively scored items; Not 
sure is response of Neither agree nor disagree 
 
  
 
 
106 
 The SWDS is a 6-item measure to assess degree of satisfaction with the process of 
informed health care decision-making (Holmes-Rovner et al., 1996).  Scores range from 
6-30 with higher scores indicating greater satisfaction.  A score ≥!24.0 on the SWDS has 
been used to demarcate satisfaction with the decision (Hitz, Ribi, Li, Klingbiel, Cerny, & 
Koeberle, 2013).  The mean score of the SWDS was 24.00 ± 4.60.  The mean and range 
of scores for the items of the SWDS are depicted in Table 4.4.   
 
Table 4.4  
 
Descriptive Statistics for Items of the Satisfaction with Decision Scale1 (N = 95) 
 
Note. 1. Satisfaction with Decision Scale (Holmes-Rovner et al., 1996) 
 
Item 
Possible 
Score 
Mean ± 
SD 
Range 
of 
Scores 
I was adequately informed about the different 
options available for prenatal screening for 
chromosome problems for my baby. 
1 – 5 3.82 ± 0.99 1 - 5 
The decision I made was the best decision for me 
personally. 1 – 5 
4.20 ± 
0.74 3 - 5 
The decision I made was consistent with my values. 1 – 5 3.71 ± 1.09 1 - 5 
I expect to carry out the decision. 1 – 5 4.19 ± 0.72 3 - 5 
I had as much input as I wanted in the choice to use 
prenatal screening for chromosome problems for 
my baby. 
1 – 5 3.99 ± 1.00 1 - 5 
I am satisfied with the decision I made about 
prenatal screening for chromosome problems with 
my baby. 
1 - 5 4.08 ± 
0.50 
2 – 5 
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 The HLQ is a multi-dimensional assessment of health literacy with nine subscales 
(Osborne et al., 2013).  Five of the subscales measure core behavioral competencies 
necessary for health care decision-making and were included in the survey.  In general, 
participants reported moderate to high health literacy across the five domains.   
 Reliability of the scales.  Cronbach’s alpha coefficients were estimated for each 
of the scales.  Table 4.2 includes the estimated reliability for each scale.  Reliability 
coefficients above .80 are highly desirable, while reliability coefficients of .70 to .75 may 
be adequate (Polit, 2010).  The SWDS and the five subscales of the HLQ each 
demonstrated desirable reliability.  For the MSSKQ, the estimate of reliability using 
Cronbach’s alpha was 0.69, which is less than desirable.  However, Cronbach concluded 
that the alpha formula is not appropriate for scales for which questions are designed to 
target different areas or processes because alpha assumes essential tau-equivalence 
(Cronbach & Shavelson, 2004).  Thus, alpha assumes that the scale is unidimensional and 
that the covariances between items are essentially equal (DeVellis, 2017; Tavakol & 
Dennick, 2011).  As factorial validity has not been demonstrated for the MSSKQ, it is 
reasonable to consider an alternative to Cronbach’s alpha for an estimate of reliability for 
the MSSKQ.  Guttman’s labmda2 is recognized as a more appropriate estimate of 
reliability than Cronbach’s alpha, in most cases, because it does not have the assumptions 
of tau-equivalence (Revelle & Zinbarg, 2009; Sijtsma, 2009).  Therefore, Guttman’s 
lambda2 for the MSSKQ was calculated (λ2 = .70).  The value of .70 is acceptable and 
approaches the estimates of reliability of the MSSKQ reported in the literature (Glazier et 
al., 1997; Goel et al., 1996).  In sum, the estimates of reliability calculated for the five 
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scales used in this study indicate that the items performed relatively consistent with how 
they performed in previous studies (Glazier et al., 1997; Goel et al., 1996; Holmes-
Rovner et al., 1996; Osborne et al., 2013). 
Univariate Analyses 
  Key variables were assessed for normality and the presence of outliers using 
boxplots and histograms.  No extreme outliers were identified across the key variables.  
Histograms, P-P plots, and 1-sample Kolmogorov-Smirnov tests were used to assess 
normality and indicated that the key variables were normally distributed. 
Bivariate Analyses 
 Bivariate analyses included the key variables of educational level, parity, race/ 
ethnicity, screen uptake, MSSKQ scores, SWD scale scores, and the following domains 
of health literacy measured by the HLQ: Feeling understood and supported by healthcare 
providers, Appraisal of health information, Ability to actively engage with health care 
providers, Ability to find good health information, and Understand health information 
enough to know what to do.  An indicator variable was created for Caucasian/White non-
Hispanic race/ethnicity with the reference category being other race/ethnicity (i.e., 
women who did not identify as Caucasian/White non-Hispanic).  Scatterplots with 
LOESS and linear fit lines were used to explore bivariate relationships and indicated 
linear relationships between the key variables.  Bivariate analyses were conducted 
between key variables using Spearman’s rho and point biserial correlation coefficients.  
These results are displayed in Table 4.5.  The results suggest that 30 out of 54 
correlations were statistically significant.  The variable of parity did not have statistically 
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significant correlations.  Screen uptake was significantly and negatively correlated with 
the health literacy domain of Ability to find good health information, rho(93) = -.225, p < 
.05), suggesting that positive screen uptake is weakly correlated with decreasing Ability 
to find good health information.  Each of the remaining statistically significant 
correlations were positive in their direction.  The significant positive correlation 
coefficients for educational level suggest that increasing educational attainment has a 
moderately positive relationship with the key variables of Caucasian/White non-Hispanic 
race/ethnicity, rpb (93) = .360,  p < .01; MSSKQ scores, rho(93) = .461,  p < .01; SWDS 
scores, rho(93) = .441,  p < .01; Feeling understood and supported by healthcare 
providers, rho(93)  = .417,  p < 0.01; Appraisal of health information, rho(93) = .400,  p 
< .01; Ability to actively engage with health care provider, rho(93) = .477,  p < .01; 
Ability to find good health information, rho(93) = .512,  p < .01; and Understand health 
information enough to know what to do, rho(93) = .597,  p < .01 (Polit, 2010).  The 
significant positive correlation coefficients for Caucasian/White non-Hispanic 
race/ethnicity suggest that Caucasian/White non-Hispanic race/ethnicity has a moderately 
positive relationship with MSSKQ scores, rpb (93) = .384,  p < .01; SWDS scores, rpb (93) 
= .397,  p < .01; Feeling understood and supported by healthcare providers, rpb (93)  = 
.274,  p < 0.01; Appraisal of health information, rpb (93) = .397,  p < .01; Ability to 
actively engage with health care provider, rpb (93) =. 459,  p < .01; Ability to find good 
health information, rpb (93) = .418,  p < .01, and Understand health information enough 
to know what to do, rpb (93)  = .451,  p < .01.  In general, the significant and positive 
correlation coefficients between the MSSKQ scores, the SWDS scores, and the five 
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subscales of the HLQ (Feeling understood and supported by healthcare providers, 
Appraisal of health information, Ability to actively engage with health care provider, 
Ability to find good health information, and Understand health information enough to 
know what to do) suggest moderate to strong positive relationships between the 
instrument scale scores (Polit, 2010).  This means that as scores on one of the instruments 
increased, scores on each of the other instruments also increased.
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Table 4.5 
 
Intercorrelations Between Key Study Variables (N = 95) 
 
Variable 1 2 3 4 5 6 7 8 9 10 
1 Education level  -          
2 Parity  
≥ 1, 0 (RC) 1 
.093 -         
3 Race/ethnicity 
Caucasian, Other (RC)1 
.360** .092 -        
4 Screen uptake  
No uptake (RC)1 
-.209* .017 -.200 -       
5 MSSKQ2  .461** -.032 .384** -.018 -      
6 SWDS3  .441** .182 .397** -.091 .390** -     
7 Feeling understood  
and supported4 
.417** .179 .274** -.072 .299** .618** -    
8 Appraisal of 
 health information4 
.400** .058 .397** -.178 .361** .482** 
 
.627** -   
9 Ability to actively  
engage with providers4 
.477** .103 .459** -.028 .523** .370** .367** .465** -  
10 Ability to find  
good health information4 
.512** .141 .418** -.225* .472** .674** .605** .677** .511** - 
11 Understand health  
information4  
.597** .178 .451** -.159 .425** .543** .494** .506** .662** .801** 
Note.*p < .05; **p < .01 
1. RC = Reference category 
2. Maternal Serum Screening Knowledge Questionnaire (MSSKQ) (Goel et al., 1996) 
3. Satisfaction with Decision Scale (SWDS) (Holmes-Rovner et al., 1996) 
4. Subscale of the Health Literacy Questionnaire (HLQ) (Osborne et al., 2013) 
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Research Question 1 
 Specific Aim 1: To assess women’s satisfaction with decisions made for prenatal 
aneuploidy screening.   
 Research question 1: Are women satisfied with the decisions they make for 
prenatal aneuploidy screening?   
 Descriptive statistics were used to estimate the proportion of women who are 
satisfied with decisions made for prenatal aneuploidy screening along with the 95% 
confidence interval (CI).  The established cut-off score of 24 for the SWDS was used to 
indicate satisfaction with decisions made for prenatal aneuploidy screening ((Hitz et al., 
2013; Holmes-Rovner, 1996).  Descriptive statistics indicate that 55 of the 95 participants 
scored ≥"24.0 on the SWDS.  The proportion of participants with scores ≥"24.0, along 
with a 95% confidence interval using the Wilson limits was computed (Brown, Cai, & 
DasGupta, 2001).  Table 4.6 illustrates the results of the proportion estimation of women 
who reported satisfaction with decisions made for prenatal aneuploidy screening as 
measured by the SWDS.  Results show that 57.9% [47.8%, 67.3%] of the sample 
reported satisfaction with decisions made for prenatal aneuploidy screening.  Thus, if this 
study were repeated over and over again, each time with 95 participants, then the true 
population percent who are satisfied with decisions made for prenatal aneuploidy 
screening would be enclosed by the interval (47.8%, 67.3%) approximately 95% of the 
time.  Additionally, descriptive statistics indicate that 40 of the 95 participants scored 
<"24.0 on the SWDS.  The proportion of participants with scores <"24.0, along with a 
95% confidence interval using the Wilson limits was computed.  The results show that 
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42.1% [32.7%, 52.2%] of participants did not report satisfaction with decisions made for 
prenatal aneuploidy screening.  Thus, if this study were repeated over and over again, 
each time with 95 participants, then the true population percent who do not report 
satisfaction with decisions made for prenatal aneuploidy screening would be enclosed by 
the interval (32.7%, 52.2%) approximately 95% of the time.   
 
Table 4.6 
 
Satisfaction with Decisions Made for Prenatal Aneuploidy Screening1 (N = 95) 
 
Note. 1. As measured by the Satisfaction With Decision Scale (Holmes-Rovner et al., 
1996). 
 
  
Satisfaction with  
Decision Scale  
Interpretation 
Frequency Percentage [95% CI] 
Satisfied with decision 55 57.9% [47.8%, 67.3%] 
Not satisfied with decision 40   42.1% [32.7%, 52.2%] 
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Research Question 2 
 Specific Aim 2: To assess the influences of health literacy on women’s 
understanding of prenatal aneuploidy screening. 
 Research question 2: What is the relationship of health literacy to women’s 
understanding of prenatal aneuploidy screening?  Specifically, do the five domain scores 
of health literacy (HLQ domain scores) influence women’s understanding of prenatal 
aneuploidy screening (MSSKQ scores), adjusting for educational level, and 
race/ethnicity, and uptake of the prenatal aneuploidy screen? 
 The five domain scores of health literacy (Feeling understood and supported by 
healthcare providers, Appraisal of health information, Ability to actively engage with 
health care providers, Ability to find good health information, and Understand health 
information enough to know what to do), the independent variables, were regressed on 
MSSKQ scores (the dependent variable), adjusting for educational level, race/ethnicity, 
and uptake of the prenatal aneuploidy screen.  Regression assumptions were evaluated 
with analysis of studentized deleted residuals.  The P-P plot and 1-sample Kolmogorov-
Smirnoff test indicated normal distribution of the residuals.  The scatterplot of 
studentized deleted residuals versus predicted Y indicated no violations of the regression 
assumptions of linearity, normality, or homoscedasticity.  The Durbin-Watson statistic 
for autocorrelation of residuals in linear regression was acceptable, indicating no 
violation of the assumption of independence (1.79; Norušis, 2007).  Collinearity statistics 
were checked with Variance Inflation Factors (VIFs) with values greater than 7 
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considered problematic; VIFs were acceptable (max VIF = 3.89; Tabachnick & Fidell, 
2013).   
 Multiple linear regression of MSSKQ scores occurred with two-stage hierarchical 
modeling.  In the first linear model, educational level, race/ethnicity, and uptake of the 
prenatal aneuploidy screen were regressed on MSSKQ scores.  Variables in the second 
linear model were added to (a) identify if the HLQ domain scores significantly influenced 
MSSKQ scores and (b) detect if a significant R2 change occurred between Model 1 and 
Model 2.  In the second linear model, Feeling understood and supported by healthcare 
providers, Appraisal of health information, Ability to actively engage with health care 
providers, Ability to find good health information, and Understand health information 
enough to know what to do were added to the regression model.  Complete results for the 
multiple linear regression for Aim 2 are presented in Table 4.7.   
 In Model 1 of the multiple linear regression for Specific Aim 2, educational level, 
race/ethnicity, and uptake of the prenatal aneuploidy screen were found to explain a 
significant amount of the variance in mean MSSKQ scores (R2 =.251, adjusted R2 = .227, 
F(3, 91) = 10.18, p < .001).  Statistical significance was found for educational level and 
race/ethnicity in relation to MSSKQ scores as the dependent variable.  For each 
additional educational level (some college, college degree, or graduate degree) beyond 
high school, the predicted mean MSSKQ score increased by 0.356 points, adjusting for 
uptake of the prenatal aneuploidy screen and race/ethnicity (b = 0.356; 95% CI [0.580, 
1.996], p < .001).  The predicted mean MSSKQ score increased by 0.269 point for 
Caucasian/White non-Hispanic women compared to women who are not 
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Caucasian/White non-Hispanic, adjusting for uptake of the screen and educational level 
(b = 0.269; 95% CI [0.699, 4.383], p = .007)).  Thus, educational level and race/ethnicity 
significantly predicted the mean MSSKQ scores in Model 1 for Specific Aim 2.  
 In Model 2 of the multiple linear regression for Specific Aim 2, educational level, 
race/ethnicity, uptake of the prenatal aneuploidy screen, and the five subscales of the 
HLQ (Feeling understood and supported by healthcare providers, Appraisal of health 
information, Ability to actively engage with health care providers, Ability to find good 
health information, and Understand health information enough to know what to do), were 
found to explain a significant amount of the variance in mean MSSKQ scores (R2 = .386, 
adjusted R2 = .329, F(5, 86) = 6.753, p < .001).  Uptake of the prenatal aneuploidy screen, 
educational level, race/ethnicity, and the five subscales scores of the HLQ account for 
32.9% of the variation in MSSKQ scores.  The R2 change indicates that the addition of 
the five HLQ subscales to the model significantly explained an additional 13.5% of the 
variation in mean MSSKQ scores compared with Model 1 (R2change = .135, F change = 
3.767, p = .004).  Statistical significance was found for educational level and Ability to 
actively engage with health care providers in relation to MSSKQ scores as the dependent 
variable.  For each additional educational level (some college, college degree, or graduate 
degree) beyond high school, the predicted mean MSSKQ score increased by 0.225 points, 
adjusting for race/ethnicity, uptake of the prenatal aneuploidy screen, Feeling understood 
and supported by healthcare providers, Appraisal of health information, Ability to 
actively engage with health care providers, Ability to find good health information, and 
Understand health information enough to know what to do (b = .225; 95% CI [0.047, 
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1.585], p = .038).  For each additional point increase in the Ability to actively engage with 
health care providers scale score of the HLQ, the predicted mean MSSKQ score 
increased by 0.317 points, adjusting for educational level, race/ethnicity, uptake of the 
prenatal aneuploidy screen, Feeling understood and supported by healthcare providers, 
Appraisal of health information, Ability to find good health information, and Understand 
health information enough to know what to do (b = .317; 95% CI [0.532, 2.635], p = 
.004).   
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Table 4.7 
Summary of Hierarchical Multiple Linear Regression of Maternal Serum Screening 
Knowledge Questionnaire1 Scores (N =95) 
 
 Model 1 Model 2 
Variable β 95% CI p β 95% CI p 
Uptake of screen 
.103 [0.644, 2.249] .273 .075 [-0.808, 1.974] .407 
Educational level 
.356  [0.580, 1.996] <.001  .225 [0.047, 1.585]  .038 
Race/ Ethnicity 
.269 [0.699, 4.383] .007  .113  [-0.862, 2.991]  .275 
Feeling understood  
and supported by health 
care providers 2 
  
.037 [-1.338, 1.825] .760 
Critical appraisal of 
health  information2 
  
.016 [-1.635, 1.863] .897 
Ability to actively  
engage providers2 
 
  
.317 [0.532, 2.635] .004 
Ability to find good 
health  information2 
  
.278 [-0.421, 4.762] .100 
Understand health 
information enough to 
know what to do2 
  
.159 [-0.614, 3.197] .321 
R2  .251 .386 
adjusted R2 .227 .329 
p for change in R2 < .001 < .001 
Note. 
1. Maternal Serum Screening Knowledge Questionnaire (Goel et al., 1996). 
2. Subscale of the Health Literacy Questionnaire (Osborne et al., 2013). 
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Research Question 3 
 Specific Aim 3: To assess the influences of health literacy and understanding of 
prenatal aneuploidy screening on women’s satisfaction with decisions made for prenatal 
aneuploidy screening. 
 Research question 3: What is the relationship of health literacy and 
understanding of prenatal aneuploidy screening to women’s satisfaction with decisions 
made for prenatal aneuploidy screening?  Specifically, do the five domain scores of 
health literacy (HLQ domain scores) and understanding of prenatal aneuploidy screening 
(MSSKQ scores) influence women’s satisfaction with decisions made for prenatal 
aneuploidy screening (SWDS scores), adjusting for uptake of prenatal aneuploidy 
screening and parity? 
 The five domain scores of health literacy (Feeling understood and supported by 
healthcare providers, Appraisal of health information, Ability to actively engage with 
health care providers, Ability to find good health information, and Understand health 
information enough to know what to do) and MSSKQ scores, the independent variables, 
were regressed on SWDS scores (the dependent variable), adjusting for uptake of the 
prenatal aneuploidy screen and parity.  Regression assumptions were evaluated with 
analyses of studentized deleted residuals.  Normal distribution of the residuals was 
indicated by the P-P plot and 1-sample Kolmogorov-Smirnoff test.  A scatterplot of 
studentized deleted residuals versus predicted Y indicated no violations of linearity, 
normality, or homoscedasticity.  Evaluation of the Durbin-Watson statistic indicated no  
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violation of the regression assumption of independence (2.05; Norušis, 2007).  
Collinearity statistics were acceptable (max VIF = 4.00; Tabachnick & Fidell, 2013).   
 Multiple linear regression of SWDS scores occurred with two-stage hierarchical 
modeling.  In Model 1 of Specific Aim 3, parity and uptake of the prenatal aneuploidy 
screen were regressed on SWDS scores.  Variables in Model 2 were added to the model 
to (a) identify if the HLQ domain scores significantly influenced SWDS scores and (b) 
assess if a significant R2 change occurred between Model 1 and Model 2.  Thus the five 
domains of health literacy and MSSKQ scores were added to the regression model in the 
second linear model.  Complete results for the multiple linear regression for Specific Aim 
3 are presented in Table 4.8.   
 In Model 1 of the multiple linear regression for Specific Aim 3, parity and uptake 
of the prenatal aneuploidy screen did not explain a significant amount of the variance in 
mean SWDS scores (R2 =.055, adjusted R2 = .035, F(2, 92) = 2.697, p = .073).  For 
Model 1, statistical significance was found for parity in relation to SWDS scores as the 
dependent variable.  The predicted mean SWDS score increased by 0.223 point for 
women who have completed at least one pregnancy with a fetus who reached at least 
week 20 of gestation compared to nulliparous women, adjusting for uptake of the prenatal 
aneuploidy screen (b = 0.223; 95% CI [0.023, 0.459], p = .030).  
 In Model 2 of the multiple linear regression for Specific Aim 3, parity, uptake of 
the prenatal aneuploidy screen, Feeling understood and supported by healthcare 
providers, Appraisal of health information, Ability to actively engage with health care 
providers, Ability to find good health information, Understand health information enough 
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to know what to do, and MSSKQ scores were found to explain a significant amount of the 
variance in mean MSSKQ scores (R2 =.464, adjusted R2 = .414, F(6, 86) = 8.75, p = 
.004).  This means that parity, uptake of the prenatal aneuploidy screen, the five subscale 
scores of the HLQ, and MSSKQ scores account for 41.4% of the variation in mean 
SWDS scores.  The R2 change indicates that the addition of the five HLQ subscale scores 
and the MSSKQ scores to the model significantly explained an additional 40.8% of the 
variation in mean SWDS scores compared with Model 1 (R2change = .408, F(6, 86)change = 
10.912, p < .001).  Statistical significance was found for Feeling understood and 
supported by health care providers and Ability to find good health information in relation 
to SWDS scores as the dependent variable.  For each additional point increase in the 
Feeling understood and supported by health care provider scale, the predicted mean 
SWDS score increased by 0.329 points, adjusting for parity, uptake of the prenatal 
aneuploidy screen, Appraisal of health information, Ability to actively engage with health 
care providers, Ability to find good health information, Understand health information 
enough to know what to do, and MSSKQ scores (b = .329; 95% CI [0.142, 0.725], p = 
.004).  For each additional point increase in the Ability to find good health information 
scale, the predicted mean SWDS score increased by 0.402 points, adjusting for parity, 
uptake of the prenatal aneuploidy screen, Feeling understood and supported by health 
care providers, Appraisal of health information, Ability to actively engage with health 
care providers, Understand health information enough to know what to do, and MSSKQ 
scores (b = .402; 95% CI [0.137, 1.109], p = .013).  
  
 
 
122 
Table 4.8 
Summary of Hierarchical Multiple Linear Regression for Satisfaction With Decision 
Scale1 Scores (N =95) 
 
 Model 1 Model 2 
Variable β 95% CI p β 95% CI p 
Parity 
.223 [0.023, 0.459] .030 .041 [-0.136, 0.226] .623 
Uptake of screen 
-.082  [-0.435, 0.184] .422  .023 [-0.216, 0.286]  .783 
Feeling understood 
and supported2  
    .329  [0.142, 0.725]  .004 
Critical appraisal of 
health information2 
   -.075 [-0.426, 0.214] .513 
Ability to actively 
engage with 
healthcare providers2 
   -.029 [-0.228, 0.171] .778 
Ability to find good 
health information2 
   .402 [0.137, 1.109] .013 
Understand health 
information enough 
to know what to do2 
   .050 [-0.348, 0.497] .727 
MSSKQ3 scores 
   .106 [-0.017, 0.060] .281 
R2  .055 .464 
adjusted R2 .035 .414 
p for change in R2 .073  .004 
Note. 
1. Satisfaction with Decision Scale (Holmes-Rovner et al., 1996). 
2. Subscale of the Health Literacy Questionnaire (Osborne et al., 2013). 
3. MSSKQ = Maternal Serum Screening Knowledge Questionnaire (Goel et al., 1996). 
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 Analysis of influence.  Cook’s distance, leverage points, and DFBeta statistics 
were evaluated.  Cook’s distance measures the simultaneous change in all regression 
coefficients, with values > 1 being problematic (Montgomery, Peck, & Vining, 2012).  
Evaluation of Cook’s distance values for the regression models revealed no cases with 
substantial influence on all regression coefficients (maximum Cook’s distance = 0.29).  
High leverage indicates unusual combinations of the independent variables.  Leverage 
values were considered influential if participants exceeded 0.168 (2 x average centered 
leverage) for the regression models for both Specific Aim 2 and Specific Aim 3 
(Montgomery et al., 2012).  There were four cases with leverage > 0.168.  DFBeta 
statistics measure the change that each case has on the regression coefficient.  A cutoff of 
0.205 was used for DFBetas (2/ √95) (Montgomery et al., 2012).  Evaluation of DFBetas 
indicates that no cases were unusually influential in estimating the regression 
coefficients.  In sum, the analysis of influence indicates no substantial influence on the 
multiple linear regressions performed. 
Chapter Summary 
 Ninety-five adult women aged 18 years and older, who were 18 or more weeks 
pregnant were recruited to take a Qualtrics survey using convenience sampling of 
recipients of an electronic pregnancy and parenting newsletter distributed in western 
North Carolina.  The survey was used to collect data on participants’ demographic and 
obstetrical information and included five scales: the MSSKQ (Goel et al., 1996), the 
SWDS (Holmes-Rovner et al., 1996), and five subscales of the HLQ (Osborne et al., 
2013).  The average age of participants was 31 years.  The sample predominantly 
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identified as Caucasian/White non-Hispanic and the majority of participants were 
college-educated.  Approximately 1 in 4 participants (24%) were experiencing pregnancy 
for the first time.  Over one-half (55.3%) of participants reported having the prenatal 
aneuploidy screen, while the remaining women reported that they did not have the screen 
(38.9%) or were unsure if they had the screen (5.3%).  Eight of the 12 items of the 
MSSKQ, which measures knowledge of prenatal aneuploidy screening, were answered 
correctly by the majority of participants, while four of the items of the MSSKQ were 
answered incorrectly by the majority of participants.  
 Analysis for Specific Aim 1 indicates that 57.9% [47.8%, 67.3%] of the sample 
reported satisfaction with decisions made for prenatal aneuploidy screening as measured 
by the SWDS (Holmes-Rovner et al., 1996).  Multiple linear regression models were 
utilized for the analyses for Specific Aim 2 and Specific Aim 3.  Analyses for Specific 
Aim 2 indicate that educational level, race/ethnicity, uptake of the prenatal aneuploidy 
screen, and the five subscale scores of the HLQ (Feeling understood and supported by 
healthcare providers, Appraisal of health information, Ability to actively engage with 
health care providers, Ability to find good health information, and Understand health 
information enough to know what to do; Osborne et al., 2013), explain a significant 
amount (32.9%) of the variance in mean MSSKQ (Goel et al., 1996).  Each educational 
degree (Associate’s, Bachelor’s, and graduate) attained beyond high school and 
increasing Ability to actively engage with health care providers as measured by the HLQ 
(Osborne et al., 2013) are significantly associated with increased understanding of 
prenatal aneuploidy screening as measured by MSSKQ scores.  Analyses for Specific 
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Aim 3 indicate that parity, uptake of the prenatal aneuploidy screen, the five subscale 
scores of the HLQ (Feeling understood and supported by healthcare providers, Appraisal 
of health information, Ability to actively engage with health care providers, Ability to 
find good health information, and Understand health information enough to know what to 
do; Osborne et al., 2013), and MSSKQ scores explain a significant amount (41.4%) of the 
variation in mean SWDS scores (Holmes-Rovner et al., 1996).  The health literacy 
domains of Feeling understood and supported by health care providers and Ability to 
find good health information as measured by the HLQ (Osborne et al., 2013) are 
significantly associated with greater satisfaction with decisions made for prenatal 
aneuploidy screening as measured by the SWDS. 
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CHAPTER V
DISCUSSION 
 
 
Introduction 
 The aims of this study were to examine the relationships between women’s 
understanding of prenatal aneuploidy screening, health literacy, and satisfaction with 
decisions made for prenatal aneuploidy screening.  The five domains of health literacy 
examined in this study are labeled Feeling understood and supported by health care 
providers, Appraisal of health information, Ability to actively engage with health care 
providers, Ability to find good health information, and Understand health information 
enough to know what to do (Osborne et al., 2014).  A survey to collect data on women’s 
understanding of prenatal aneuploidy screening, the five domains of health literacy, and 
satisfaction with decisions made for prenatal aneuploidy screening was completed by 95 
pregnant women living in western North Carolina.  The survey was distributed via 
electronic mail to recipients of an electronic pregnancy and parenting newsletter.  In this 
chapter, an overview of the study findings is presented followed by explanation and 
interpretation of the findings in relation to prior research.  Conceptual considerations and 
implications for practice, education, and policy are discussed.  Limitations of findings are 
considered, and recommendations for future research are delineated. 
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Overview of Major Findings 
 Satisfaction with decisions made for prenatal aneuploidy screening was reported 
by 57.9% of the sample.  Increasing Ability to actively engage with health care providers 
was significantly associated with increased understanding of prenatal aneuploidy 
screening.  Feeling understood and supported by health care providers, Appraisal of 
health information, Ability to find good health information, and Understand health 
information enough to know what to do were not significantly associated with 
understanding of prenatal aneuploidy screening.  Feeling understood and supported by 
health care providers and Ability to find good health information were significantly 
associated with increased satisfaction with decisions made for prenatal aneuploidy 
screening.  Appraisal of health information, Ability to actively engage with health care 
providers, Understand health information enough to know what to do, and understanding 
of prenatal aneuploidy screening were not significantly associated with satisfaction with 
decisions made for prenatal aneuploidy screening. 
Discussion 
Sample Comparison with Population and Prior Research 
 The mean age of participants was 31.2 years.  The sample had a higher number of 
multigravidas (75.8%) compared to primigravidas (24.2%).  Nationally, the mean age of 
mothers giving birth for the first time is 26.3 years (Martin, Hamilton, & Osterman, 
2017).  In 2016, the birth rate among women aged 30 to 34 years surpassed the birth rate 
of women aged 25 to 29 years, the demographic with the highest birth rate for over three 
decades (Martin et al., 2017).  The mean age of the sample therefore aligns with the 
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national trend of women in their thirties having a higher fertility rate than younger 
women.   
 Race/ethnicity.  The survey was distributed to recipients of a pregnancy and 
parenting electronic newsletter through Mission Health in western North Carolina.  
Mission Health primarily serves residents of the following counties in North Carolina: 
Buncombe, Haywood, Henderson, Madison, McDowell, Transylvania, and Yancey.  
Among infants born in these counties, approximately 55% are born to Caucasian/White 
mothers, 27% are born to Black/African American mothers, 15% are born to Hispanic 
mothers, and the remaining 3% are born to other racial/ethnic minorities (North Carolina 
State Center for Health Statistics, 2014).  This population is fairly representative of 
national trends for which approximately 53% of births occur to Caucasian/White 
mothers, 15% to Black/African American mothers, 22% to Hispanic mothers, and 10% to 
other racial/ethnic groups (Monte & Ellis, 2014).!!!
! For the participants in this study, 78.9% identified as Caucasian/White non-
Hispanic, 13.7% identified as Black/African American, 4.2% identified as Hispanic, and 
3.2% identified as Asian.  The findings indicate that the sample in this study has a greater 
proportion of Caucasian/White women and a smaller proportion of Black/African 
American and Hispanic women compared to the population of women giving birth in 
western North Carolina.  In comparison with prior research concerning prenatal screening 
among women in North America, this sample had a larger number of Black/African 
American and Hispanic women than the samples in Constantine et al. (2014) and Dixon 
and Burton (2014).  The sample in this study had similar racial and ethnic representation 
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to Farrell et al.’s (2011) study for which the sample was 74.4% White, 14.0% 
Black/African American, and 2.1% Hispanic.  The over-representation of 
Caucasian/White women in this study may be explained by the relatively lower rates of 
internet use among racial/ethnic minorities in the U.S.  Seventy-eight percent of 
Black/African Americans and 81% of Hispanics use the internet, compared to 85% of the 
Caucasian/White population in the U.S. (Perrin & Duggan, 2015).   
 Educational level.  Most participants had either a college (33.7%) or graduate 
(25.3%) degree, with the remainder having completed some years of college (21.1%) or 
high school (20.0%).  The approximate proportion of adults in the area served by Mission 
Health who hold a high school diploma or higher degree ranges from 80.7-89.7%, and 
those with a bachelor’s degree or higher ranges from 21.7-35.9% (U.S. Census Bureau, 
2016).  As the sample did not include individuals without a high school diploma or 
equivalent, the sample does not represent that sector of the population. 
 Offer and uptake of the prenatal aneuploidy screen.  The majority (88.4%) of 
participants reported that they were offered the prenatal aneuploidy screen.  However, 
7.4% of participants were not sure if they were offered the screen, and 4.2% of 
participants reported that they were not offered the prenatal aneuploidy screen.  While the 
majority (91.6%) of the sample responded that they were not told by a health care 
provider that their baby might be affected by a chromosome problem, 5 women (5.3%) 
were not sure whether or not they were told that their baby might have a chromosome 
problem.  These findings suggest that aneuploidy screening and diagnostic testing are not 
being discussed and offered to all women early in pregnancy as recommended by the 
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American Congress of Obstetricians and Gynecologists (ACOG; 2016b) or that some 
women do have inadequate understanding of discussions about the prenatal aneuploidy 
screen and its results.  
 The majority (55.8%) of women in the sample underwent prenatal aneuploidy 
screening.  Over one-third (38.9%) of the sample declined the prenatal aneuploidy screen 
and 5.3% did not know whether or not they had the screen.  More women in this study 
underwent prenatal aneuploidy screening compared with Dixon and Burton’s (2014) 
study regarding informed choice for prenatal screening in Ontario, Canada, for which 
48.5% of the sample chose to have a prenatal screen.  Additionally, a greater number of 
women in this study underwent prenatal aneuploidy screening compared with the 
proportion (27.4%) of women who underwent screening in Constantine et al.’s (2014) 
study examining informed choice for prenatal screening in the Midwest United States 
(U.S.).  The increased proportion of women who had the prenatal aneuploidy screen in 
this sample compared with the aforementioned studies may be explained by increasing 
numbers of women accepting the prenatal aneuploidy screen following ACOG’s 
recommendation in December 2012 that all women be offered prenatal aneuploidy 
screening (ACOG, 2016b).  International reports indicate that when health policy shifts to 
the offer of prenatal aneuploidy screening for all women, screening becomes more widely 
adopted by women (Zeng, Zannoni, Löwy, & Camporesi, 2016).   
Understanding of Prenatal Aneuploidy Screening 
 Understanding of prenatal aneuploidy screening was measured by the MSSKQ 
scale.  The range of possible scale scores for the MSSKQ is -2 to 2 (Goel et al., 1996).  
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Previous cut-offs for the MSSKQ are as follows: Scores ≤ 0 indicate guessing or lack of 
information; scores > 0 and < 0.5 indicate a low level of knowledge; scores 0.5 through 
1.0 indicate moderate level of knowledge; and scores > 1.0 indicate a high level of 
knowledge (Goel et al., 1996; Glazier et al., 1997).  For this sample, the mean scale score 
of the MSSKQ was 0.63 (SD=0.29).  Using the established cut-offs, results of the survey 
show that on average participants demonstrated moderate knowledge of prenatal 
aneuploidy screening.  In this study, the MSSKQ was adapted to include only the 12 
items that pertained to aneuploidy screening and not to include the two items specific to 
neural tube defects.  Consequently, comparison of this study’s MSSKQ scores with 
previous reports of MSSKQ scores should be done with caution.  The mean MSSKQ 
scale score for this sample was higher than the mean MSSKQ scale score (0.62) reported 
with its initial use by Goel et al. (1996) among higher income and highly educated 
pregnant women, but lower in comparison to the mean MSSKQ scale score (0.78) among 
the same sample at re-test.  The mean MSSKQ scale score for the sample in this study 
was lower compared to the mean MSSKQ scale score (0.89) for the treatment group and 
higher than the mean MSSKQ scale score for the control group (0.52) in Glazier et al.’s 
(1997) study investigating the efficacy of a revised educational pamphlet.   A majority of 
participants in this study did not demonstrate adequate understanding for one-third (4 of 
12) of the items measuring understanding of prenatal aneuploidy screening, as discussed 
below.   
 Inadequate understanding of the information that the screen provides.  
Among participants, 32.6% responded incorrectly to If the prenatal screen is abnormal, 
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something is usually wrong with the baby (False), and 30.5% neither agreed nor 
disagreed with this statement, for a mean score of 0.08 (SD=0.91).  Additionally, the 
mean score for If the prenatal screen is abnormal, something is usually wrong with the 
baby is lower in comparison to the mean score (0.53) reported for this item by Goel at al. 
(1996).  This finding suggests that many participants may not understand that the prenatal 
aneuploidy screen functions as a screen to demarcate higher risk, but not certitude, of 
having a baby with a chromosomal anomaly.  The finding may also indicate that many 
women do not clearly understand the distinction between a screen and a diagnostic test.  
The findings here support Seror and Ville’s (2009) finding that approximately 50% of 
women who are offered screening are not aware of the implications of screening or do 
not adequately understand the intent of screening. 
 Inadequate understanding that the screen is optional.  Among participants, 
35.8% responded incorrectly to Having prenatal screening is routine for all women 
(False), while 22.1% of participants neither agreed nor disagreed with this statement, for 
a mean score of 0.14 (SD=1.06).  The mean score for Having prenatal screening is 
routine for all women among this sample is lower in comparison to the mean score (0.55) 
reported for this item by Goel at al. (1996).  The finding suggests that many women may 
perceive prenatal aneuploidy screening as a routine aspect of standard prenatal care and 
may not understand that the offer of the screen includes a choice to be made rather than 
compliance with standard care.  This finding supports Jaques et al. (2005) and Chiang et 
al. (2006) research that found that many women perceive the offer of prenatal aneuploidy 
screening as assent to routine care rather than as a choice.  An alternative explanation is 
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that contemporary interpretation of this item may be influenced by prenatal aneuploidy 
screening being more frequently offered and accepted than it was 10 or 20 years ago, 
with the screen viewed as commonly occurring among women rather than as a standard 
part of prenatal care. 
  Inadequate understanding that invasive diagnostic testing would be offered 
in the event of a positive screen.  Among the participants, 8.4% responded incorrectly to 
Amniocentesis can cause miscarriage in 1 in 200 women (True), and 43.2% neither 
agreed or disagreed with this statement, for a mean score of 0.40 (SD=0.642).  The mean 
score for Amniocentesis can cause miscarriage in 1 in 200 women among the participants 
in this study is lower in comparison to the mean score (0.75) reported for this item by 
Goel at al. (1996).  Additionally, 14.7% of participants responded incorrectly to 
Amniocentesis is a test of the mother’s blood that can detect Down syndrome (False), and 
43.2% of participants neither agreed nor disagreed with this statement, for a mean score 
of -0.18 (SD=1.21).  The mean score for Amniocentesis is a test of the mother’s blood 
that can detect Down syndrome among this study’s participants is lower in comparison to 
the mean score (-0.04) reported for this item by Goel at al. (1996).   
 The findings for these latter two items indicate that many women do not have 
adequate knowledge of the diagnostic tests (including amniocentesis) that are used to 
confirm the findings of a positive screen nor adequate knowledge of the risks associated 
with the diagnostic tests.  The findings for the two items concerning amniocentesis may 
also point to decreased familiarity with amniocentesis secondary to lower rates of 
amniocentesis among women today compared to the late 1990s, when the MSSKQ was 
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developed (Turner, Rad, Afshar, Aghajanian, Williams, & Esakoff, 2014).  The results 
support Rowe et al.’s (2006) finding that nearly one-third of the women offered prenatal 
screening were unsure of what the options would be and what type of tests would be 
offered following a positive screen result.  The results also support Farrell et al.’s (2011) 
conclusion that many women do not consider the risks associated with diagnostic testing 
and the potential cascade of post-test decisions when considering prenatal aneuploidy 
screening.  
 Prenatal aneuploidy screening is the first step in a potential series of decisions 
about diagnostic testing and possible pregnancy termination in the event of confirmation 
of fetal chromosomal anomaly.  Gert (2002) has suggested that when informing patients, 
health care providers should share information that would not be a surprise to themselves, 
but which they believe would be a surprise to the patient.  Whereas it would not be 
surprising to the health care provider that the next steps following a positive prenatal 
aneuploidy screen would be the offer of invasive diagnostic testing, this study’s findings, 
in combination with the aforementioned prior studies (Farrell et al., 2011; Rowe et al., 
2006), suggest that the offer of amniocentesis and its associated risks would be surprising 
for many women.  Thus, the findings point to a need for more explicit discussions about 
what the next steps would be following a positive prenatal aneuploidy screen, specifically 
the option of invasive diagnostic testing and the subsequent possibility of making a 
decision about pregnancy termination. 
 The findings suggest inadequate understanding of prenatal aneuploidy 
screening.  This study was informed by Faden and Beauchamp’s (1986) model of 
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informed choice.  Faden and Beauchamp identify three essential conditions of informed 
consent: (a) intentional authorization, (b) substantial understanding of the act and its 
consequences, and (c) freedom from coercive control.  Substantial understanding includes 
(a) cognitive awareness of the proposed treatment, the alternatives, and the possible 
consequences of that act, and (b) cognizance that one is granting authorization (Faden & 
Beauchamp, 1986).  This study’s findings on women’s understanding of prenatal 
aneuploidy screening call into question whether women understand that the prenatal 
aneuploidy screen (a) provides information about the risk of having a baby with a 
chromosome abnormality rather than certitude of fetal anomaly, (b) is an option that they 
can choose to accept or decline, and (c) will require additional decision-making 
concerning invasive diagnostic testing and its associated risks in the event of a positive 
screen.  
Health Literacy 
 Feeling understood and supported by health care providers, Appraisal of health 
information, Ability to actively engage with health care providers, Ability to find good 
health information, and Understand health information enough to know what to do were 
measured by subscales of the Health Literacy Questionnaire (HLQ) (Osborne et al., 2014)   
Higher HLQ subscale scores represent greater health literacy.  This author was not able to 
locate any reports of prior use of the HLQ among pregnant women nor adult women 
living in the U.S.  Beauchamp et al. (2015) used the HLQ to assess health literacy among 
adults living in Australia, with the majority being female and living with at least one 
health condition.  Compared with the HLQ subscale scores for Beauchamp et al.’s 
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sample, this study’s sample yielded lower mean scores for Feeling understood and 
supported by health care providers (3.04), Ability to actively engage with health care 
providers (3.73), and Understand health information enough to know what to do (3.73).  
Beauchamp et al. report mean scores of 3.21 for Feeling understood and supported by 
health care providers, 3.97 for Ability to actively engage with health care providers, and 
3.85 for Understand health information enough to know what to do.  The comparison also 
shows that the sample in this study had higher mean scores for Appraisal of health 
information (2.91) and Ability to find good health information (3.92) compared with the 
sample in Beauchamp et al. (2015).  Beauchamp et al. report mean scores of 2.78 for 
Appraisal of health information and 2.92 for Ability to find good health information.  
Results indicate that on average participants reported moderate to high levels of health 
literacy across the five domains of health literacy measured by the HLQ and that the 
subscale scores for the five domains of health literacy are comparable with prior use of 
the HLQ among adult women. 
Satisfaction with Decisions Made for Prenatal Aneuploidy Screening 
 Satisfaction with decisions made for prenatal aneuploidy screening was measured 
by the Satisfaction with Decisions Scale (SWDS; Holmes-Rovner et al., 1996).  The 
range of possible scores for the SWDS is 6 to 30 with higher scores indicating greater 
satisfaction and scores ≥ 24.0, signifying satisfaction with a given decision (Holmes-
Rovner et al., 1996; Palmer-Wackerly et al., 2017; Wills & Holmes-Rovner, 2003).  The 
mean score of the SWDS was 24.00 (SD=4.60).  Results show that 57.9% (95% 
CI=47.8%, 67.3%) of the sample reported satisfaction with decisions made for prenatal 
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aneuploidy screening and that 42.1% (95% CI=32.7%, 52.2%) of participants did not 
report satisfaction with decisions made for prenatal aneuploidy screening.  To this 
author’s knowledge, no prior studies have measured women’s satisfaction with decisions 
made for prenatal aneuploidy screening.   
 Women’s satisfaction with decisions made for prenatal aneuploidy screening was 
compared to published reports of women’s satisfaction with other health care decisions.  
A lower percentage of women in this study demonstrated satisfaction with decisions 
made for prenatal aneuploidy screening compared to the percentage of women (80.6%) 
who demonstrated satisfaction with decisions made for breast cancer treatment (Lantz et 
al., 2005).  Additionally, a lower percentage of women in this study demonstrated 
satisfaction with decisions made for prenatal aneuploidy screening compared to the 
percentage of women (74.0%) who demonstrated satisfaction with decisions made for 
type of delivery (Cesarean or vaginal) (Wittmann-Price et al., 2011).  Hence, the women 
in this study demonstrated lower satisfaction with decisions made for prenatal aneuploidy 
screening when compared to reports of satisfaction for other women’s health care 
decisions.  
The Relationship of Health Literacy to Understanding of Prenatal Aneuploidy 
Screening 
 To examine the relationship of health literacy to understanding of prenatal 
aneuploidy screening, the five domains of health literacy (Feeling understood and 
supported by health care providers, Appraisal of health information, Ability to actively 
engage with health care providers, Ability to find good health information, and 
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Understand health information enough to know what to do) were regressed on MSSKQ 
scores, while controlling for uptake of the prenatal aneuploidy screen, educational level, 
and race/ethnicity.  Increasing Ability to actively engage with health care providers was 
significantly associated with increased understanding of prenatal aneuploidy screening.  
Feeling understood and supported by health care providers, Critical appraisal of health 
information, Ability to find good health information, and Understand health information 
enough to know what to do were not associated with understanding of prenatal 
aneuploidy screening.  The significant R2 change between the first and second regression 
models indicates that 32.9% of the variation in understanding of prenatal aneuploidy 
screening can be explained by uptake of prenatal aneuploidy screening, educational level, 
race/ethnicity, and the the five domains of health literacy.  Thus, while each of the five 
domains of health literacy did not individually predict understanding of prenatal 
aneuploidy screening, the addition of the five domains of health literacy helps to explain 
the variation in understanding prenatal aneuploidy screening. 
 Educational level was included in the regression of MSSKQ scores as a control.  
The finding that educational level is significantly associated with increasing 
understanding of prenatal aneuploidy screening is to be expected and consistent with 
previous studies.  Both Schoonen et al. (2012) and Van den Berg et al. (2005) found a 
better knowledge of screening among women with higher educational attainment. 
 The author is not aware of any previous study specifically examining the 
relationship between the health literacy domain of Ability to actively engage with health 
care providers and understanding of prenatal aneuploidy screening.  However, the 
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significant relationship supports prior research.  Martin et al. (2016) found a significant 
association between women’s psychosocial communication and health care providers’ 
psychosocial questions, affective communication, and the duration of counseling for 
prenatal fetal anomaly screening.  Martin et al. (2016) suggested that the positive 
association may be explained by individual characteristics of women, including a “better 
ability to engage in psychosocial interactions,” (Martin et al., 2016, p.89).  The findings 
of this study, in conjunction with Martin et al.’s (2016) findings, suggest that 
understanding of prenatal aneuploidy screening is enhanced by a woman’s interaction 
and communication with her health care providers.  When women are actively engaged 
with their providers in discussions about prenatal aneuploidy screening, they are more 
likely to make an informed decision. 
 It was unexpected that Understand health information enough to know what to do 
did not individually predict understanding of prenatal aneuploidy screening because the 
complexity of the information about prenatal aneuploidy screening and women’s 
difficulty in understanding the information is well-documented in the literature (Farrell et 
al., 2011; Fransen et al., 2010; Georgsson Öhman et al., 2009; Park & Matthews, 2009; 
Seror & Ville, 2009).  A possible explanation for this lack of a significant relationship 
between Understand health information enough to know what to and understanding of 
prenatal aneuploidy screening is that the range of scores measuring Understand health 
information enough to know what to do was relatively narrow (2.60 – 5.00 out of a 
possible score of 5) compared with the range of scores for the other four domains of 
health literacy.  This narrow range of scores for Understand health information enough to 
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know what to do may be due in part to the majority of the sample having a college degree 
or graduate degree.  More highly educated individuals have demonstrated increased 
cognitive ability to understand health information as well as greater confidence in their 
ability to understand health information (Bo, Friis, Osborne, & Maindal, 2014; Cutler & 
Lleras-Muney, 2010).  Further, the items on the survey that assessed Understand health 
information enough to know what to do are part of the HLQ, for which participants are 
asked to respond to statements about health care and health information in general rather 
than specific to the topic of prenatal aneuploidy screening.  It is possible that some 
women who may have difficulty understanding the specific information about prenatal 
aneuploidy screening well enough to know what to do did not report difficulty in 
Understand health information enough to know what to do when considering general 
health information.   
The Relationship of Health Literacy and Understanding of Prenatal Aneuploidy 
Screening to Satisfaction with Decisions Made for Prenatal Aneuploidy Screening 
 To examine the relationship of health literacy and understanding of prenatal 
aneuploidy screening to satisfaction with decisions made for prenatal aneuploidy 
screening, the five domains of health literacy (Feeling understood and supported by 
health care providers, Appraisal of health information, Ability to actively engage with 
health care providers, Ability to find good health information, and Understand health 
information enough to know what to do) and MSSKQ scores were regressed on SWDS 
scores.  While controlling for parity and uptake of the prenatal aneuploidy screen, results 
indicate that increasing Feeling understood and supported by health care providers and 
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increasing Ability to find good health information are significantly associated with 
increasing satisfaction with decisions made for prenatal aneuploidy screening.  Appraisal 
of health information, Ability to actively engage with health care providers, Understand 
health information enough to know what to do, and understanding of prenatal aneuploidy 
screening were not significantly associated with satisfaction with decisions made for 
prenatal aneuploidy screening.  The R2 change between the first and second regression 
models was significant, indicating that 41.4% of the variation in satisfaction with 
decisions made for prenatal aneuploidy screening can be explained by parity, uptake of 
prenatal aneuploidy screening, the five domains of health literacy, and understanding of 
prenatal aneuploidy screening.  Thus, while three of the five domains of health literacy 
and understanding of prenatal aneuploidy screening did not individually predict 
satisfaction with decisions made for prenatal aneuploidy screening, the addition of the 
five domains of health literacy and understanding of prenatal aneuploidy screening helps 
to explain the variation in satisfaction with decisions made for prenatal aneuploidy 
screening. 
 No previous studies were identified that examined the influence of the five health 
literacy domains and understanding of prenatal aneuploidy screening on satisfaction with 
decisions made for prenatal aneuploidy screening.  The significant relationships between 
Feeling understood and supported by health care providers and Ability to find good 
health information and satisfaction with decisions made for prenatal aneuploidy 
screening support prior research on women’s experiences with prenatal aneuploidy 
screening.  Van den Berg et al. (2005) found that informed decision-making was a 
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significant predictor of satisfaction with decisions made for prenatal screening.  
Additionally, Ahmed et al. (2014) learned that most women want health professionals to 
help them work through information about prenatal aneuploidy screening to help them 
discern which choice is best for them.  The results of this study in conjunction with Van 
den Berg et al.’s (2005) and Ahmed et al.’s (2014) research indicate that a woman’s 
satisfaction with decisions made for prenatal aneuploidy screening increases when she 
has access to high-quality information and feels supported by health care professionals to 
understand the information and arrive at a decision that aligns with her values. 
 It is surprising that understanding of prenatal aneuploidy screening did not 
individually predict women’s satisfaction with decisions made for prenatal aneuploidy 
screening.  According to Holmes-Rovner et al. (1996), satisfaction with a decision occurs 
with intentional evaluation of available information on the options and risks involved 
with a course of action and alignment of values.  Thus, adequate understanding of the 
screen is conceptually a necessary feature of satisfaction with a decision for prenatal 
aneuploidy screening.  Additionally, informed decision-making is associated with greater 
satisfaction with decisions about prenatal aneuploidy screening (Van den Berg et al., 
2005).  One explanation for why understanding of prenatal aneuploidy screening did not 
individually predict satisfaction with decisions made for prenatal aneuploidy screening is 
that the participants’ perception of being adequately informed about prenatal aneuploidy 
screening, which is measured by the SWDS, may be greater than their objective 
understanding of prenatal aneuploidy screening, which is measured by the MSSKQ.  
Extant research indicates that women frequently have inadequate understanding of 
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prenatal aneuploidy screening, the implications of screening, and the conditions detected, 
despite having received information (Farrell et al., 2011; Fransen et al., 2010; Georgsson 
Öhman et al., 2009; Park & Matthews, 2009; Seror & Ville, 2009).  It is possible that 
some women in this study may have indicated that they felt adequately informed about 
the screen (on the SWDS) while demonstrating inadequate understanding of prenatal 
aneuploidy screening (as measured by the MSSKQ).  Additionally, some people may be 
less likely to question their satisfaction with a decision once the decision is made and 
cannot be changed.  An alternative explanation is that the MSSKQ may not measure what 
women believe is relevant and important to know about prenatal aneuploidy screening.  
In this scenario, some women may have demonstrated inadequate understanding of 
prenatal aneuploidy screening while reporting high satisfaction with their decisions 
because they believe that they were adequately informed on the issues surrounding 
prenatal aneuploidy screening that they identify as salient.  
Conceptual Considerations  
 The significance of the associations between the health literacy domains of Ability 
to actively engage with health care providers and understanding of prenatal aneuploidy 
screening and Feeling understood and supported by health care providers and Ability to 
find good health information and satisfaction with decisions made for prenatal 
aneuploidy screening may be explained by Nutbeam’s (2000) explication of the three 
levels of health literacy.  Nutbeam conceived of three subtypes of health literacy: basic 
functional health literacy, communicative/interactive health literacy, and critical health 
literacy.  Feeling understood and supported by health care providers, Ability to actively 
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engage with health care providers and Ability to find good health information, are the 
three domains of health literacy that comprise communicative/interactive health literacy 
(Nutbeam, 2000; Osborne et al., 2013).  Communicative/interactive health literacy 
includes the advanced cognitive and literacy skills required to actively participate in and 
derive meaning from various forms of communication and to apply new information to 
dynamic situations (Nutbeam, 2000).  Therefore, Feeling understood and supported by 
health care providers, Ability to actively engage with health care providers, and Ability 
to find good health information impact the information-gathering and problem-solving 
processes necessary for effective health care decision-making (Jordan, Buchbinder, & 
Osborne, 2010; Nutbeam, 2000).  The overall findings of this study indicate that 
communicative/interactive health literacy, as conceived by Nutbeam, significantly 
influences understanding of prenatal aneuploidy screening and satisfaction with decisions 
made for prenatal aneuploidy screening.   
Conclusions 
 The following conclusions are drawn from the findings of this study: 
 1. Women did not have sufficient understanding that the prenatal aneuploidy 
screen (a) provides information about the risk of having a baby with a chromosome 
abnormality rather than certitude of fetal anomaly, (b) is an option that they can choose to 
accept or decline, and (c) will require additional decision-making, in the event of a 
positive screen, concerning invasive diagnostic testing, its associated risks, and possible 
termination.  
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 2. Ability to actively engage with health care providers significantly influenced 
understanding of prenatal aneuploidy screening.   
 3. Feeling understood and supported by health care providers and Ability to find 
good health information significantly influenced satisfaction with decisions made for 
prenatal aneuploidy screening.   
 4. Nearly 1 out of every 2 women failed to demonstrate satisfaction with their 
decision made for prenatal aneuploidy screening.  This means that that nearly half of the 
decisions made for prenatal aneuploidy screening were inadequately informed and/or 
incongruent with the patient’s values. 
Implications for Practice, Education, and Policy 
 The responsible translation of reproductive and genetic technologies into prenatal 
care requires that health care professionals ensure women’s informed decision-making in 
clinical practice (Badzek, Henaghan, Turner, & Monsen, 2013).  As members of the 
prenatal care team, professional registered nurses have a professional and ethical 
responsibility to facilitate women’s informed decision-making for prenatal aneuploidy 
screening.  Professional registered nurses have an ethical duty to ensure that women 
understand what it is that they are accepting or declining with decisions for prenatal 
aneuploidy screening.  This study’s findings suggest that women have inadequate 
understanding that the prenatal aneuploidy screen (a) provides information about the risk 
of having a baby with a chromosome abnormality rather than certitude of fetal anomaly, 
(b) is an option that they can choose to accept or decline, and (c) will require additional 
decision-making concerning invasive diagnostic testing in the event of a positive screen. 
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 This study indicates that a woman’s communicative/interactive health literacy 
plays a critical role in the problem-solving and evaluation of health information required 
for women to attain substantial understanding of prenatal aneuploidy screening and to 
make decisions about prenatal aneuploidy screening that are aligned with their values.  
The findings highlight the need for patient-centered strategies that promote open and 
intentional communication about prenatal aneuploidy screening (Moore, Titler, Kane 
Low, Dalton, & Sampselle, 2015).  In this study, nearly half of women made decisions 
regarding prenatal aneuploidy screening that were based on inadequate understanding 
and/or that were incongruent with their values.  It is imperative that health care 
professionals ensure that women have substantial understanding of prenatal aneuploidy 
screening so that women can make decisions for screening that are informed and 
consistent with their values.  Interventions are needed to (a) ensure access to 
comprehensive information about prenatal aneuploidy screening with assessment of 
women’s understanding, (b) facilitate women’s active engagement through the creation 
of a prenatal care environment that conveys understanding and nonjudgmental guidance 
throughout the decision-making process, and (c) address the educational needs of health 
professionals who provide prenatal care. 
 Ensuring access to comprehensive information and assessing women’s 
understanding of prenatal aneuploidy screening.  Prenatal care professionals, 
including professional registered nurses, have an ethical responsibility to know that 
women understand what it is that they are accepting or declining with the offer of 
prenatal aneuploidy screening (Consensus Panel on Genetic/Genomic Nursing 
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Competencies, 2009).  Interventions are needed to ensure that women are provided with 
accurate, unbiased, and comprehensive information about prenatal aneuploidy screening.  
This information should include the implications of screening and the conditions 
screened.  To avoid women being surprised in the trajectory of prenatal care, the 
information should include the possibility of subsequent decision-making about 
diagnostic testing and pregnancy termination.  Further, this information needs to be in 
plain language that is accessible to women with lower literacy and numeracy skills and 
available to women in their preferred language. 
 It is not enough to provide women with information.  It is imperative that health 
care professionals assist women to attain a basic understanding of prenatal aneuploidy 
screening before making their decisions.  Nurses have expertise in using a variety of 
creative methods to teach patients about complex health topics.  Professional registered 
nurses can partner with genetic counselors and prenatal care providers, including 
advanced practice nurses, to develop a variety of instructional tools to help women 
understand prenatal aneuploidy screening.  Further, as members of the prenatal care team, 
it is incumbent upon professional registered nurses to assess women’s understanding of 
prenatal aneuploidy screening.  Registered nurses need to work within their practice 
settings to establish a process by which women’s understanding of prenatal aneuploidy 
screening is assessed and resources are provided when misunderstanding occurs.  
 Facilitating women’s active engagement and creating a supportive, 
nonjudgmental prenatal care environment.  Informed consent is an interaction 
between health care professionals and patients that requires clear and specific 
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communication regarding the issues at stake (Badzek et al., 2013).  How information is 
provided and the manner in which it is explained may have more influence on a woman’s 
health decision than the amount of information that is presented (Moore et al., 2015).  In 
practice, health literacy is a function of the relationship between individual 
communication capacities and the health care system (Baker, 2006).  Therefore, 
interventions are needed to create a process in which women can have meaningful 
discussions about prenatal aneuploidy screening with prenatal care providers.  Registered 
nurses have a social and professional responsibility to be informed and educate other 
health professionals on the positive associations between supportive communication and 
women’s understanding of prenatal aneuploidy screening and satisfaction with their 
decisions for screening.  Interventions are needed to support women in articulating their 
concerns and asking pertinent questions about prenatal screening.  In their advocacy role, 
professional registered nurses can be present in discussions about prenatal aneuploidy 
screening to verify that women understand that they have a genuine choice of whether or 
not to use the screen and to assess for possible misinterpretation of information (Skirton, 
Lewis, Kent, & Coviello, 2010).  A nonjudgmental prenatal care environment should 
include the support women are provided whether they choose to accept or decline the 
screen.  Further, as environmental factors (e.g., workload, short appointment times) affect 
how providers engage patients in clinical decision-making and with prenatal aneuploidy 
screens increasingly being offered to women in the first trimester, interventions are 
needed to allow for adequate time for discussion about prenatal aneuploidy screening 
during the initial prenatal care appointment (Allyse et al., 2015; Moore et al., 2015). 
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 Addressing the educational needs of prenatal care providers.  Previous 
research suggests that educational gaps exist among health care providers on prenatal 
aneuploidy screening, including the professional guidelines and policies for prenatal 
aneuploidy screening, limitations of screening, and resources available for parenting a 
child with disabilities (Farrell et al., 2011; Haymon et al., 2014).  As a result, health care 
professionals may be inadequately prepared to have the type of meaningful discussions 
about prenatal aneuploidy screening that assist women in making informed decisions.  
Educational interventions are needed to train health care providers on managing 
discussions about prenatal aneuploidy screening to assist women in understanding the 
information about prenatal aneuploidy screening and to guide women in making 
decisions that are well-informed and consistent with the woman’s values.   
Limitations of the Study 
 Threats to internal validity.  Internal validity involves the rigor and degree of 
control in a study (Gliner, Morgan, & Leech, 2009).  Research conducted with human 
subjects, especially research using nonexperimental methods, often has methodological, 
design, and data limitations that can reduce the extent to which inferences can be made 
(Gliner et al., 2009).  By design, this correlational study focused on the relationships 
between women’s understanding of prenatal aneuploidy screening and satisfaction with 
decisions made for prenatal aneuploidy screening and aspects of health literacy that are 
potentially amenable to interventions.  This study is likely limited by unmeasured 
personal, social, and contextual factors that may influence women’s understanding of 
prenatal aneuploidy screening and satisfaction with decisions made for prenatal 
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aneuploidy screening.  The mode of the exchange of information (written, oral, 
discussion, video, etc.) between women and their prenatal care providers and the duration 
of time spent presenting and discussing the screen may influence women’s understanding 
of prenatal aneuploidy screening and satisfaction with decisions made for prenatal 
aneuploidy screening.  This study is also limited by the type of data collected.  Although 
it was assumed that participants answered the survey questions honestly and accurately, 
the results cannot be verified.  This study may also be limited by the content of the 
MSSKQ.  While the MSSKQ has been validated in prior research with women 
undergoing prenatal aneuploidy screening, the types of screens offered and the timing of 
the screens are different today than when the MSSKQ was developed (Goel et al., 1996; 
Glazier et al., 1997).  These differences may affect how women understand the 
underlying constructs that are assessed with the MSSKQ.   
 Threats to external validity.  External validity refers to the extent to which 
findings can be generalized beyond the study (Gliner et al., 2009).  The present study is 
limited by convenience sampling of women who receive the electronic pregnancy and 
parenting newsletter distributed through Mission Health System in western North 
Carolina.  The primary limitation of convenience sampling is that the accessible 
population might not be representative of the theoretical population, thereby limiting 
external validity (Gliner et al., 2009).  While this study included a higher proportion of 
racial/ethnic minorities compared to other studies investigating informed decision-
making for prenatal screening (Constantine et al. 2014; Dixon & Burton, 2014), this 
study had a smaller proportion of Black/African American and Hispanic women 
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compared to the population of women giving birth in western North Carolina.  
Additionally, the sample was predominantly college-educated.  Therefore, this study’s 
findings should be interpreted with caution for women who are racial/ethnic minorities 
and women who are not college-educated.  Lastly, as convenience sampling was used, the 
confidence intervals presented in this study should be interpreted with caution. 
Recommendations for Future Research 
 Future research needs to investigate mechanisms to promote open communication 
concerning prenatal aneuploidy screening between women and prenatal care providers.  
Research is essential to identify communication strategies that help women to actively 
engage with their prenatal care providers and feel understood when articulating concerns 
and making decisions about prenatal aneuploidy screening.  Additionally, it is necessary 
to investigate the influence of health literacy on women’s understanding of prenatal 
aneuploidy screening among vulnerable populations, including racial and ethnic 
minorities and women with no college education.  Moreover, it is imperative to explore 
women’s informed decision-making for prenatal aneuploidy screening in the context of 
the legal framework for abortion in the U.S., where gestational limits on pregnancy 
termination currently vary by state. 
  Future research should address questions regarding how prenatal care providers 
can facilitate women’s informed decision-making for prenatal aneuploidy screening.  It is 
important to determine the knowledge base of prenatal care providers on the topic of 
prenatal aneuploidy screening and to identify their educational needs concerning prenatal 
aneuploidy screening.  Quality assurance studies are needed to investigate the provision 
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of comprehensive and unbiased information about prenatal aneuploidy screening.   
Further, there is a need for studies to develop and test interventions for prenatal care 
providers to improve their capacity to discuss prenatal aneuploidy screening with patients 
and provide guidance in decision-making without influencing the final choice for such 
screening.  
 Lastly, as the types of screens offered for prenatal aneuploidy screening have 
evolved with advancements in genetics and technology over the past 10 to 20 years, 
psychometric evaluation of the MSSKQ (Goel et al., 1996) is warranted.  Psychometric 
evaluation should include examination of the content validity of the MSSKQ with subject 
matter experts in the context of first-trimester screening options.  Moreover, assessment 
of construct validity via factorial validity is necessary to determine if the underlying 
putative structure of the MSSKQ adequately measures women’s knowledge of prenatal 
aneuploidy screening. 
Chapter Summary 
 As prenatal aneuploidy screening is increasingly offered to all pregnant women, 
health care providers have the responsibility to support women in making an informed 
and autonomous decision that is aligned with the patient’s values.  This study 
demonstrates a clear need for improving women’s understanding of prenatal aneuploidy 
screening to enable women to make decisions that are congruent with their personal 
beliefs and values.  While a majority (57.9%) of the sample demonstrated satisfaction 
with decisions made for prenatal aneuploidy screening, a substantial proportion (42.1%) 
did not report satisfaction with decisions made for prenatal aneuploidy screening.  This 
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study shows that women’s informed decision-making for prenatal aneuploidy screening is 
a process that is supported by the communicative/interactive health literacy domains of 
Feeling understood and supported by health care providers, Ability to actively engage 
with health care providers, and Ability to find good health information.  Understanding of 
prenatal aneuploidy screening was predicted by Ability to actively engage with health 
care providers.  Satisfaction with decisions made for prenatal aneuploidy screening was 
predicted by Feeling understood and supported by health care providers and Ability to 
find good health information.  As genetic and reproductive technologies continue to 
develop, options for prenatal screening will become more diverse, and decisions about 
prenatal screening will likely become increasingly complex and morally contentious.  
The results of this and other studies highlight the importance of deliberate exchange of 
information and discussion between women and their prenatal care providers in decisions 
about prenatal screening (Farrell et al., 2011; Farrell et al., 2014; Martin et al., 2016; Park 
& Matthews, 2009).  To facilitate informed decision-making for prenatal aneuploidy 
screening, it is important to create a health care environment in which clear and 
comprehensive information about prenatal aneuploidy screening and its implications is 
provided, understanding of prenatal aneuploidy screening is assessed, active and direct 
communication about prenatal screening occurs, and women feel supported and 
understood by their prenatal care providers in the decision-making process.
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nstitutional Review Board 
509 Biltmore Avenue, Asheville, North Carolina 
28801 phone (828) 213-1105   fax (828) 213-7056 
www.missionhospitals.org 
"
"
"
Date: July 28, 2017 
"
To: Tamra Shea, MSN 
From:& Mission"Health"Institutional"Review"Board"
"
Study&Title:& [1070492?1]"Health"Literacy,"Understanding,"and"Decisional"
Satisfaction"in"Women's"Informed"Decision?Making"for"Prenatal"
Aneuploidy"Screening"
IRB Reference #: 17-07-1716, NF 
Submission Type: New Project 
"
Action: Determination of Exempt Status 
Decision Date: July 28, 2017 
"
On July 28, 2017, the Mission Health Institutional Review Board reviewed your proposed study, 
"[1070492-1] Health Literacy, Understanding, and Decisional Satisfaction in Women's 
Informed Decision-Making for Prenatal Aneuploidy Screening" via Exempt Review and 
determined that this project is EXEMPT from IRB review 21 CFR 56.104; 45 CFR 46.101(b), 
category 2. 
"
We"will"file"a"copy"of"this"correspondence"in"our"office."
"
You"must"notify"the"IRB"of"any"changes"in"this"project"that"may"alter"the"IRB's"determination."As"with"
any"changes"to"the"research"itself,"financial"relationships"or"interests"that"develop"with"a"sponsor"later"or"
over"time"must"be"brought"to"the"attention"of"the"Mission"Health"Cancer"Institutional"Review"Board"and"to"
Mission"Health's"Corporate"Compliance"Officer"for"further"consideration."
"
If"you"have"any"questions,"please"contact"Elizabeth"Hamilton"at"(828)"213?1105"or"
elizabeth.hamilton@msj.org."Please"include"your"study"title"and"reference"number"in"all"correspondence"
with"this"office."
This"letter"has"been"electronically"signed"in"accordance"with"all"applicable"federal"regulations"and"a"copy"
of"this"letter"is"retained"within"the"electronic"study"folder"and"Mission"Health"System"records."
"
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"
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UNCG INSTUTIONAL REVIEW BOARD EXEMPT STATUS LETTER 
 
 
OFFICE&OF&RESEARCH&
INTEGRITY&
2718"Beverly"Cooper"Moore"
and"Irene"Mitchell"Moore"
Humanities"and"Research"
Administration"Bldg."
PO"Box"26170"
Greensboro,"NC"27402?6170"
336.256.0253"
Web"site:"
www.uncg.ed
u/orc"
Federalwide"
Assurance"
(FWA)"#216"
To: Tamra Shea, School of Nursing 
 
From: UNCG IRB 
"
Date: 6/15/2017 
"
RE:"Notice"of"IRB"Exemption"
Exemption Category: 2.Survey, interview, public observation 
Study #: 17-0224 
Study&Title:"Health"Literacy,"Understanding,"and"Decisional"Satisfaction"in"Women's"Informed"
Decision?Making"for"Prenatal"Screening"
"
This"submission"has"been"reviewed"by"the"IRB"and"was"determined"to"be"exempt"from"further"
review"according"to"the"regulatory"category"cited"above"under"45"CFR"46.101(b)."
"
Study Description: 
&
Women"are"routinely"asked"to"consent"to"prenatal"aneuploidy"screening"to"detect"fetal"chromosomal"
problems"in"early"pregnancy"despite"evidence"that"many"women"do"not"understand"what"they"are"
consenting"to."The"objective"of"this"proposed"study"is"to"investigate"the"relationships"between"women's"
understanding"of"prenatal"aneuploidy"screening,"health"literacy,"and"satisfaction"with"decisions"made"for"
prenatal"aneuploidy"screening."
"
Specific&Aim&1:"To"assess"women’s"satisfaction"with"decisions"made"for"prenatal"aneuploidy"screening."
"
Research&Question&1:"How"satisfied"are"women"with"the"decisions"they"make"for"prenatal"
aneuploidy"screening?"
"
Specific&Aim&2:"To"assess"the"influence"of"health"literacy"on"women’s"understanding"of"prenatal"
aneuploidy"screening."
"
Research&Question&2:"What"is"the"relationship"of"health"literacy"to"women’s"understanding"of"
"
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prenatal"aneuploidy"screening?"
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Specific&Aim&3:"To"assess"the"influences"of"health"literacy"and"understanding"of"prenatal"
aneuploidy"screening"on"women’s"satisfaction"with"decisions"made"for"prenatal"aneuploidy"
screening."
"
Research&Question&3:"What"is"the"relationship"of"health"literacy"and"understanding"of"prenatal"
aneuploidy"screening"to"women’s"satisfaction"with"decisions"made"for"prenatal"aneuploidy"
screening?"
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implemented."Please"utilize"the"most"recent"and"approved"version"of"your"consent"form/information"
sheet"when"enrolling"participants."The"IRB"will"maintain"records"for"this"study"for"three"years"from"the"
date"of"the"original"determination"of"exempt"status."
"
Signed letters, along with stamped copies of consent forms and other 
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consent forms must be used unless the IRB has given you approval to waive 
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issue with the stamped consents forms. 
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Please"be"aware"that"valid"human"subjects"training"and"signed"statements"of"confidentiality"for"
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you"will"also"need"to"remain"in"compliance"
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APPENDIX C 
 
RECRUITMENT EMAIL 
 
 
Please consider completing a survey for pregnant women on how they understand and 
view information on prenatal care and screening.  The information you provide will help 
to improve health care for expectant mothers, and the survey takes less than 15 minutes to 
complete.   
  
Upon completion of the survey, you will be eligible to win one of two $50.00 gift cards to 
Target or WalMart!. 
  
To participate, simply click on the link: "Let Us Know What You Think" 
  
Thank you so much for assisting in improving care for women and children. 
  
Tamra L. Shea, MSN, RN 
and 
Denise Côté-Arsenault, PhD, RN, FNAP, FAAN 
The University of North Carolina Greensboro 
  
Mary Ellen Wright, PhD, APRN, CPNP 
Nurse Researcher Women’s and Children’s Health 
Mission Health 
 
"
"
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APPENDIX D 
 
CONSENT FORM 
 
 
UNIVERSITY OF NORTH CAROLINA GREENSBORO 
and 
MISSION HEALTH SERVICES 
CONSENT TO ACT AS A HUMAN PARTICIPANT 
 
Project Title: Health Literacy, Understanding, and Decisional Satisfaction in Women’s 
Decision-Making for Prenatal Aneuploidy Screening 
 
Principal Investigator and Faculty Advisor: Tamra L. Shea and Dr. Denise Côté-
Arsenault 
 
 
What are some general things you should know about research studies?  
You are being asked to take part in a research study.  Your participation in the study is 
voluntary. You may choose not to join, or you may withdraw your consent to be in the 
study, for any reason, without penalty. Research studies are designed to obtain new 
knowledge. This new information may help people in the future.  There may not be any 
direct benefit to you for being in the research study. There also may be risks to being in 
research studies. If you choose not to be in the study or leave the study before it is done, 
it will not affect your relationship with the researcher, the University of North Carolina at 
Greensboro, or your treatment at Mission Health Services.  
Details about this study are discussed in this consent form.  It is important that you 
understand this information so that you can make an informed choice about being in this 
research study.  
 
You may print this page on your web browser to obtain a copy of this consent form.  If 
you have any questions about this study at any time, you should ask the researchers 
named in this consent form. Their contact information is below.  
Voluntary participation: Your participation in the study is completely voluntary.  The 
treatment and services you receive at this clinic or practice will not be affected by your 
participation in this study.  Participation in the research project will in no way affect your 
current or future receipt of services from this clinic site or practice. 
 
What is the study about?  
This is a research project.  Your participation is voluntary. The purpose of the study is to 
advance understanding of the women’s decision-making for prenatal screening. 
 
 
"
 
192 
Why are you asking me? 
Any woman who is ≥"18 weeks pregnant, who is receiving prenatal care, who is ≥"18 
years old, and who is English-speaking, is invited to participate in this study. 
 
What will you ask me to do if I agree to be in the study? 
You are asked to complete an online survey about your experiences with decision-making 
for prenatal screening and your understanding of health information.  The survey will 
also include questions about your obstetric history and general questions about you, such 
as your age and race/ethnicity.  You may stop taking the survey at any time. It is 
anticipated that the survey will take approximately 20 minutes to complete. There is little 
likelihood of any physical risk as a result of participation in this research project.  
Participants are not asked to perform any tasks as a part of the survey that could result in 
physical harm.  There is no physical assessment or invasive procedures in this study.  
There is no direct involvement with the fetus. 
If you have questions about this study, please contact Tamra Shea, RN at (828) 545-9809. 
Is there any audio/video recording? 
There is no audio or video recording in this study. 
 
What are the risks to me? 
The Institutional Review Boards at the University of North Carolina at Greensboro and at 
Mission Health System has determined that participation in this study poses minimal risk 
to participants.  You will be asked to provide information about your experience of 
decision-making, understanding of health information, obstetric history, and demographic 
data.  These questions have a small likelihood of low embarrassment or upset feelings by 
questions that ask you to think about your access to and understanding of health 
information, communicating with health professionals, decision-making processes, and 
obstetric history.  As pregnant women are at risk of being fatigued, a potential risk would 
be contribution to fatigue. The likelihood of physical fatigue is minimal and the 20 
minutes to complete the survey are no more than regular waiting times in most clinics.  
If you have questions, want more information, or have suggestions, please contact: 
Tamra Shea, RN, MSN (principal investigator); (828) 545-9809;  tlshea@uncg.edu.)AND  
Denise Côté-Arsenault, PhD (faculty sponsor,); (336) 334-5182; d_cotear@uncg.edu). 
 
If you have any concerns about your rights, how you are being treated, concerns or 
complaints about this project or benefits or risks associated with being in this study please 
contact the Office of Research Integrity at UNCG toll-free at (855)-251-2351. 
 
Are there any benefits to society as a result of me taking part in this research? 
The study may help us understand prenatal screening from the woman’s perspective.  
Findings will inform interventions and education for care providers to improve prenatal 
care. 
 
 
 
"
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Are there any benefits to me for taking part in this research study? 
There are no direct benefits to you for participating in this research study.   
 
Will I get paid for being in the study?  Will it cost me anything? There is no cost to 
participate in the study.  As an incentive, upon completion of the survey you will be 
eligible to enter a lottery for one of two $50 gift cards.  Should you choose to withdraw 
from the study prior to completing the survey, the incentive will not be offered.  Entry 
into the lottery for the gift cards will occur through a linked survey.   
 
How will you keep my information confidential? 
All information obtained in this study is strictly confidential and anonymous unless 
disclosure is required by law.  The information that you give in the study will be handled 
confidentially. Your data will be de-identified which means that your name will not be 
linked to the data.  As this is an online survey, absolute confidentiality of data provided 
through the Internet cannot be guaranteed due to the limited protections of Internet 
access.  Please be sure to close your browser when finished so no one will be able to see 
what you have been doing. The de-identified data will be stored in a database stored on a 
secured server.  The de-identified data will be kept for ten years or the completion of all 
analyses, whichever occurs first. 
  
What if I want to leave the study? 
You have the right to refuse to participate or to withdraw at any time, without penalty.  If 
you do withdraw, it will not affect you in any way.  If you choose to withdraw, you may 
request that any of your data which has been collected be destroyed unless it is in a de-
identifiable state. The investigators also have the right to stop your participation at any 
time.  This could be because the entire study has been stopped.  If you want to withdraw 
from the study, you may stop answering the survey questions at any time.  
What about new information/changes in the study?  
If significant new information relating to the study becomes available which may relate 
to your willingness to continue to participate, this information will be provided to you. 
 
Voluntary Consent by Participant: 
By completing this survey, you are agreeing that you read, or it has been read to you, and 
you fully understand the contents of this document and are openly willing consent to take 
part in this study.  All of your questions concerning this study have been answered.  By 
completing this survey, you are agreeing that you are 18 years of age or older and are 
agreeing to participate in this study described to you by Tamra Shea. 
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APPENDIX E 
 
STUDY"SURVEY"
"
"
Maternal&Serum&Screening&Knowledge&Questionnaire&(MSSKQ)&
This&part&of&the&survey&asks&about&how&you&understand&and&view&information&on&
prenatal&screening.&
DIRECTIONS:&The"following"questions"contain"a"number"of"statements"with"which"some"
people"agree"and"others"disagree.""Please"rate"how"much"you"personally"agree"or"
disagree"with"these"statements"by"checking"on"the"box"next"to"the"response."
1." If"the"results"of"the"prenatal"screen"are"abnormal,"further"tests"are"needed"to"
tell"if"something"is"wrong."
"
"Strongly"
disagree"
"Disagree" Neither"
agree"nor"
disagree"
"Agree" Strongly"agree" "
2." Women"who"have"a"normal"prenatal"screening"can"be"sure"that"they"will"have"
a"healthy"baby."
"
"Strongly"
disagree"
"Disagree" Neither"
agree"nor"
disagree"
"Agree" Strongly"agree" "
3." The"prenatal"screen"only"detects"Down"syndrome."
"
"Strongly"
disagree"
"Disagree" Neither"
agree"nor"
disagree"
"Agree" Strongly"agree" "
4." If"the"prenatal"screen"is"abnormal,"something"is"usually"wrong"with"the"baby."
"
"Strongly"
disagree"
"Disagree" Neither"
agree"nor"
disagree"
"Agree" Strongly"agree" "
5." Prenatal"screening"is"not"accurate"when"done"at"the"wrong"time"of"pregnancy."
"
"Strongly"
disagree"
"Disagree" Neither"
agree"nor"
disagree"
"Agree" Strongly"agree"
"
"
"
"
" "
"
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6." Having"prenatal"screening"is"routine"for"all"women."
"
"Strongly"
disagree"
"Disagree" Neither"
agree"nor"
disagree"
"Agree" Strongly"agree" "
7." Amniocentesis"can"cause"miscarriage"in"1"in"200"women."
"
"Strongly"
disagree"
"Disagree" Neither"
agree"nor"
disagree"
"Agree" Strongly"agree"
" "
8." Ultrasound"can"be"used"to"find"every"kind"of"birth"defect."
"
"Strongly"
disagree"
"Disagree" Neither"
agree"nor"
disagree"
"Agree" Strongly"agree"
"
"
"
9." Amniocentesis"is"a"test"of"the"mother’s"blood"that"can"detect"Down"syndrome."
"
"Strongly"
disagree"
"Disagree" Neither"
agree"nor"
disagree"
"Agree" Strongly"agree" "
10."The"chance"of"having"a"baby"with"Down"syndrome"is"higher"the"older"the"
mother."
"Strongly"
disagree"
"Disagree" Neither"
agree"nor"
disagree"
"Agree" Strongly"agree" "
11."All"children"born"with"Down"syndrome"have"severe"physical"and"mental"
disabilities"that"require"lifelong"care"in"an"institution."
"
"Strongly"
disagree"
"Disagree" Neither"
agree"nor"
disagree"
"Agree" Strongly"agree" "
12."If"amniocentesis"shows"Down"syndrome,"the"only"options"are"to"have"a"baby"
with"Down"syndrome"or"to"terminate"the"pregnancy."
"
"Strongly"
disagree"
"Disagree" Neither"
agree"nor"
disagree"
"Agree" Strongly"agree" "
 
 
 
"
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Satisfaction with Decision Scale 
 
In this part of the survey, we want to learn about your decision-making for prenatal 
screening for chromosome problems with your baby. 
 
DIRECTIONS: Please answer the following questions about your decisions about 
prenatal aneuploidy screening to learn if your baby might have a chromosome problem.  
Please indicate to what extent each statement is true for you AT THIS TIME. (Select one 
number for each statement.) 
 
 
1. I was adequately informed about the different options available for prenatal screening 
for chromosome problems with my baby.  
 
"Strongly"
disagree!
"Disagree! "Neither"
agree"nor"
disagree!
"Agree! "Strongly"
agree"
 
 
 
 
 
2. The decision I made was the best decision for me personally. 
 
"Strongly"
disagree!
"Disagree! "Neither"
agree"nor"
disagree!
"Agree! "Strongly"
agree"
 
 
 
 
3. I decision that I made was consistent with my values. 
 
"Strongly"
disagree!
"Disagree! "Neither"
agree"nor"
disagree!
"Agree! "Strongly"
agree"
 
 
 
 
 
 
"
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4. The expect to continue to carry out the decision that I made about prenatal screening 
for chromosome problems with my baby. 
 
"Strongly"
disagree!
"Disagree! "Neither"
agree"nor"
disagree!
"Agree! "Strongly"
agree"
 
 
 
 
 
5. I had as much input as I wanted in the choice to use prenatal screening for 
chromosome problems with my baby. 
 
"Strongly"
disagree!
"Disagree! "Neither"
agree"nor"
disagree!
"Agree! "Strongly"
agree"
 
 
 
 
 
6. The am satisfied with the decision I made for prenatal screening for chromosome 
problems with my baby. 
 
"Strongly"
disagree!
"Disagree! "Neither"
agree"nor"
disagree!
"Agree! "Strongly"
agree"
 
"
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Questions&to&Collect&Demographic&and&Obstetric&Data 
&
This&part&of&the&survey&is&to&learn&background&information&about&you&and&your&
obstetric&history.&
& &
DIRECTIONS:&Please"fill"in"the"blank"or"circle"the"number"of"your"answer.&
&
"
1.""""""Please"state"your"age"in"years."""""""""""""""""""""""""""""""""""""""""""""""""""_____years"
""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""
"
2.""""""What"is"the"highest"grade"you"have"completed?""""""""""
""""""""""""""""a."Less"than"High"School"Diploma""
""""""""""""""""b."High"School"Diploma"or"GE"
""""""""""""""""c."Some"college"
""""""""""""""""d."Associate"or"Bachelor’s"degree""""""""""""
""""""""""""""""e."Graduate"degree"
"
3.""""""Which"of"these"groups"best"represents"your"race"or"national"ethnicity?""""""""""""""""""
"""""""""""""""""a.""American"Indian/"Alaska"Native""""""""""""""""""""""""""""""""
"""""""""""b.""Asian"
"""""""""""""""""c.""African"American"
"""""""""""""""""d.""Caucasian/"White"(not"Hispanic)"
"""""""""""""""""e.""Hispanic/"Latino"
"""""""""""""""""f."""Hawaiian"Native/"Pacific"Islander"
"""""""""""""""""e.""Other_______________"(fill"in)""
&
&
DIRECTIONS:&Please&&fill&in&the&blanks&or&select&your&answer.&&&
Please&give&details&for&“If&Yes”&answer&below.&
&
4."""""""Are"you"currently"pregnant?""""""Yes"""""No""""""Not"Sure"
"
&&&&&&&&&&If&Yes,&continue&to&question&5.&&If&no:&Skip&to&question&10.&
"
5."""""""How"many"weeks"pregnant"are"you?""________"
"
6."""""""Have"you"been"told"by"your"health"care"provider"that"an"ultrasound"done"for"this"
pregnancy"shows"that"your"unborn"child"might"have"a"chromosome"problem?"""""""""""
" Yes""""""No"""""Not"Sure"
""""""""
"
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7."""""""" For"this"pregnancy,"were"you"offered"a"screen"to"see"if"your"baby"might"have"a"
chromosome"problem?""""""""""""
" " " Yes""""""""No""""""""Not"Sure"""
"
&&&&&&&&&&& If&Yes,&continue&to&question&8.&&If&no:&Skip&to&question&9.&
"
"
8." " " How"was"the"information"about"the"screen"given"to"you?"""
" " " Verbal/Oral" Written""(pamphlet)" """Discussion"" Not"Sure"
"
"
9."""""""" For"this"pregnancy,"have"you"had"a"screen"to"see"if"your"baby"has"a""""""""""
chromosome"problem?"""""""""" " "
" " " Yes"""""No""""""Not"Sure"
"
"
10.""""""""How"many"times"have"you"been"pregnant?"""
""""""""""""(including"your"current"pregnancy,"if"you""are"pregnant)?"""________"
"
"
11."""""""How"many"pregnancies"have"you"completed"through"20"weeks?"________"
"
"
12."" How"many"children"have"you"given"birth"to?""_______"
"
"
13."" How"would"you"describe"your"experience"or"contact"with"individuals"with"
disabilities?"
"
" Little"or"none"at"all" " Some"" " Above"average" Frequent
"
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APPENDIX F 
 
HLQ LICENSE AGREEMENT 
 
 
HLQ Licence Agreement Parties 
Deakin University 
ABN 56 721 584 203 
a body politic and corporate established pursuant to the Deakin University Act 2009 (Vic) of Locked Bag 20000, 1 
Gheringhap Street, Geelong, Victoria, 3220 
(Deakin) 
The party identified in item 1 of the Schedule 
(Licensee) 
 
Background 
 
Deakin and Monash University own the Health Literacy  Questionnaire (HLQ). 
 
Deakin administers licences to the HLQ on behalf of the owners. 
 
The Licensee seeks to obtain a licence to use HLQ for the Approved Purposes and Deakin has agreed to provide a licence 
in respect of HLQ (Licence) to the Licensee on the terms and conditions of this Agreement. 
 
Agreement 
 
Definitions and Interpretation 
Definitions 
In this Agreement: 
 
Approved Purposes means the purposes described in Item 3 of the Schedule. 
 
Commencement Date means 14 days following the date on which the last of the parties signs this Agreement. 
 
HLQ means the health literacy questionnaire developed by Richard Osborne, Rachelle Buchbinder, Gerald Elsworth and 
Roy Batterham and more fully described at "The  grounded 
. psychometric development and initial validation of the Health Literacy Questionnaire (HLQ)" BMC 
Public Health 2013, 13:658. 
 
Intellectual  Property  in respect of HLQ means any and all statutory and other proprietary rights in respect of HLQ 
recognised at common law, or laws relating to trademarks, patents, circuit  layout, copyrights, designs, confidential 
information, know how and all other rights with respect to Intellectual Property as defined in article 2 of the July 1967 
Convention establishing the World Intellectual Property Organisation. 
 
Licence Fee means the fee payable by the Licensee to Deakin during the Term in consideration for the grant of licence 
to use HLQ. The Licence Fee is set out in Item 2 of the Schedule. 
 
Term means the period identified in Item 4 of the Schedule, which commences on the Commencement Date. 
Territory means the territory in which the Licensee Is licensed to administer and supply HLQ as identified in Item 5 of 
the Schedule. 
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Interpretation 
 
In this Agreement, unless the context requires otherwise, a reference to: 
 
a clause or schedule, is a reference to a clause of or schedule to this Agreement; 
 
'this Agreement' includes any schedules and attachments to this Agreement; 
 
a document or agreement, including this Agreement, includes a reference to that document or agreement as novated, 
altered or replaced from time to time; 
 
a person, includes a partnership, joint venture, unincorporated association, corporation and a government or statutory 
body or authority; 
 
'dollars' or'$' is a reference to Australian dollars; 
 
a business day means a day other than a Saturday or Sunday on which banks are open for.business in Melbourne, 
Victoria and if the day on which a thing is to be done under this Agreement is not a business day, it must be done on the 
next business day; 
 
any law or legislation includes any statutory modification or amendment of that law or legislation and any subordinate 
legislation or regulations made under that law or legislation; 
 
writing includes typewriting, printing, photocopying and any other method of representing words, figures or symbols in 
a permanent visible form; 
 
the word 'include' or 'including' is to be interpreted without limitation; 
 
0) the singular includes the plural and the plural includes the singular; and 
 
(k) a gender includes all genders. 
 
. 1.3 If a word or phrase is given a defined meaning, other grammatical forms of that 
word or phrase have a corresponding meaning. 
 
Headings are for reference only and do not affect the meaning of this Agreement. 
 
This Agreement may not be interpreted adversely to a party only because that party was responsible for preparing it. 
 
 
Licence 
 
Deakin grants to the Licensee a non-exclusive, non-transferable, revocable licence (excluding any right of sub-
licence) to use, reproduce and communicate HLQ for the Approved Purposes in the Territory and for the Term, 
subject to the terms and conditions of this Agreement. 
 
If provided in Item 6 of Schedule 1, Deakin grants to the Licensee the right to use the HLQ to prepare and produce a 
cultural adaptation and/or translation of the HLQ into the language identified in Item 6 of Schedule 1 (Translation)  
subject to the following  conditions: 
 
Licensee must undertake the cultural adaptation and/or translation of the HLQ only in accordance with the Translation 
and Cultural adaptation procedure attached as Annexure A; 
 
"
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Licensee must provide a copy of the forward and backward translations to Deakin for approval at least 60 days before 
Licensee proposes to administer the HLQ (Administration Date) to allow sufficient time for review of documents by 
Deakin, preparation of the provisional final translation of the HLQ, local validation, and finalisation as described in 
Annexure A; 
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Deakin will own all Intellectual Property rights in the Translation and the Licensee assigns such rights to Deakin upon 
their creation. 
 
If, with Deakin's prior consent, the Licensee engages a third party to prepare the Translation, such third party must 
assign to Deakin in writing all Intellectual Property rights in the Translation. Deakin is entitled to approve the contents 
of the agreement between the Licensee and third party translator as a condition of providing its consent pursuant to this 
clause 2.2(d). 
 
The Licensee acknowledges  that it may not disclose,  use, reproduce,  communicate  or exploit or permit such 
disclosure, use, reproduction or communication  of HLQ  for any purpose  other than the Approved Purposes, or in any 
jurisdiction other than the Territory, unless otherwise agreed  in writing with Deakin. · 
Licence Fee 
 
In consideration for the grant of the Licence for the Term, the Licensee will pay to Deakin the Licence Fee at the times 
and in the manner set out in Item 2 of the Schedule. 
 
If the Licence Fee is specified in Item 2 of the Schedule as payable annually then, subject to clause 3.3, it must be paid 
annually in advance in each year of the Term. The first payment must be paid on or before the Commencement Date, 
and thereafter must be paid on or before each anniversary date of the Commencement Date during the Term. 
 
By agreement with Deakin, the Licensee may pay the Licence Fee payable for each year of the Term in a single payment 
which must be made on or before the Commencement Date. 
 
Deakin reserves the right to revi.se the Licence Fee for 
 
any use of HLQ in excess of the number of implementations specified in the Approved Purpose; or 
 
any subsequent extension of this Licence Agreement. 
 
 
Obligations  of Licensee 
 
The  Licensee must: 
 
ensure that HLQ is used only for the Approved  Purposes; 
 
reproduce  and communicate  HLQ only for the Approved Purposes: 
 
unless permission is granted in Item 6 of Schedule 1, not modify or translate HLQ, without the express written approval  
of Deakin; 
 
The  Licensee  will itself administer  HLQ.   The Licensee  acknowledges  and agrees that  it must implement HLQ in a 
manner that ensures  the monitoring, calculation  and reporting  by the Licensee of usage of HLQ, and that may (at the 
sole discretion  of Deakin)  be readily audited  by Deakin. 
 
other than as provided by clause 2.2 , the Licensee must not, and must not allow or cause any other person to: 
 
print, copy,  reproduce  or communicate  HLQ by any means  or in any form; 
"
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give, lease, assign, license, sub-license, transfer, distribute, disclose, disseminate  or publish HLQ in any form to any 
other person or attempt to do any  of these acts without the written authority of Deakin; 
 
reverse  engineer  or decompile HLQ; or 
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alter, change, remove or obscure any notices or other indications (including copyright notices) as to ownership of  HLQ. 
 
The Licencee must provide to Deakin 
 
a de-identified copy of the data in a locked Excel or other standard database agreed with Deakin; and 
additional non-identifying information about the person to whom the HLQ was administered as determined in consultation 
with Deakin. 
 
Intellectual Property 
 
The Licensee agrees that all Intellectual Property in HLQ, and any content and/or documentation that accompany and/or 
are made available through HLQ, and in any modifications, new versions or enhancements to HLQ (whether authorised 
or unauthorised) belongs to Deakin, and that the only rights the Licensee has in HLQ are those granted to it under  this 
Agreement. 
 
The  Licensee  agrees  that  if  any  modifications  (whether  authorised   or  unauthorised) are made to HLQ by or 
on behalf of the Licensee or as a consequence of the Licensee's use of HLQ, including cultural adaptations and/or 
translations as set out in clause 2.2, all Intellectual Property in such modifications must be assigned to Deakin, and 
the Licensee will do all things reasonably necessary (including the execution of documentation) to effect such 
assignment upon request by Deakin. 
 
 
Warranties  and Limitation of Liability 
 
The Licensee agrees that, to the extent permitted by Australian law, all warranties (including implied warranties), other 
than express warranties given in this Agreement, in respect of the subject matter of this Agreement  are excluded  and of 
no effect.  Where the exclusion  of a given implied warranty would be void or unenforceable, the Licensee agrees that 
Deakin's liability. for a breach of such warranty will be limited, at Deakin's discretion to the re-supply of HLQ  or the 
payment  of the cost of the re-supply of HLQ. 
 
For the avoidance of doubt, the-Licensee agrees that it uses HLQ entirely at its own risk, and Deakin does not warrant 
that HLQ is suitable  for any particular purpose, that HLQ  will function or perform in a particular manner, or that the 
Licensee will derive any particular  result  or outcome from its use of  HLQ. 
 
The Licensee agrees that Deakin's aggregate liability for all causes of action against Deakin, whether contractual, 
tortious or otherwise,  will not exceed the aggregate  of Licence Fees paid by the Licensee  as at the date on which the 
first  such cause of action  arose.   Deakin  will not be liable to the Licensee for any indirect or consequential losses, 
damages, costs and/or expenses  incurred  or sustained  by the Licensee under,  or as a result of exercising  rights  in, this 
Agreement  (including  as a result of any negligence  by  Deakin),  and in particular  will not be liable for any loss of 
revenue or profits, loss of data, loss of goodwill or failure to realise an anticipated  saving or benefit. 
 
The  Licensee  agrees to indemnify  Deakin  from and against  liability and all loss and damage of any kind whatsoever 
caused  directly  or indirectly  by any claim or action against Deakin arising directly or indirectly out of the Licensee's 
use of HLQ  or any breach by the Licensee of the terms  and conditions  of this Agreement. 
 
Termination 
Deakin may terminate this Agreement immediately by giving written notice of termination  to the Licensee  if the 
Licensee: 
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breaches its obligations in respect of this Agreement and fails to remedy such breach within 14 days of receiving a 
notice from Deakin specifying the breach, and requesting its rectification; or 
 
fails to pay Licence Fees payable under this Agreement within 30 days of invoice by Deakin, 
 
The Licensee may terminate this Agreement on 30 days' notice to Deakin. Termination by the Licensee under this 
clause 7.2 will not attract any obligation for Deakin to reimburse the Licensee any Licence Fees paid by the 
Licensee to the date of termination. 
 
Upon termination of this Agreement, all licences granted under this Agreement terminate, and th  Licensee must 
immediately cease all use of HLQ. 
 
Termination, completion or expiry of this Agreement for any reason shall not extinguish or otherwise affect: 
 
any rights of either  party against  the other which: 
 
accrued prior to the time of the termination; or 
 
otherwise relate to or may arise at any future time from any breach or non  observance of obligations  under this 
Agreement  which  arose prior to the time of the termination,  completion  or expiry; or 
 
the provisions of this Agreement, which by their nature survive termination (including clauses 4, 5, 6, 7.3 and 8). 
 
Confidentiality 
 
The Licensee undertakes to keep secret and protect the confidential nature of all 
information and documentation provided. to it, learnt by it or to which it has or has 
had access, arising out of or in connection with any aspect of the negotiation or 
performance of this Agreement including,without  limitation,  the   terms   of  this   
Licence   Agreement,  the 
Licence Fee, and any source code  and object  code for HLQ  ("Confidential 
Information"). To this end the Licensee must not use, disclose or in any way 
communicate to any other person the details of any Confidential Information 
without the prior written consent of Deakin. 
GST 
 
Unless otherwise expressly stated, all consideration to be provided under this Agreement is exclusive of GST. 
 
If GST is imposed on any supply made under this Agreement, unless the consideration for that supply is specifically 
described in this Agreement as 'GST inclusive', the recipient of the taxable supply must pay to the supplier an additional 
amount equal to the GST payable on the taxable supply. Subject to the recipient receiving a tax invoice in respect of the 
supply, payment of the GST must be made at the same time as payment for the taxable supply. 
 
If this Agreement requires a party to pay for, reimburse or contribute to any expense, loss or outgoing of another party, 
and that other party can obtain an input tax credit on an acquisition associated with the expense, loss or outgoing, the 
amount required to be paid, reimbursed or contributed by the first party will be the amount of the expense, loss or 
outgoing reduced by the amount of that input tax credit. The reduction is to be made before any increase for GST under 
clause 9.2. 
 
Terms used in this clause 9 have the meaning given to them in the A New tax System (Goods and Services Tax) Act 1999 
(Cth). 
D 
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Notices 
 
A notice, demand, consent or other communication (Notice) given to a party under this Agreement is only effective if it 
is in writing delivered or sent by prepaid post to that party at its address set out in this Agreement. 
Subject to clause 10.3 a Notice given for any purpose under this Agreement is taken to be received: 
 
if hand delivered, on delivery; 
if sent by prepaid post, three (or in the case of a Notice sent to another country, nine) business days after the date of 
posting; 
 
If any Notice is given on a day that is not a business day or after 5.00pm on a business day in the place of business of the 
receiving party, it is to be treated as having been given at the beginning of the next business day. 
 
If a party gives the other party three business days' notice of a change of its address a Notice is only effective if it is 
given to that party at the latest address. 
 
Dispute Resolution 
 
Where there is a dispute concerning this Agreement, a party alleging the dispute must serve on the other party a notice 
setting out the details of the dispute. 
 
On receipt of a notice under clause 11.1 senior officers representing each of the parties must meet within five business 
days and, acting reasonably and in good faith, do their best to resolve the dispute through negotiation. 
 
Neither party may commence any court proceedings (except for applications for urgent injunctive relief) for a period of 
20 days after the meeting referred to in clause 11.2. 
Miscellaneous 
Entire Agreement 
This Agreement constitutes the entire agreement between the parties as to its subject matter. It supersedes all prior 
understandings or agreements between the parties and any prior condition, warranty, indemnity or representation 
imposed, given or made by a party in connection with that subject matter. 
Variation 
This Agreement may only be altered or varied in writing signed by each of the parties. 
 
Waiver 
 
A waiver of any right under this Agreement must be in writing signed by the party granting it. A waiver is only effective 
in relation to the particular obligation or breach for which it is given.  It is not to be taken as an implied waiver of any 
other obligation or breach or an implied waiver of that obligation on any other occasion. 
 
The fact that a party fails to do, or delays in doing, something the party is entitled to do under this Agreement does not 
amount to a waiver. 
Assignments and Transfers 
 
A party must not assign or transfer any of its rights or obligations under this Agreement without the prior written 
consent of the other party. 
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Part or all of any clause of this Agreement  that is illegal or unenforceable  in any jurisdiction will be severed in the 
relevant  jurisdiction and the remaining provisions of this Agreement  will continue in force. The legality or 
enforceability of the provision in any other jurisdiction will not be affected. 
 
Costs 
 
Except as otherwise set out in this Agreement,  each party must pay its own costs and expenses in relation to preparing, 
negotiating, executing and completing this Agreement and any document related to this Agreement. 
 
Execution of Separate Documents 
, •'i   .1.i. >('! ,·1\· -.;·:   , ... · 
This Agreetiientiis properly executed when; 
;:  ,·.••   :: .;' _ ,'·    I ; .       , .:  .•;  '/'; 
each party executes this document; or 
 
if the parties execute separate but identical documents, when those separately executed documents are exchanged 
between the parties, including by mail, facsimile transmission or electronically. 
 
Governing Law · 
 
This Agreement is governed by the laws of the State of Victoria. 
 
 
 
 
 
"
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Schedule 1  
Licence Number: L1624IF 
Item 1 – The Licensee 
(Parties) 
 
Name: The University of North Carolina at Greensboro 
Address: UNCG School of Nursing, PO Box 26170, 
Greensboro, NC 27402-6170 USA 
Authorised Officer: Dr. Heidi Krowchuk 
Tel: (336) 334-4899 
Email: heidi_krowchuk@uncg.edu 
Item 2 – Licence Fee Waived (for the duration of the term) 
 
Item 3 – Approved Purpose 
 
Purpose: Use of the English HLQ for the project 
“Influences on Women’s Decision-Making 
Concerning Prenatal Screening” 
Number of Authorised 
Implementations: 
 
112 
 
Item 4 – Term of Licence 
 
Start Date: 24th June 2016 
End Date: 31st December 2017 
 
Item 5 – Territory 
 
USA 
 
Item 6 – Cultural Adaptation and/or Translation Rights 
 The Licensee does not have a right to prepare or 
obtain a cultural adaptation of the HLQ 
 The Licensee does not have a right to obtain a 
translation of the HLQ 
 
